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INTRODUCTION 
Sepsis continues to be a clinical problem with metabolic and 
cardiovascular complications (232). Mortality from septic shock has 
remained near 50% for the last 20 years in spite of the use of 
antibiotics and advances in critical care medicine (250,278,290). 
Gram-negative bacteria are responsible for the vast majority of septic 
shock cases in adults (437). Endotoxin derived from the outer cell 
wall of Gram-negative bacilli produces symptoms similar to those 
observed in septic shock when it is injected into animals (232,437). 
These symptoms include fever, reduced blood pressure and altered 
levels of plasma metabolites (232,250). However, the onset of these 
symptoms is generally earlier and the magnitude and duration of 
symptoms may vary from those observed in a clinical situation (419). 
In this study, a bacteremic model of sepsis was adopted which produces 
symptoms of septic shock over a longer interval of time than 
endotoxin. Although the bacteremic model may not completely duplicate 
the conditions found in humans, it provides another animal model that 
can be used to investigate the spectrum of problems which develop 
during sepsis and septic shock. 
Metabolic changes observed during sepsis include alterations in 
carbohydrate, protein and lipid metabolism (232,290). A common 
feature of most animal models of septic shock is an initial hyper-
glycemia followed by hypoglycemia and accompanied by increased glucose 
1 
utilization (101,429). However, septic patients challenged with an 
oral glucose load are unable to respond to the glucose challenge with 
adequate stimulation of peripheral glucose utilization (175,235). 
Alterations in skeletal muscle metabolism during sepsis could 
contribute significantly to changes in total peripheral glucose 
utilization. To date, studies have shown that though basal muscle 
glucose utilization is increased (420), insulin-stimulated muscle 
glucose utilization is often depressed in the septic state (324,325). 
Alterations in glucose utilization may be due to changes in the rate-
limiting steps of glycolysis, viz. glucose transport, hexokinase, 
phosphofructokinase and pyruvate dehydrogenase (PDH). Previous 
studies have shown alterations in basal and insulin-dependent PDH 
activity during sepsis (337,397). Changes in the membrane sugar 
carrier could also account for sepsis-induced alterations in glucose 
utilization. A major objective of this dissertation was to determine 
whether basal and insulin-mediated glucose transport were altered in 
skeletal muscles from bacteremic and endotoxic rats. 
2 
The intracellular signals responsible for modulating glucose 
transport remain unresolved. Several investigators have proposed that 
elevation of intracellular ca2+ plays a role in mobilizing the glucose 
carrier from the cytosol into the plasma membrane (28,85,196,369). 
Therefore, the altered cellular ca2+ regulation observed during 
endotoxic shock (122,272,348,350) and presumably in septic shock, may 
contribute to changes in glucose transport. Hepatocytes from 
endotoxic animals have elevations in both free and exchangeable 
intracellular Ca2+ (348,350). In addition, agonist-stimulated ca2+ 
3 
release from the endoplasmic reticulum (ER) was attenuated in these 
(272) Cellular exchangeable (ca2+] increased in skeletal hepatocytes · 
muscle from rats exposed to endotoxin (122). The increased 
intracellular ca2+ in muscle may result from alterations in ca2+ 
movements across the sarcolemmal membrane, sarcoplasmic reticulum (SR) 
and/or mitochondria. Thus, a second objective of this study was to 
determine whether Ca 2+ regulation is altered in skeletal muscles from 
bacteremic rats. 
The increased cytoplasmic (ca2+] and attenuated release of ca2+ 
from ER in hepatocytes were prevented by administering ca2+ channel 
antagonists along with the endotoxin (272,350). Increased exchange-
able (Ca2+] observed in skeletal muscles from endotoxic rats also was 
reduced when ca2+ blockers were coadministered with endotoxin (122). 
These data suggest that ca2+ channels in liver and skeletal muscle 
plasma membranes may contribute to the changes in cellular (Ca2+). In 
this study, experiments were done to determine whether these ca2+ 
antagonists could prevent alterations in basal and insulin-mediated 
glucose transport and ca2+ regulation in skeletal muscles from 
bacteremic rats. An additional portion of this study assessed the 
ability of ca+ modifying agents to reproduce the changes in glucose 
transport observed in bacteremic rats. These two approaches provided 
evidence that altered ca2+ regulation contributed to changes in 
skeletal muscle glucose transport during bacteremia. 
A review of the literature concerning the various topics of this 
dissertation as well as the results of the experimental studies and 
their discussions are presented in chapters 1 through 7. The studies 
4 
which characterized the changes in basal and insulin-mediated glucose 
transport in skeletal muscle during bacteremia are presented in 
chapters 2 and 3. Skeletal muscle ca2+ regulation was assessed in the 
study presented in chapter 4. Experiments described in chapters 5 and 
6 were designed to determine whether addition of ca2+-modifying agents 
to control muscles could reproduce the changes in glucose transport 
observed in muscles from bacteremic rats. The ability of ca2+ channel 
antagonists to prevent the changes in skeletal muscle glucose 
transport during bacteremia was examined in chapter 7. Chapter 8 
contains the overall conclusions drawn from the experimental data. In 
Chapter 9, the event(s) leading up to altered glucose transport and 
the subsequent ramifications of changes in skeletal muscle 
carbohydr~te metabolism during septic shock are discussed. 
CHAPTER I 
LITERATURE REVIEW 
A. ANIMAL MODELS OF SEPTIC SHOCK 
Sepsis in humans may progress into shock which is characterized 
by: 1) the development of an inadequate utilization of metabolic 
substrates and 2) a diminished supply of blood to peripheral tissues 
(290). Several animal models have been developed to study the 
metabolism and cardiovascular changes found in sepsis and septic 
shock. Early studies indicated that bacterial infections could 
produce a shock state when bacteria were destroyed and components of 
the bacteria were subsequently released into the bloodstream where 
they acted as antigens to stimulate the reticule-endothelial system 
(RES) (232). The resulting "hypersensitivity'' response was believed 
to account for the clinical symptoms of shock (232). Investigators 
eventually established that many of the symptoms associated with 
septic shock could be reproduced by injecting endotoxin (192,232,295). 
Endotoxin is composed of lipopolysaccharide (LPS) and associated 
protein from the bacterial cell wall of Gram-negative bacteria (295). 
Lipopolysaccharide is composed of a lipid A region containing 
pyrophosphate plus long chain fatty acids which are linked to 
diglucosamine; an R core region of short chain sugars connected to 
diheptose and 2-keto-3-deoxyoctonoic acid (KDO); and an 0 side chain 
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which also is composed of sugars (295,376). Although the outer side 
chain polysaccharide provides antigenic specificity, many of the 
actions of endotoxin can be reproduced with the lipid A moiety of the 
LPS molecule (295,376). When injected into animals, endotoxin 
initiates rapid metabolic and cardiovascular changes (192,232,256,429) 
with a rapid onset of the hypodynamic and hypometabolic state and 
thus, is considered an acute model of septic shock. 
Studies of sepsis have established that many changes may not 
result directly from endotoxin (419). Instead, increased production 
of some hormones and the release of immunomodulatory mediators from 
the RES are responsible for many of the metabolic and hemodynamic 
alterations (192). In addition, investigators realized that sepsis is 
characterized by an initial hyper-hemodynamic (hyperdynamic) and 
hypermetabolic interval which may progress into a hypodynamic and 
hypometabolic state of shock. As a result there has been a need for 
animal models which more closely mimic this biphasic effect and 
subsequently, several models have been developed. One of these animal 
models is the injection of live Gram-negative bacteria into animals. 
Generally, the Gram-negative bacteria used in live bacterial models 
are Escherichia coli or Pseudomonas (97,168,319,364,437). Bacteria 
can be administered intravenously (iv), intraperitoneally (ip) or 
subcutaneously (sc)(419). Intravenous administration results in the 
acute onset of shock whereas ip and sc injections provide a focus of 
infection and sepsis develops over a more prolonged time period (419). 
However, the onset of shock in live bacteria models tends to be acute 
in comparison to the development of shock during human sepsis (419). 
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Clinical sepsis is often characterized by a focus of infection 
containing obligate anaerobes such as Bacteroides, as well as 
facultative anaerobes such as~- coli (422). Many times, the gut 
flora appear to be involved in the development of an infection. The 
animal models developed to more closely mimic these conditions include 
cecal ligation and subsequent puncture, followed by expression of the 
feces into the abdominal cavity (CLP); and implanted pellets 
containing known quantities of bacteria along with sterilized fecal 
material to act as an adjuvant to infection (419). An abdominal 
peritonitis develops in both of these models, and a chronic septic 
state is produced (419). Implanted pellets offer the advantage of 
using a known species and quantity of bacteria. In CLP, the bacterial 
load is not as easily quantitated but it is a less complicated way of 
inducing sepsis with a focus of infection. Although each model can be 
advantageous for specific research questions, the relevance and 
importance of a specific alteration depends on its presence in human 
sepsis and its contribution to the understanding of the septic process 
itself. 
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B. CARBOHYDRATE METABOLISM DURING SEPSIS AND SEPTIC SHOCK 
1) Plasma levels of sugars and related metabolites. 
Alterations in plasma sugar were documented as early as 1877 when 
Bernard observed increased blood sugar during hemorrhage (422). More 
recently, investigators have reported hyperglycemia followed by a 
progressive hypoglycemia in various models of sepsis and endotoxic 
shock (131,133). The time course and magnitude of change in plasma 
glucose depends on several factors including the model of sepsis 
studied (419), dietary state (134), and severity of the septic or 
endotoxic insult (256). Plasma lactate generally increases in both 
clinical and experimental sepsis and the severity of the septic insult 
often correlates with the magnitude of increase in plasma lactate 
(256). Hormones which regulate plasma glucose and carbohydrate 
metabolic processes also change with sepsis. In the initial stages of 
sepsis, plasma insulin increases or remains unchanged but as septic 
shock develops, insulin falls to very low values (97,133,168). 
Whether insulin alterations follow changes in plasma glucose levels or 
vice versa remains unclear (48). Macrophage derived mediators, which 
appear to have insulin-like effects are also released in response to 
injury and/or infection. Counterregulatory hormones such as glucagon 
(105), catecholamines (97,105,168,220) and glucocorticoids (105) and 
growth hormone (97) generally increase and remain elevated throughout 
the septic insult. 
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Early investigators utilized glucose and insulin tolerance tests 
to assess metabolic changes in plasma sugar levels and the associated 
metabolic hormones. Howard (199) studied Korean war casualties and 
reported findings from several critically injured patients including 
one septic patient. These patients exhibited elevated blood glucose 
levels compared to controls. They also developed much higher glucose 
values over a longer period of time when given an oral glucose 
tolerance test compared to control patients. An intravenous (iv) 
insulin injection (0.1 U/kg) resulted in a large decrease in blood 
glucose in control subjects and this decrease was attenuated in the 
severely injured patients which was attributed to insulin resistance 
in peripheral tissues (199). Ross et al. (333) interpreted these 
results as an indication of increased hepatic glycogenolysis and 
gluconeogenesis since glucose assimilation was not different in their 
own patients before and after surgery. Other earlier investigators 
(183) concluded that peripheral glucose utilization was decreased in 
some instances and unaltered in others although direct experimental 
evidence was not available. 
Clinical studies have focused more specifically on post-surgical 
septic patients (105). Blood glucose, hepatic glucose production and 
forearm glucose utilization were increased in septic patients compared 
to controls (175). An iv glucose injection produced results similar 
to those observed by Howard (175,199). In addition, Gump et al. (175) 
reported that iv glucose did not inhibit hepatic gluconeogenesis and 
did not adequately stimulate peripheral glucose utilization. Howard 
(199) had previously noted the similarity to diabetic states and 
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observed that the metabolic alterations could not be explained by 
decreased insulin production. Insulin secretion in response to the 
glucose was actually elevated in septic patients compared to controls 
(l75). In addition, subsequent studies in rats have shown that there 
is insulin hypersecretion during endotoxic shock (133,433). 
More recent clinical studies indicate that most septic patients 
are glucose intolerant but the metabolic profile may differ among 
patients. Dahn et al. (103) described one subset of patients which 
have elevated levels of glucagon, epinephrine, and growth hormone. 
This group responded appropriately to iv glucose with increased 
insulin and growth hormone as well as a tendency for glucagon to 
decrease or remain unchanged. A second subgroup responded to iv 
glucose with little or no change in insulin, glucagon or growth 
hormone despite elevated glucagon and epinephrine prior to glucose 
infusion. The later group exhibited elevated glucose clearance per 
unit of plasma insulin and increased hepatic glucose production under 
resting conditions (105,106) indicating alterations in both basal and 
insulin-mediated metabolism. These studies indicate that the changes 
in carbohydrate metabolism during sepsis are complex and the 
contribution of various organs and metabolic hormones to a particular 
plasma glucose level cannot be assessed from the experimental and 
clinical studies that have been reported to date. 
2) Kinetics of plasma glucose and related metabolites. 
Investigators have quantified production and utilization of glucose 
and other metabolites in vivo using slow constant infusions of 
radioisotope-labelled glucose in various models of sepsis and septic 
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shock. The rate of glucose appearance (Ra), rate of glucose 
disappearance (Rd), and the metabolic clearance rate (MCR) which 
normalizes Rd for changes in plasma glucose were calculated. Fasted 
dogs given a lethal dose of Escherichia coli endotoxin developed 
hyperglycemia during the first 60 min which progressed to hypoglycemia 
by 120 min (429,430). During hyperglycemia, Ra and Rd increased 
significantly but Rd exceeded Ra (430). Both Rd and Ra progressively 
decreased back near control levels by 180 min although Rd still 
exceeded Ra (429,430). The metabolic clearance rate remained elevated 
throughout the experiment (429,430) and the magnitude of the MCR 
increase appeared to be greater in nonsurviving dogs than in surviving 
dogs (430). Plasma lactate, lactate production and utilization also 
increased with this model (430). Much of the lactate utilized was 
found in the form of glucose indicating its use in gluconeogenesis. 
Similar results were observed in rats given lethal or sublethal doses 
of~. coli endotoxin (255,256). In addition, decreased insulin and a 
sustained increase in plasma glucagon were observed. These studies 
indicated that both increased hepatic gluconeogenesis and peripheral 
glucose utilization, independent of plasma glucose concentrations 
occurred with endotoxic shock. Other models of sepsis (361) as well 
as septic shock (428) have produced qualitatively similar results to 
those observed with endotoxin. Twenty four hrs after dogs were given 
a nonlethal dose of live ~. coli (1010 organisms) bacteria, they 
developed increased glucose clearance although plasma glucose and 
glucose production were unaltered (361). Guinea pigs given the same 
amount of bacteria (LD50) developed changes similar to those found in 
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rats and dogs given endotoxin (428). The hypoglycemia and progressive 
· R were not as severe in survivors compared to decrease in a 
nonsurvivors. In addition, the increase in glucose disappearance did 
not translate into increased glucose oxidation in survivors or 
nonsurvivors. Rats receiving a nonlethal intraperitoneal (ip) 
injection of ~. coli (total of 1011 organisms in 3 ip injections) and 
those exposed to cecal ligation and puncture (CLP) developed similar 
profiles (179,256). From these studies, the overall conclusion is 
that alterations in both glucose utilization and production occur 
during sepsis. However, the alterations depend on the length and 
magnitude of the insult and plasma glucose does not always indicate 
the presence of changes in its production or utilization. 
3) Skeletal muscle carbohydrate metabolism. Skeletal muscle 
could contribute significantly to the increased peripheral glucose 
utilization observed during sepsis. Normally, muscle consumes fatty 
acids but circulating hormones, mediators or ischemic related 
reductions in 02 utilization may cause muscle to switch to glucose for 
its energy needs (89,336). Furr et al. (147) examined the effect of 
endotoxin on glucose uptake in isolated forelimb of the dog. They 
were unable to observe any major increase in glucose uptake in 
denervated and innervated forelimb, in situ, in fasted dogs up to 4 
hrs after iv injection of 3 mg/kg ~. coli endotoxin despite increased 
vascular resistance and decreased arterial glucose delivery. However, 
diaphragms removed from fasted rats exhibited a 60-70% increase in 
basal glucose oxidation 3 hrs after Salmonella enteritidis endotoxin 
(iv) (132). Similar results were obtained in soleus muscles from 
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d ra~s subJ"ected to cecal ligation and puncture 16 to 24 hrs faste ~ 
prior to glucose uptake measurements, in vitro (420). Rats given b· 
£._oli (iv) endotoxin developed increased MCR and also showed increased 
glycolysis and glycogen synthesis in isolated epitrochlearis muscles 
at a time when cardiovascular and plasma metabolite changes were 
evident (13,256). 
Romanosky et al. (332) reported increased glucose uptake in the 
isolated, perfused hindlimbs of fasted, anesthetized dogs given 0.4 
mg/kg b· coli endotoxin. The increase in glucose utilization occurred 
at a time when hypoglycemia and hypoinsulinemia were present. 
Skeletal muscle blood flow was significantly diminished but oxygen 
consumption was unchanged so that 02 availability was not a cause of 
increased glucose utilization. Romanosky and coworkers (332) also 
reported increased lactate production by muscle in spite of the 
unchanged 02 consumption. Meszaros et al. (285) reported increased 
uptake and phosphorylation of 2-deoxyglucose (2DG) in gastrocnemius, 
quadriceps, abdominal muscle and diaphragm, in vivo, 3 hrs after b· 
coli endotoxin administration to conscious, fasted rats. The 
elevation persisted in quadriceps, abdominal muscle and diaphragm 24 
and 48 hrs after endotoxin administration. Basal glucose utilization 
in isolated epitrochlearis muscles, in vitro, increased 3 hrs after 
endotoxin was given as was total peripheral glucose utilization (285). 
Raymond et al. (326,327) did not find any changes in gracilis muscle 
glucose uptake in dogs given t. coli endotoxin (2 mg/kg) over 6 hrs 
when muscle blood flow was constant. However, they observed increased 
glucose uptake in the same muscle 4 to 6 hrs after infusion of live t. 
1 . nder constant flow conditions (326). Furthermore, endotoxin £.9 1 u 
d . tl into the muscle circulation for 5 min increased perfused irec y 
glucose uptake without changing 02 uptake, pH or temperature 
( 326,327). The authors concluded that the discrepancy in models was 
due to the rapid clearance of the iv endotoxin from the circulation 
and a constant release of endotoxin with the injection of bacteria 
(326,327). These studies indicated an increase in muscle glucose 
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utilization independent of plasma glucose at a time when muscle oxygen 
consumption was unaltered. Although decreased blood flow may 
contribute to the elevation of glucose uptake, the studies of Raymond 
et al. (326) showed an elevation even when blood flow was maintained 
at control values. Moreover, Meszaros et al. (285,287) indicated that 
glucose metabolic changes occurred even when endotoxic animal 
mortality was low. 
Insulin-mediated glucose uptake in skeletal muscle also was 
reported to change in various models of septic shock. ~ichterman et 
al. (420) performed in vitro studies on soleus muscles from CLP-
treated rats and reported similar responses in glucose utilization 
compared to controls. Insulin-mediated increases in glycolysis and 
glycogen synthesis were enhanced in epitrochlearis muscles from 
endotoxic rats compared to controls (13). The enhanced in vitro 
carbohydrate metabolic response to insulin in skeletal muscle is 
different from that observed in perfused gracilis muscle studies 
(324,325). Raymond et al. (324,325) reported a complete absence of 
glucose uptake response to insulin in pentobarbital anesthetized 
endotoxic and bacteremic dog gracilis muscles maintained under 
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cons tant flow conditions. 
Although the results of Raymond et al. 
( 324 ,325) support previous studies on glucose and insulin tolerance in 
. nts and in intact animals, the in vitro work suggests either that patie ~ ~~-
the surrounding milieu of nutrients caused the effect observed in vivo 
or that both enhanced and attenuated insulin-mediated glucose 
utilization can occur during the course of septic shock depending on 
the severity and time course of the model. 
4) Effectors of altered carbohydrate metabolism. Events and 
factors leading to the altered skeletal muscle carbohydrate metabolism 
remain controversial. Wichterman et al. (420) postulated that hypoxia 
or ischemia leading to hypoxia caused an increase in muscle glucose 
utilization presumably due to the shift in energy production from 
glucose oxidation to glycolysis. However other investigators 
(326,332) indicated that elevated glucose utilization occurred even 
when Oz consumption was unchanged from control values. The study of 
diaphragms from endotoxic rats indicated that glucose oxidation might 
be elevated rather than depressed (132). The idea that there may be 
an uncoupling of electron transport and ATP formation has yet to be 
ruled out. Increased body temperature also has been correlated with 
increased basal carbohydrate metabolism (191,256) but this was 
attributed to parallel or common events (256). In addition, several 
studies have shown alterations without observing changes in body and 
muscle temperature (326). Other investigators found that endotoxin 
directly activates glucose uptake (326) although similar changes in 
skeletal muscle metabolism occur with burn (301) or trauma (383) not 
associated with sepsis. 
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The alterations in circulating hormone levels have also been 
d t explain changes in skeletal muscle carbohydrate metabolism in use o 
septic states (47,48). Increased circulating levels of insulin during 
1.• 5 may explain an increase in the apparent basal carbohydrate seps , 
metabolism but not the attenuated response to glucose or insulin 
challenge. In addition, increased basal glucose metabolism has been 
observed in the absence of insulin (420). Elevations in 
counterregulatory hormones (20,103) such as catecholamines, glucagon 
and growth hormone have been used to explain altered metabolic states 
during sepsis. Bessey et al. (20,21) reported increased basal glucose 
utilization and attenuated glucose utilization during a euglycemic 
insulin clamp experiment in individuals given 25-30 ng/kg/min of 
epinephrine. However, Hargrove et al. (179) demonstrated that neither 
Q or fil adrenergic blockade prevented changes in glucose Rd, Ra or MCR 
in bacteremic rats. Glucagon alters carbohydrate metabolism but its 
primary site of action is on the liver and glucagon infusion has no 
effect on peripheral carbohydrate metabolism (21,320). Instead, 
Bessey et al. (21) have shown that infusion of epinephrine and 
cortisol can mimic many of the metabolic effects observed in septic 
patients. Glucocorticoid and growth hormone levels increase during 
sepsis (103,104) but their role in altering peripheral glucose 
metabolism is not known. Dahn et al. (104) found a lower mortality in 
septic patients which responded to a glucose challenge with increased 
growth hormone compared to nonresponding patients, suggesting that 
growth hormone may be important. 
Sepsis activates the release of macrophage-derived mediators 
such as monokines and these mediators have been shown to have 
bol ic effects (258,339,386). Glucose clearance time was reduced meta 
in rats given a glucose challenge along with 50-100 Units of IL-1 
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( 339). Tumor necrosis factor (TNF) also has been shown to have 
effects on metabolic hormones and plasma carbohydrate metabolite 
levels (286,386). However, other investigators (14,286) were unable 
to show that human rTNF (-10 7 units) altered peripheral glucose 
utilization after 3 hrs of TNF infusion in conscious rats. Lee et al. 
(258) examined the role of monokines in muscle carbohydrate 
metabolism. They found that murine rIL-la had no effect on 2-
deoxyglucose (2DG) transport while human rTNF increased 2DG transport 
(EC 5o=36 nM) in the L6 muscle cell line after 19 hrs. When cells were 
incubated with a crude monokine preparation, glucose transport was 
stimulated within 3 hrs. The experimental evidence indicates that 
monokines may mediate carbohydrate metabolism although their 
contribution to changes observed during septic shock are complex and 
not completely understood. 
18 
C. STUDIES OF SKELETAL MUSCLE SUGAR TRANSPORT 
1) Introduction. Membrane sugar transport has been studied 
since the early 1900s but it was not until the 1940's that 
investigators realized the importance of facilitated diffusion in 
metabolism (259). Early observations of the facilitated diffusion 
process indicated stereospecificity for sugars, saturability, 
temperature-sensitivity, and inhibitor specificity of facilitated 
transport (259). Facilitated diffusion is found in red blood cells 
(RBCs), placenta. liver, adipose tissue, as well as in cardiac and 
skeletal muscle (259). Much information about the facilitated glucose 
carrier protein has been obtained from studies on RBCs (218,259). It 
is now established that the glucose carrier consists of a 55 kDa 
glycoprotein found in electrophoretic band 4.5 of the RBC proteins 
(218). More recently, the glucose transporter gene has been localized 
to a -15 Kb fragment on fibroblast chromosome 1 (365). The transfer 
of sugar across the membrane through the carrier appears to conform to 
first order kinetics (421). The carrier transfers sugar in both 
directions although glucose is rapidly metabolized upon entering the 
cell so little if any moves out under physiological conditions 
(259,421). Although sugar transport in adipose tissue, cardiac and 
skeletal muscle is a facilitated carrier-mediated system, it is unlike 
the RBC carrier because it is insulin sensitive (233,259). 
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Skeletal muscle is considered to be metabolically important 
since it is the primary metabolic fuel consumer (304). Under 
physiological conditions, skeletal muscle utilizes fatty acids for 
most of its energy needs but carbohydrates become a primary energy 
source during stressful conditions (304). Skeletal muscle sugar 
transport is the rate-limiting step in glucose utilization (233) and 
insulin acts as the primary regulator of glucose transport and 
subsequent steps in glucose utilization (233,259). Thus, more recent 
studies have focused on factors regulating muscle sugar transport with 
major emphasis on mechanisms involved in insulin activation of sugar 
transport. Adipocyte sugar transport is similar to that of muscle 
(83,87,259) and many of the steps involved in insulin-activation of 
sugar transport have been determined in adipocytes and extrapolated to 
skeletal muscle. 
2) Techniques for sugar transport measurements. Several 
techniques are available to measure sugar transport. Since glucose is 
rapidly metabolized after being transported, most techniques 
capitalize on glucose analogs which are readily transported but not 
metabolized (259). Early studies (248,259) utilized the slowly 
metabolized sugar galactose but recent investigators have used non-
metabolizable 3-0-methylglucose (3MG), xylose, and 2-deoxy-D-glucose 
(2DG). 3MG is transported but not further metabolized and xylose is 
transported but poorly metabolized (259). When 2DG is transported it 
is phosphorylated to form 2-deoxy-glucose-6-phosphate (2DG6P) and 
under conditions where transport is rate-limiting, it can be measured 
to assess transport. In addition, cytochalasin b specifically 
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inhibits facilitated glucose transport (79,366). Transport kinetics 
lucos e 3MG and 2DG appear to be similar (60,189,233,246,298) for g ' ' 
although in some cases 2DG appeared to be metabolized (60). Recently 
D'Amore and Lo (102) proposed that 2DG and 3MG use two different 
glucose transport systems. The authors proposed that glucose and 2DG 
used two transport systems while 3MG used only one system. The system 
used by 2DG was affected by conditions which did not affect the 3MG 
system. Glucose controls were not performed to determine whether 
agents also altered glucose utilization. In addition, the agents 
which did not alter 3MG transport in the D'Amore and Lo study (102) 
have been shown to alter skeletal muscle 3MG transport in previous 
studies (80,85,245,246). The Ki reported for glucose and 3MG were 
similar to those reported in earlier studies on skeletal muscle 
(61,298). The results do not support the hypothesis that 2DG (not 
3MG) is the only analog which reflects changes in skeletal muscle 
glucose transport. 
The analog 2DG is most widely used to measure muscle sugar 
transport under in vivo conditions. Basal sugar transport can be 
obtained from fasted subjects when insulin is low and insulin 
stimulation of transport is measured after a bolus injection or during 
a constant infusion of insulin or glucose (197,198). The main 
advantage in using 2DG is that a unidirectional transport can be 
calculated from the rate of 2DG disappearance, the rate of 2DG6P 
appearance or the rate coefficient for the disappearance or 
appearance. However, care must be taken that degradation of 2DG6P by 
phosphatases does not enter into the measurement (368). Other 
t abolizable glucose analogs such as 3MG are not trapped in the nonme 
21 
cell . However, net uptake of 3MG into tissues in vivo was measurable 
. g radioisotopically labelled 3MG (297). In vivo accumulation 
us in 
within the cell is a measurement of the net flux. The Km for the 
transport of 3MG was 2.4 rnM in frog sartorius muscle (298) and 4.6 mM 
in barnacle muscle (60) with an apparent Km of 35 rnM for glucose 
uptake in rat soleus muscle (67). The EC50 of the glucose transport 
response for insulin is approximately 1-4 nM (162,262). 
The environment surrounding muscle tissue is better controlled 
under in vitro conditions. Therefore, much information about the 
regulation of glucose transport has come from in vitro studies. 
Recent studies have focused on isolated muscle groups such as soleus 
or epitrochlearis in which there are no torn fibers (13,67,245,246). 
Apparently, sugar transport in freshly isolated skeletal muscle cells 
has not been widely successful. Instead, cultured muscle cell lines 
such as the L6 or BC3H-l lines have been used to study transport 
(240,241). Uptake and efflux of hexose sugars have been studied in 
isolated muscles and cultured cell lines (62,124,240,245). The 
greatest success in measuring influx has been obtained with 2DG since 
it is transported and phosphorylated which prevents it from being 
transported out of cells and thus, linear uptake rates can be measured 
for a reasonable time period (233). Other analogs such as 3MG move 
out of cells such that a net uptake rate (using the radioisotopic 
method) is measured rather than a unidirectional influx (245,298). A 
general problem in studies of sugar influx into isolated, intact 
muscles has been that the time required for equilibration of sugar 
the media and interstitial space may be too long to permit 
between 
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. ·al influx measurements (246). In order to measure unidirectional 
in1t1 
Or t without the inclusion of a phosphorylation step and to transp 
eliminate the problems with extracellular equilibration, investigators 
have used efflux of radiolabelled sugar from preloaded muscles (246). 
The appearance of radioactivity in the media can then be used to 
calculate the rate and rate coefficient for the transport process. In 
addition, this technique offers the advantage of being able to measure 
basal and stimulated transport in the same muscle. Carruthers (60) 
found that transport was symmetrical in single barnacle muscle cells 
while Narahara and Ozand (298) found that transport was asymmetric in 
frog sartorius muscle. In rat skeletal muscle, the initial uptake and 
release of 3MG (uptake= 0.12 µmol/kg wet wt/rnM; efflux= 0.16 µmol/kg 
wet wt/mM) were similar indicating that transport was approximately 
symmetrical (245). 
3) Modulation of basal sugar transport. Basal sugar transport 
in skeletal muscle can be affected by physiological, pharmacological, 
and pathophysiological conditions. Physiological conditions which are 
known to alter basal sugar transport include dietary state, exercise 
and aging. Exercise (107,209,214,335,402) and contractile activity 
(317) are associated with increased basal glucose transport in 
skeletal muscle as measured in perfused hindlimb preparations 
(209,317) or in vitro (107,401). 
Dietary state has less of an effect on basal sugar transport but 
may modulate changes in transport in conjunction with other factors. 
Diet has been manipulated either with starvation or by changing the 
ratio of fat to carbohydrate consumption. Starvation caused reduced 
Ut ilization in human forearm (310) but had little effect on glucose 
utilization in perfused hindlimbs (19,42,163,335). In vivo glucose 
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ZDG uptake was markedly reduced in working muscles (208). In contrast 
starvation (42) increased basal glucose transport in isolated muscle. 
The decreased glucose utilization observed in vivo was possibly due to 
increased use of fatty acids and not glucose to meet energy demands 
(208) and related to changes in hormonal regulation of metabolism 
(304). Diets high in fat had little effect on glucose uptake in 
perfused rat hindlimbs (289) and had no detectable effect on glucose 
transport in isolated muscles or membranes (169,172). Glucose 
utilization appeared to decrease in isolated soleus muscles from rats 
given a high fat diet (172). Exercise-induced increases in glucose 
utilization and glucose transport were reduced moderately by a high 
fat diet and completely prevented with a high carbohydrate diet (436). 
High carbohydrate diets allow more rapid glycogen repletion than high 
fat diets but glycogen alone could not account for the dietary effect. 
Instead, diet appears to modulate recycling and membrane availability 
of glucose transporters (436). 
Skeletal muscle glucose utilization and transport activities 
change during growth and development and during the aging process. 
Basal glucose transport and utilization are at peak levels in juvenile 
rats (162,208) and decrease with aging in rats and elderly humans 
(135,163). The age-associated changes in skeletal muscle sugar 
transport and the effects of diet and exercise on transport suggest 
that several cellular modulators may regulate glucose transport. 
Several studies have determined how glucose transport is 
Ulated within cells. In these studies, agents which modify sugar reg 
transport are added to isolated muscles before or during transport 
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measurements (24-27,29,245,246). Since skeletal muscle and adipocyte 
glucose transport are similar, studies on isolated adipocytes have 
provided information relevant to muscle sugar transport. Hormones or 
mediators which affect cell metabolism have been used to determine 
whether they modulate glucose transport (29,126,245). Several 
investigators have focused on the effect of transmembrane Na+ and K+ 
gradients on sugar transport (25,27,28,246). Agents known to modify 
specific intracellular ions, metabolites or enzyme activities have 
been used to determine whether a coupling exists between cellular 
metabolic energy or metabolic pathways and sugar transport (80,248). 
Counterregulatory hormones may influence skeletal muscle glucose 
transport. Glucagon has no effect on skeletal muscle glucose 
utilization (320) and did not influence glucose transport in barnacle 
muscle fibers (15). Epinephrine is known to reduce peripheral glucose 
utilization in vivo (251). In perfused hindlimbs, epinephrine alone 
stimulated glucose uptake in a dose-dependent manner (75). Several 
investigators also have examined the effect of epinephrine on glucose 
transport. Bihler et al. (29) reported that low doses of epinephrine 
reduced basal glucose transport in rat hemidiaphragms while high doses 
stimulated transport. The low dose effects were blocked by the ~l 
antagonist practolol while the high dose effects were blocked with the 
~2 antagonist butoxamine. However, epinephrine inhibited glucose 
transport in rat soleus muscle (29). Other investigators found that 
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· activated hexokinase via a ~-adrenergic signal (15,75,213) 
epinephrine 
t affect skeletal muscle glucose transport. A third group but did no 
of investigators (86,323) found that ~-adrenergic stimulation of 
soleus muscle actually stimulated basal glucose transport. 
Epinephrine stimulated glucose transport in frog sartorius muscles 
( 391 ). These studies indicate that the ~-adrenergic signal initiated 
by epinephrine may have multiple actions which may depend on the 
length of exposure to epinephrine. Initial application of epinephrine 
may stimulate hexokinase to a point where glucose transport is no 
longer rate-limiting, and thus the increased transport observed by 
some investigators results from activation of hexokinase. Direct 
addition of cAMP to muscle inhibits glucose transport (15) which 
indicates that the inhibitory effects of epinephrine may be due to 
direct effects of cAMP-dependent protein kinase on glucose transport. 
Investigators also have shown that the second messenger cGMP stimulate 
glucose transport although the mechanism(s) involved and the 
physiological importance are unknown (15). 
Growth hormone and its associated mediators, insulin-like growth 
factors (IGF-1, IGF-II) also stimulate glucose transport in a manner 
similar to insulin and bind to specific receptors which activate many 
of the same cellular processes as does insulin. Although growth 
hormone has little direct effect on glucose transport (126), IGF-I 
(62,126) and IGF-II (126) stimulate skeletal muscle glucose transport 
via specific but separate receptors. IGF-I activates a membrane 
receptor with tyrosine kinase activity and appears to share an 
intracellular messenger system with insulin for activation of glucose 
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transport (126,438,440). Although IGF-I and insulin can bind to each 
other's membrane receptors in some organ systems (212), investigators 
have found that IGF-I and insulin do not work via binding to the 
other's membrane receptor in skeletal muscle (62,299,318). IGF-II 
also activates glucose transport although the receptor and cellular 
messenger system are unrelated to those of insulin and IGF-I (202). 
The transmembrane Na+ and K+ gradients can affect basal sugar 
transport in several skeletal muscles including soleus, diaphragm and 
extensor digitorum longus (EDL) (28,83,246). Reduction of the 
transmembrane Na+ gradient by equimolar substitution of extracellular 
Na+ ([Na+J 0 ) with Li+ (77,246) stimulates basal sugar transport. 
Reduction of [Na+] 0 by equimolar substitution with extracellular [K+] 
([K+] 0 ) stimulates glucose transport not only due to a low [Na+] 0 -
mediated increase carrier mediated transport, but also due to a 
nonspecific increase for glucose transport that was due to high [K+] 0 -
induced swelling. The Na+;K+ ATPase inhibitor ouabain also reduces 
transmembrane [Na+] gradients and is known to stimulate glucose 
transport (24,78,369). This effect is not immediate but may require 
up to 90 min of incubation before an increase in transport is 
detectable (245). Reduction of the Na+ gradient also can be achieved 
with the Na+ ionophore monensin (28) or with veratrine (369). When 
added to skeletal muscle, monensin and veratrine stimulate glucose 
transport immediately (28,369). However, Bihler and coworkers (28) 
observed that the transmembrane Na+ gradient did not directly 
influence glucose transport. Instead, accumulation of Na+ in the 
cellular compartment is thought to reduce Na+/ca2+ exchange across the 
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sarcolemma and intracellular organelles, which in turn results in 
increased intracellular Ca2+ ([Ca2+Ji) (28). According to this 
hypothesis, glucose transport is stimulated as [Ca 2+Ji accumulates 
which may account for the delayed increase in transport observed with 
agents such as ouabain. The cellular processes activated by a rise in 
[Ca2+li and which in turn activate glucose transport are not known. 
In contrast to the above studies, Kitasato and Marunaka (237) found 
that a portion of skeletal muscle glucose transport is Na+-dependent 
but its contribution to overall glucose transport was small. 
Addition of [K+] 0 is known to depolarize muscle cells and 
increase cellular respiration (227,307,395). As indicated above, 
equimolar substitution of [Na+] 0 with high [K+] 0 led to an increase in 
skeletal muscle glucose transport (246,391,444). Although this 
increase was attributed partly to high [K+] 0 -induced cellular swelling 
by Kohn and Clausen (246), Valant and Erlij (391) reported that K+-
induced increases in glucose transport were blocked by cytochalasin b 
(a specific blocker of glucose transport) which suggested a K+-
mediated increase in carrier-mediated transport. Valant and Erlij 
(391) also found that the enhanced glucose transport was prevented 
with dantrolene (an excitation-contraction coupling antagonist) which 
indicates that ca2+ release from the sarcoplasmic reticulum (SR) may 
be involved in the K+-induced stimulation of glucose transport. The 
increased respiration also is dependent on the depolarization induced 
release of ca2+ from the sarcoplasmic reticulum (SR) (395). In 
addition, the direct release of SR ca2+ by ryanodine stimulates 
cellular respiration (216,418). Other investigators have observed 
·ncreased (K+] 0 diminished basal glucose transport in skeletal that i 
le and the return of muscles to a low [K+] 0 media stimulated the muse 
transport process (24,27,79). 
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Several investigators have attempted to correlate ca2+ movements 
with changes in glucose transport (28,85,369), since changes in 
cellular (Ca2+] appear to mediate changes in glucose transport similar 
to those observed when transmembrane ion gradients (i.e. Na+,K+) are 
altered. Holloszy and Narahara (196) were first to propose that ca2+ 
may cause changes in skeletal muscle glucose transport. They found 
that 3MG transport in frog sartorius muscles progressively increased 
as extracellular (ca2+] ([Ca2+] 0 ) was increased in K+-depolarized 
muscles. Addition of [Ca 2+) 0 also enhanced the effects of cGMP on 
glucose transport (15). Other investigators have since expanded on 
these observation by measuring the effect of various agents on soleus 
muscle 3MG transport and 4 5ca2+ efflux or uptake (28,85,369). The 
agents tested include 2,4-dinitrophenol, hyperosmolar mannitol media, 
caffeine, A23187, insulin, vanadate, veratrine, trypsin, and p-
chloromercuribenzoic acid (PCMB) as well as electrical stimulation and 
sudden increases in temperature subsequent to a previous cooling 
(80,85,369). In these experiments, hexose transport and 4 5ca2+ efflux 
were stimulated within a similar time interval. Bihler and coworkers 
(28) found that monensin stimulated skeletal muscle glucose transport 
along with an increase in 4 5ca2+ uptake. These investigators 
(28,80,369) postulated that elevation of (Ca 2+Ji enhanced glucose 
transport. However, in these studies the magnitude of 45ca2+ flux did 
correlate with the magnitude of change in glucose 
not always 
transport. 
Other investigators attempted to change [Ca2+Ji directly to 
determine whether glucose transport was altered. When [Ca 2+Ji was 
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increased in dialyzed barnacle muscle fibers, glucose transport also 
was stimulated (15). Addition of the ca2+ chelator EDTA to media 
containing no added Ca2+ resulted in decreased basal glucose transport 
in soleus muscles when the incubation period extended beyond 30 min 
(164,439). Basal sugar transport was transiently stimulated during 
shorter exposure periods to EDTA (439) and EGTA had no effect on 
transport. The results of these experiments could not be explained by 
changed in cellular [Ca2+]. Instead, the stimulatory effect was 
attributed to the chelation of Mg2+ while the subsequent inhibitory 
effect was due to a decrease in ATP (439). 
Calcium ionophores also have produced variable effects on 
skeletal muscle glucose transport. The ionophore A23187 stimulated 
skeletal muscle 3MG efflux and increased [Ca2+] 0 enhanced the 
ionophore effect on transport (80). Bihler et al. (26) observed that 
high [A23187] (6-20 µM) stimulated glucose transport and 45ca2+ 
uptake, but smaller concentrations inhibited transport and 4 5ca2+ 
uptake in rat atria and hemidiaphragms. These results led the authors 
to conclude that A23187 may act on additional cellular processes. 
Other investigators either have observed no effect of A23187 on 
glucose transport (171,178,240) or a decrease in glucose transport 
(240). In addition, Hall et al. (178) observed that A23187 inhibited 
glucose transport when ca2+ and Mg2+ were not added to the incubation 
d ·a and this effect was reversed when Mg2+, but not Ca
2+ was added 
me i 
h dl.·a These results suggest that the ca2+ ionophore back to t e me . 
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A231 37 may affect other cellular processes and ions which can modulate 
glucose transport. 
The ionophores A23187 and ionomycin do have nonspecific effects 
(l70). Both A23187 (296) and ionomycin (291) cause cytoplasmic 
alkalinization and data from Klip et al. (242) suggests that 
alkalinization increases basal sugar transport. However, in 
fibroblasts ionophore-induced alkalinization results from ca2+-
dependent protein kinase C activation of Na+;H+ exchange (296). An 
increase in [Ca 2+Ji could act independently to activate glucose 
transport and cause cellular alkalinization. Both ionophores also 
have been shown to uncouple mitochondrial oxidative phosphorylation 
(149) which could deplete cellular ATP and perhaps stimulate glucose 
utilization. Baker and Carruthers (15) and Smith et al. (367) 
initially proposed that decreased [ATP] could increase basal sugar 
transport but Clausen (80) has cited several examples of elevated 
basal transport with maintenance of energy stores. Clausen (80) 
pointed out that A23187 affects Mg2+ transport and intracellular [K+] 
([K+]i), and Hall et al. (178) suggested that the primary effect of 
A23187 on sugar transport was related to Mg2+. Ionophore effects have 
also been attributed to the activation of other cellular processes. 
Recently, Drummond et al. (120) found A23187 increased protein 
synthesis in hamster fibroblasts without a change cytoplasmic free 
[Ca 2+J. Instead, A23187 depletion of [ca2+li stores was crucial to 
the effects on gene expression (120). SR (18) and mitochondria (226) 
dep leted of ca2+ by both ionophores and these changes could can be 
modulate sugar transport. 
31 
Although experiments with ionophores have not provided 
unequivocal evidence that Ca 2+i may be involved in regulating glucose 
transport, recent studies in adipocytes have provided somewhat more 
concrete evidence that changes in [Ca2+]i affect glucose transport. 
Pershadsingh et al. (312) found that glucose transport was stimulated 
by vanadate, phorbolester and concanavalin A. This stimulation was 
prevented in cells loaded with Quin-2AM, which presumably quenched the 
transient increase in [Ca2+li· In addition, insulin and sulfonylureas 
both increase cytosolic free [Ca 2+] in isolated adipocytes (117) and 
stimulate glucose transport (330). In addition, studies in 
fibroblasts (2,431), adipocytes (236) and cultured skeletal muscle 
(129,374) have shown that phorbol esters stimulate basal glucose 
transport. Phorbol esters activate protein kinase C activity (63) and 
this enzyme may be involved in modulating basal glucose transport 
activity (129). In one recent study, phorbol esters had minimal 
effects on glucose transport in half-solei and hemidiaphragms (370). 
However, the authors did not rule out the possibility that 
physiological activators of protein kinase C may stimulate glucose 
transport (370). 
Several types of stresses and pathophysiological conditions are 
associated with changes in skeletal muscle metabolism which can partly 
he attributed to alterations in basal glucose transport. Diabetes is 
associated with decreased skeletal muscle glucose transport (403,404) 
and transport can be restored to control values by administration of 
l ·n to diabetic animals (225,404). A decrease in muscle glucose inSU 1 
ort also is observed in genetic (96) and chemically-induced transp 
(Z0 3 ) obesity despite increases in plasma glucose and insulin levels 
(96,311). 
Removal of neuromuscular stimulation via limb immobilization, 
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muscle unloading or denervation results in a decrease in basal glucose 
utilization and transport (50,184,363). When limbs are subsequently 
allowed to move freely or are reloaded, these metabolic changes are 
quickly reversed (184,363). Other forms of limb immobilization are 
associated with increased basal glucose transport (363) which 
indicates that more than one cellular process may be affected. 
Exposure of animals to cold or to stresses such as anoxia, endotoxin, 
or burn injury may result in increased transport (67,248,285,388,392, 
442). However, in vivo measurements were made in some of these 
studies (285,388) and therefore, the changes in glucose transport may 
be due to alterations in insulin sensitivity. The signal(s) which 
stimulate glucose transport during anoxia and endotoxic shock require 
further investigation. The mechanism responsible for increased 
transport following burn injury also has not been elucidated although 
similar changes in burn and denervation suggest that interruption of 
nerve stimulation may contribute to these changes (388,389). 
4) Coupling between insulin binding and activation of glucose 
transport. In recent studies, investigators have examined the 
mechanisms which couple insulin binding to its receptor and the 
subsequent stimulation of glucose transport. Insulin binding to the 
Q-subunit (Mr 135 kDa) of the receptor stimulates tyrosine kinase 
. i·ty located on the ~-subunit (Mr 95 kDa) (315). The tyrosine 
activ 
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kinase autophosphorylates other tyrosine residues on the ~-subunit and 
further enhances tyrosine kinase activity. In addition, the ~-subunit 
tyrosine kinase phosphorylates cellular proteins including histone 2B 
and angiotensin II (51,309,315). The subsequent actions of the 
phosphorylated proteins/enzymes and their targets are not understood. 
Other cellular factors also are capable of modulating insulin receptor 
activity. Protein kinase C appears to phosphorylate serine residues 
on the ~-subunit and this results in attenuation of insulin-activated 
tyrosine kinase activity (33,380). Activation of cAMP-dependent 
protein kinase also phosphorylates serine residues on the insulin 
receptor which are believed to attenuate insulin receptor binding 
(66,315). In addition, cAMP-dependent protein kinase attenuates 
tyrosine kinase activity although the mechanism is not known 
(315,381). Vanadate activates the insulin receptor tyrosine kinase 
activity which is thought to occur via phosphorylation of serine 
residues on the ~-subunit (121,288,315,384). Recently, it has been 
shown that the receptor contains a calmodulin binding site (160,165). 
When insulin binds to its receptor, calmodulin dissociates from the 
plasma membrane ca2+_ATPase and binds to the ~-subunit of the insulin 
receptor (65,280,313,340). As a consequence of the calmodulin 
dissociation from the ATPase, ca2+ movement to the extracellular 
compartment decreases, resulting in a localized increase of cellular 
Ca 2+, which in turn is postulated to mediate some of insulin's actions 
(280). In addition to tyrosine kinase activity and the localized 
increase in [ca2+]i, insulin has recently been shown to stimulate the 
h sis of a novel glycophospholipid (230,275,341,342) which is synt e 
1 . ved to mediate some of insulin's intracellular actions. be 1e 
Ounds containing thioesters have also been proposed as mediators comp 
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of insulin's actions (176). In addition, recent reports suggest that 
thiol groups are important for insulin receptor kinase activity (423). 
Insulin is believed to mobilize intracellular glucose 
transporters into the membrane which increases the Vmax for glucose 
transport (366,410). However, some investigators report that insulin 
also modifies the Km for glucose transport by modifying the transport 
protein (79). The cellular messengers which stimulate insulin-
mediated glucose transport have not been elucidated. The time course 
of phospholipid synthesis indicates that it is not involved in 
mediating insulin stimulation of glucose transport (228). However, 
the actions of insulin tyrosine kinase (76,115,261) and/or increased 
localized (Ca 2+Ji (280) may be involved in stimulating glucose 
transport. Experimental regimens which modify insulin tyrosine kinase 
activity also alter insulin-mediated glucose transport (54,76,96,210, 
261) but the phosphorylated intermediate(s) which mobilizes glucose 
transporters into the membrane has not been isolated. These 
modifications may have parallel effects on tyrosine kinase and glucose 
transport which may not be a direct cause-effect relationship. The 
idea that insulin stimulates glucose transport via changes in (Ca2+li 
also has been subject to criticism. Insulin stimulates endoplasmic 
reticulum (ER)/SR 45ca2+ uptake (293) and the action of the ca2+ pump 
should reduce (ca2+li which indeed was observed by Baker and 
Carruthers in barnacle muscle fibers (15). Recent studies in 
d . cytes indicate that insulin transiently stimulates [ca
2+Ji when 
a ipo 
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cellular ca2+ is measured directly (118). In addition, [Ca 2+Ji within 
a specified range appears to be required for optimal stimulation of 
glucose transport by insulin (15,117). The transient change in 
[Ca2+Ji in response to insulin may not have been detectable using 
45ca2+ flux measurements. In addition, insulin may act to locally 
increase a change in [Ca2+Ji or may activate a ca2+_dependent protein 
or flux required for the stimulation of glucose transport. 
5) Modulation of insulin-mediated ~lucose transport. As with 
basal glucose transport, the insulin-mediated glucose transport 
response can be influenced by physiological, pharmacological and 
pathophysiological events within the muscle cell. Kahn (222) 
categorized the changes that can occur in insulin-mediated transport 
as those affecting insulin sensitivity or responsiveness. Sensitivity 
and responsiveness are determined using cellular responses (e.g. 
glucose transport) over a wide range of insulin concentrations, such 
that the maximal response has reached a plateau. Insulin sensitivity 
refers to the concentrations of insulin required to give a half 
maximal cellular response. Changes in sensitivity reflect changes in 
insulin receptor affinity (222). Responsiveness indicates the maximal 
response obtained with the higher concentrations of insulin and post-
insulin-receptor binding events are responsible for changes in 
responsiveness. Alterations in sensitivity and responsiveness can be 
attributed to binding and post-binding defects, respectively because 
insulin binding studies indicate that maximum insulin action occurs 
when only 10-20% of the receptors are occupied, the rest being "spare 
36 
receptors" (139). A decrease in the number of insulin receptors would 
affect sensitivity long before maximum responsiveness and when insulin 
responsiveness is affected, there are not necessarily changes in 
insulin receptor number (222). 
Exercise and diet, as well as the aging process have been shown 
to influence skeletal muscle insulin-mediated glucose transport. 
Exercise enhances the insulin response although the exercise effect is 
transient and returns to control levels between 24 and 48 hrs after 
the last bout of exercise (210). Several investigators report that 
skeletal muscle glucose uptake and glucose transport sensitivity to 
insulin are improved (34,115,411) which can be attributed to the 
increased insulin binding to skeletal muscle during exercise 
(34,115,411). In addition, the maximal responsiveness of glucose 
transport to insulin increases in response to exercise (107,317,402) 
indicating that post-insulin receptor binding events also may be 
altered by exercise. Cold exposure is a condition similar to exercise 
since it increases thermogenesis via muscle shivering (392) . Skeletal 
muscle from cold exposed rats develops an increased maximal insulin 
transport response which was postulated to result from a post-insulin 
binding effect (392). 
Dietary changes also influence insulin responsiveness and 
sensitivity. During starvation, the sensitivity and responsiveness of 
glucose uptake to insulin increases (42,163,335). In contrast, high 
fat diets have been shown to decrease the maximum insulin-mediated 
glucose transport response in skeletal muscle (169,172,271,289). 
Although the number of high affinity sites for insulin binding were 
reduced, maximum insulin binding was not affected (169). In 
adipocytes, the reduced responsiveness has been attributed to a 
reduction in the number of glucose transporters (195). 
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Goodman et al. (162) reported that the sensitivity and 
responsiveness of skeletal muscle glucose transport to insulin peaked 
in 4 week old rats and subsequently decreased with age. They 
postulated that the decrease in sensitivity resulted from a decrease 
in the number of receptors while the decreased responsiveness was 
attributed to a reduction in the total number of glucose transporters. 
In humans, glucose utilization also decreases and Fink et al. (135) 
have shown that Vmax decreases in adipocytes from elderly patients 
which indicates the number of glucose transporters is reduced. 
Many investigators have used a pharmacological approach to 
dissect and understand the cellular events involved between insulin 
binding and the stimulation of glucose transport (24,86,240,439). 
This type of approach also is helpful in determining whether 
circulating hormones, mediators, or factors may be responsible for 
alterations in insulin-mediated transport during physiological 
situations. As with studies on basal transport, the effect of ion 
gradients on glucose transport has been studied to determine whether 
Na+, K+, or ca2+ may be involved in the transduction process (15,24, 
79,86,118,237,246,439,444). More recent studies have focused on the 
role of cellular enzymes in transducing the insulin signal into an 
increase in glucose transport (68,236,370,380). Perhaps the most 
difficult problem in the area of insulin-mediated glucose transport 
has been to distinguish between agents which interrupt or accelerate 
specific steps in the insulin signaling pathway and agents which act 
on cellular mechanisms that modulate specific steps in the pathway. 
Cori and Cori (93) were the first to observe that epinephrine 
decreased glucose clearance. Studies in perfused hindlimbs 
subsequently demonstrated that the effect of epinephrine in vivo was 
due to its ability to suppress insulin-mediated glucose uptake 
(20,75,213). In skeletal muscle, epinephrine attenuates insulin-
mediated glucose transport by decreasing the sensitivity of the 
glucose transport response for insulin (49). These results are 
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similar to those observed in adipocytes (366) and more recent studies 
in adipocytes indicate that epinephrine acts on a ~-adrenergic 
receptor to stimulate cAMP-dependent protein kinase (66,366). The 
protein kinase inhibits insulin binding to plasma membranes which 
reduces insulin sensitivity (315). However, the mechanism may be 
different in muscle since Webster et al. (411) found that epinephrine 
enhanced insulin binding to soleus muscle. Instead, epinephrine may 
reduce insulin-mediated glucose transport by decreasing insulin 
receptor tyrosine kinase activity (381). The glucocorticoid 
dexamethasone also decreased the response of glucose transport (299) 
and glycogen synthesis to insulin but had no effect on insulin binding 
(260,299). Leighton et al. (260) postulated that the glucocorticoid 
acted on a cellular event required for insulin activation of glucose 
transport. Glucose itself has been shown to modulate insulin-mediated 
glucose transport (156,436). Glucose also modulates an insulin-
mediated increase in [Ca2+li in adipocytes (117). Although the 
mechanism involved is not known, it is possible that glucose affects 
insulin-mediated transport via its enhancement of the ca 2+ signal. 
Several studies have examined the role of transmembrane ion 
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gradients in modulating or acting as a signal for insulin stimulation 
of glucose transport. Clausen and coworkers (86,246) have found that 
replacement of Na+ with Li+, Tris or choline has no effect on insulin-
mediated glucose transport in skeletal muscle. In contrast, Bihler 
(24,25) observed that addition of ouabain or small reductions in 
extracellular [Na+] ([Na+] 0 ) enhanced insulin-stimulated (0.2 mU/ml) 
glucose transport. Larger reductions in [Na+] 0 attenuated insulin-
mediated transport (25). Since Kohn and Clausen (246) measured 
transport immediately after Na+ substitution and Bihler (25) measured 
transport several minutes after exposure of muscle to low [Na+] 0 or 
ouabain, it seems that the transmembrane [Na+] gradient effect on 
insulin-mediated glucose transport takes time to develop. Bihler (25) 
has suggested that the Na+ effects on insulin-mediated transport are 
mediated via changes in [Ca2+li· As with basal glucose transport, 
Kitasato and Marunaka (237) have proposed that a portion of insulin-
stimulated glucose transport is dependent on the Na+ gradient. They 
observed that as [Na+] 0 was reduced, a component of insulin-mediated 
3MG transport also was reduced in frog sartorius muscles. 
Other investigators have proposed that K+ or its effect on 
membrane potential modulates insulin stimulation of glucose transport 
(444). Clausen and Flatman (86) as well as Stark and O'Doherty (377) 
have challenged this hypothesis and found that insulin effects on 
glucose transport are unrelated to K+-induced changes in membrane 
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potential. In addition, attenuated insulin-mediated transport has 
been observed when [K+] 0 is substituted for [Na+J 0 but this effect 
results from cellular swelling and can be prevented with hyperosmolar 
media (246). Potassium appears to be an unlikely candidate to mediate 
the actions of insulin on glucose transport. 
As with studies concerned with regulation of basal glucose 
transport, many investigators have focused on the role that Ca2+ or 
ca2+_dependent activities may play in insulin stimulation of glucose 
transport. Removal of [Ca 2+] 0 or chelation of [Ca 2+] 0 by EDTA in the 
absence of [Ca 2+J 0 resulted in an attenuation of insulin-mediated 
sugar transport (15,25,164,439). As with basal transport, EDTA also 
transiently stimulates insulin-mediated xylose transport in soleus 
muscles which is followed by an attenuation of insulin-mediated 
transport (439). Insulin-mediated 2DG transport in L6 muscle cells 
also was stimulated by EGTA (240). The inhibitory effect of EDTA was 
partially due to a reduction in insulin receptor binding and was 
attributed to ATP depletion (439). Clausen et al. (80) measured 
45 ca2+ efflux during insulin stimulation of glucose transport and 
found that ca2+ efflux increased but other investigators have been 
unable to detect an increase in cytosolic free [Ca2+] during insulin 
stimulation in various muscle preparations (15,240). An increase in 
[Ca 2+Ji in response to insulin has been detected in isolated 
adipocytes (118). McDonald and Pershadsingh (280) have suggested that 
insulin may cause localized increases in [Ca2+li which were not 
detected with the earlier techniques. Other studies also suggest that 
Ca2+ may modulate the action of insulin on glucose transport (118). 
l
·onophore A23187, which increases ca2+ permeability, attenuated 
The 
insulin stimulation of glucose transport in rat hemidiaphragms (26). 
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caffeine had a similar effect on insulin stimulation of glucose 
transport in rat soleus muscles (80,171). The ionophore and caffeine 
h ave increased [Ca 2+li beyond the physiological range and thus, may 
prevented the generation of an intracellular ca2+ transient to 
modulate insulin stimulation of transport. 
Some reports suggest that activation of ca2+_dependent protein 
kinase C may modulate insulin-stimulation of glucose transport (236). 
Protein kinase C phosphorylates the insulin receptor on ~-subunit 
serine residues and reduces insulin-stimulated tyrosine kinase 
activity (33,380). This leads to an attenuation of insulin-stimulated 
glucose transport (68,236,370). In this manner, protein kinase C 
alters insulin responsiveness and not sensitivity (68). Overall, 
experiments with protein kinase C suggest that it modulates the 
actions of insulin but is not required for insulin stimulation of 
glucose transport. ca2+_calmodulin-dependent processes also have been 
proposed to mediate the action of insulin on glucose transport 
(166,280) but there is no experimental evidence to support this 
concept. 
Pathophysiological conditions such as leprechaunism, limb 
denervation or immobilization, obesity, diabetes, and shock are 
associated with altered insulin-mediated glucose transport. The steps 
involved in insulin activation of glucose transport have been 
elucidated from skeletal muscle and adipocyte alterations which 
develop during some of these disease processes. Leprechaunism is a 
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· disorder in which patients exhibit severe glucose intolerance genetic 
( 2441 354). Submaximal (244) and supramaximal (354) insulin are unable 
to stimulate 2DG uptake in fibroblasts from these patients. Insulin 
binding is altered in some patients (54,354) although in other cases 
insulin binding was not affected (54,244) which suggests post-receptor 
alterations occur also. 
Disruption of nerve-muscle communication via limb immobilization 
or denervation also blunts insulin stimulation of glucose transport 
(50,140,306,363). Although complete dose-response curves have not 
been done in most of these studies, the results consistently suggest 
that insulin responsiveness is attenuated (50,140,306,363) while 
sensitivity is not affected (140,306). Insulin binding studies 
support this hypothesis since there are no changes in insulin binding 
(306). Thus, nerve stimulation appears to modulate one or more post-
insulin binding activities. 
In contrast, studies on obesity have shown effects on skeletal 
muscle sensitivity and responsiveness to insulin (59,96,203,311). In 
soleus muscles from genetically obese mice and mice rendered obese 
after gold-thioglucose injections, insulin binding decreased (203) and 
the sensitivity and responsiveness of 2DG uptake to insulin were 
decreased. Similar results have been obtained in genetically obese 
rats (96,311) and in humans (59). Subsequent studies have shown that 
maximal tyrosine kinase phosphorylation of the ~-subunit and of 
exogenous substrates (4 glutamate:l tyrosine copolymers) are reduced 
in obese mice (261) and humans (8,59). A recent study observed 
alterations in the insulin receptor ATP binding site (182) which could 
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reduce tyrosine kinase activity. Draznin et al. (119) also have shown 
that cytosolic free [Ca2+] is elevated in adipocytes from obese 
patients and unlike controls, it is not transiently elevated in 
response to insulin. These results suggest that post-insulin receptor 
effects also occur in insulin-responsive tissues from obese 
individuals. A decrease in glucose utilization in response to a 
euglycemic clamp in obese humans also has been attributed to changes 
in capillary density and muscle fiber type (265). Thus extracellular 
factors may also influence insulin responses. Noninsulin-dependent 
diabetes is often associated with obesity (139) but insulin binding 
does not appear to decrease in skeletal muscles from type II diabetic 
mice (360) or from humans (8,59). Instead, studies show that there is 
a decrease in $-subunit tyrosine kinase activity (8,59,360). 
Tyrosine kinase activity in type I or insulin-dependent diabetes 
also is reportedly decreased in livers from genetically diabetic rats 
and from rats given a streptozotocin injection 5 weeks earlier (309). 
In addition, hepatic insulin binding was decreased. However, Burant 
et al. (51) reported that there was an increased number of insulin 
receptors in hindlimbs from streptozotocin-injected (7 days), diabetic 
rats. The length of diabetes (5 wk vs 7 days) and the tissues used to 
measure insulin binding (liver vs muscle) may account for the 
differing results. In type I diabetes, maximum insulin-stimulated 
glucose transport is attenuated in skeletal muscle (402,403) and this 
information coupled with the diminished skeletal muscle tyrosine 
kinase activity suggests that type I diabetes results from post-
insulin binding defects. 
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Maximum insulin-mediated glucose transport also is reportedly 
attenuated in muscles from burned hindlimbs (388), muscles from uremic 
rats (276), muscles exposed to anoxia (442) and hindlimbs from 
pregnant rats (181). The mechanism(s) responsible for the diminished 
responsiveness has not been elucidated although in burned hindlimbs it 
is hypothesized that a functional denervation occurs which leads to 
altered insulin responsiveness (389). In addition, studies of anoxia 
have shown that both insulin receptor and post-receptor alterations 
are responsible for the resulting decrease in insulin-mediated glucose 
transport (442). 
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D. CONTROL AND REGULATION OF CELLULAR ca2+ 
1) Introduction. Calcium plays a role in cellular metabolic, 
mechanical and electrical activities (35,322). Cytosolic free Ca 2+ is 
responsible for many actions attributed to ca2+, although the 
cytosolic concentration (10- 7 M) in resting cells is very low (35) in 
comparison to total cellular ca2+ (-1.5-2.0 mmoles/kg wet wt) 
(35,122,125,322). Other cellular compartments, such as the 
sarcoplasmic reticulum (SR) and mitochondria buffer and store ca2+ 
(44). Along with the plasma membrane, these cellular compartments 
allow the cell to maintain a low resting level of cytosolic Ca2+ 
(Ca2+i) until a stimulus mobilizes ca2+ from these compartments into 
the cytosol. About 60% of total cellular ca2+ in skeletal muscle is 
exchangeable while 40% is nonexchangeable (35,94,122). Most of the 
exchangeable ca2+ is sequestered in the mitochondrial and SR 
compartments with only 10% left in the cytosol (35). In recent years, 
the regulation of [ca2+li by these compartments and their associated 
membranes has been the focus of many studies since it is important for 
maintenance of cellular function and integrity. 
2) Methods for the measurement of cellular ca2+ regulation. 
Several experimental techniques assess cellular ca2+ regulation. 
Total cellular ca2+ content measurements could provide information 
about gross alterations in the sum of extracellular and cellular Ca 2+ 
content without indicating changes in ca2+ movements between 
individual compartments (35). This technique is not always a reliable 
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indicator of altered ca2+ regulation since changes in any one or more 
compartment(s) though significant may be small in comparison to total 
cell ca2+ (35). Measurements of radiolabeled ca2+ ( 45 ca2+) movements 
and the use of compartmental analyses have been used to estimate 
changes within the cellular compartments (35,39,390). Overall 
cellular ca2+ regulation can also be assessed using 45 ca2+ uptake or 
efflux measurements in isolated whole organs, tissues and cells 
(35,38,394). 4 5ca2+ uptake or efflux measurements assess cellular 
exchangeable ca2+ excluding extracellular Ca2+ and thus are indicators 
of ca2+ content changes within the cell rather than the total ca2+ 
content (35-37,394). Mathematical models have been developed so that 
ca2+ movements within a cellular compartment can be determined from 
45ca2+ uptake or efflux curves (390). In addition, uptake and efflux 
measurements are used to determine changes in ca2+ movements in 
response to stimuli. Borle (35,39) concluded that 45 ca2+ uptake or 
efflux are relatively easy to perform but they often are not performed 
properly or the results are interpreted beyond the sensitivity of the 
method. 
More recently, techniques have emerged which directly assess 
cytosolic free ca2+. In one of these techniques a ca2+_sensitive, 
fluorescent dye (aequorin, Quin-2, Fura-2, Indo-1) is introduced into 
isolated cells, cells are then excited at a certain wavelength of 
light which results in a fluorescence emission of an intensity that is 
proportional to the cytosolic free (ca2+] (173). Both cytosolic free 
C 2+ 2 2 a as well as transient changes in [Ca +Ji resulting from Ca+ 
movements across the plasma membrane or organelles can be detected 
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which provides information about Ca 2+ regulation in the cell and in 
individual compartments within the cell under basal conditions and in 
the presence of various stimuli. This technique is not applicable to 
whole tissue or organs in vitro or in vivo (243,263). Recent advances 
in fluorinated ( 19F) Ca2+ chelators may allow investigators to measure 
cytosolic free ca2+ in perfused organs and possibly experimental 
animals using nuclear magnetic resonance (NMR) spectral detection 
methods (263). Another method to measure cytosolic free ca2+ involves 
the use of Ca2+-sensitive microelectrodes (264). Intracellular ca2+ 
has been measured in several tissues following the development of 
ca2+_sensitive liquid ion exchange microelectrodes (190). Some 
investigators found that the microelectrode responds too slowly to 
ca2+i transients but Levy and Tillotson (264) observed rapid responses 
to transient changes in cytosolic [ca2+li· Other investigators have 
found ca2+_sensitive electrodes are not reliable (190) although new 
ca2+_sensitive agents which improve the reproducibility of electrode 
measurements have been described (190,264). In the future, these 
microelectrodes may allow investigators to measure transient, 
localized changes in (Ca2+li which cannot be detected with other 
techniques (264). 
3) Cellular ca 2+ movements which regulate ca2+i· Cytosolic 
free Ca 2+ can change in response to physiological signals or 
pathophysiological changes which affect influx or efflux of ca2+ 
across the sarcolemmal, SR, or mitochondrial membranes (56,305,322). 
Sarcolemmal calcium movements, which may influence cellular ca2+, 
include influx via leak and voltage or agonist-sensitive ca2+ 
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channels, as well as efflux via Na+;ca2+ exchange plus an ATPase pump 
for ca2+ (35). In the SR, Ca 2+ is actively pumped into the SR lumen 
by a SR ATPase and released from SR through a passive ca 2+-release 
channel in response to various stimuli (274,283,334). Mitochondria 
pump ca2+ across the inner mitochondrial membrane into the matrix 
using a uniporter that derives its energy from the transmembrane 
potential difference generated by respiration (35,305). Mitochondria 
allow ca2+ to move out via a Na+/ca2+ exchange mechanism also believed 
to be within the mitochondrial inner membrane. Regulation of these 
individual processes are apparently important for the maintenance of 
overall [Ca2+li regulation and if the activity of one or more of these 
processes is disturbed, the result may be an alteration in overall 
cellular ca2+ regulation. 
Calcium movements across the sarcolemma depend on whether the 
muscle cell is in a resting or stimulated state. Under resting 
conditions, ca2+ influx occurs via a saturable, carrier-mediated 
process referred to as a leak channel (35). An average Km for [Ca 2+J 0 
of 0.5 mM and Vmax of 170 pmol/mg protein/min has been measured in 
excitable and nonexcitable cells although specific measurements are 
not available for skeletal muscle (35). ca2+ movements through this 
channel can be altered by changes in the transmembrane ca2+ gradient 
or by changes in ca2+ permeability across the plasma membrane. As 
[Ca2+] 0 increases, [ca2+li may also increase (35,215) although the 
increase may be rapidly buffered so that an increase in [ca2+li may be 
transient (38,84). ca2+ movements across the sarcolemma can also be 
increased with the ca2+ ionophores A23187 and ionomycin (26,215,240, 
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266). These ionophores increase overall sarcolemmal Ca
2+ permeability 
which results in a rise in [ca2+li (215) as well as increased ca2+ 
release from the SR and mictochondria (18,120,149,226). 
When skeletal muscle is electrically stimulated or depolarized, 
Caz+ movements occur through the voltage-sensitive channels as well as 
the leak channels. A slow inward sarcolemmal ca2+ channel (Ica,s or L 
channel) is activated during stimulation although its contribution to 
the action potential is minimal unless the muscle is repeatedly 
stimulated (4,17,116,161,229,375). Unlike cardiac muscle, Ica,s is 
not required for stimulation of skeletal muscle SR ca2+ release and 
the subsequent contraction (161). Another ca2+ current (transient, 
Ica,f or T channel) also has been observed in skeletal muscle but its 
functional significance is unknown (95,154). Movements across the 
sarcolemma under basal and stimulated conditions can be manipulated. 
When extracellular [Ca2+] ([Ca2+] 0 ) is depleted and muscle is 
depolarized, a decrease in [Ca2+]i occurs but does not significantly 
affect the threshold for action potentials (74) although there is an 
increased mechanical threshold and a reduction of maximum contractile 
force development (11,269) indicative of effects on excitation-
contraction coupling. Direct stimulation of SR ca2+ release and the 
resulting contracture were not affected by the reduction in [ca2+] 0 
(74,371). These results led investigators to conclude that [Ca2+] 0 
was required for a localized electric field, which in turn, allowed 
charge movement to occur within the membrane following an electrical 
stimulus (74). A portion of charge movement is believed to control SR 
Ca2+ release (253,355). When [ca2+] 0 is replaced with Mg2+, 
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excitability of stimulated skeletal muscle is not markedly altered 
( 74,269). Absence of (Ca2+J 0 without Mg2+ replacement, leads to 
depolarization (98,143) which is attributed to loss of plasma membrane 
ion selectivity or increased charge density on the external 
sarcolemmal surface (74,269). Thus, the removal of (Ca 2+J 0 may alter 
cellular functions (98,143) but the effects are not necessarily 
mediated via alterations in (Ca2+li· As [ca2+) 0 is elevated, a 
proportional increase in Ica,s occurs (116) although its contribution 
to cytosolic ca2+ is probably minimal in comparison to the effect of 
SR ca2+ release on [Ca2+li· 
The slow inward ca2+ current (Ica s or L channel) in skeletal 
' 
muscle was first described by Beaty and Stefani (17) in frog skeletal 
muscle and more recently in rat (73,116) and rabbit (406) skeletal 
muscle. The Ica f also has been observed in frog skeletal muscle (95) 
' 
although this may be a tetrodotoxin-insensitive Na+ channel capable of 
carrying divalent cations (177). Specific ca2+ channel agonists and 
antagonists have been developed to probe the L channel but not the T-
type channel. Among the selective ca2+ channel blockers of Ica,s are 
3 families of compounds which act on voltage- and agonist-sensitive 
Ca2+ channels in a variety of tissues (159). The major families of 
Ca2+ antagonists are the phenylalkylamines (verapamil), dihydro-
pyridines (nifedipine) and benzothiazepines (diltiazem) (159). The 
cations Cd2+, Mn2+, co2+, and Ni2+ also block ca2+ movements through 
this channel (73,116,167,177). Other compounds with less specificity 
also reduce channel activity including phenytoin, tricyclic 
antidepressants, local anesthetics, catecholamine receptor 
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antagonists, opiate antagonists, barbiturates, indomethacin, 
reserpine, tamoxifen and antineoplastic anthracyclines (159,167). 
ca2+_ ATPase and Na+;ca2+ exchange are believed to constitute 
the major efflux processes (35,56,58). ca2+ efflux via leak channels 
also occurs in skeletal muscle (35). However, its contribution to 
total ca2+ efflux is minimal in comparison to ca2+ ATPase and Na+;ca2+ 
exchange (0.5 %/min) and thus contributes little to the regulation of 
ca2+i (35). The characteristics of the ca2+_ATPase have been 
characterized in red blood cell and this carrier is part of the E1-E2 
family of ATPases which undergo a transient phosphorylation and 
subsequent conformational change as part of pump activity (353). 
Similar characteristics of the Ca2+-ATPase have been reported in other 
tissues (38,58,114). A few studies have reported slightly different 
ca2+_ATPase proteins on the sarcolernrna (377) and t-tubules (43). The 
pump functions with a stoichiometry for ca2+/ATP of 1:1 and 2 protons 
are exchanged for 1 ca2+ as ca2+ is pumped out of the cell (353). The 
protein responsible for ca2+_ATPase (Mr 138 kDa) activity is 
associated with the plasma membrane and ATP plus Mg2+ are necessary 
for activity (57,58,353,378). Calmodulin activates ca2+_ATPase 
activity by increasing the affinity of the protein for ca2+ as well as 
the Vmax and thus, calcium serves as both an activator and a substrate 
(35,57,353). Other activators of the ca2+ pump include acidic 
phospholipids, long chain polyunsaturated fatty acids (58) and cyclic 
nucleotide phosphodiesterases (35). This pump functions as a high 
affinity (Km for ca2+ = -1 µMin RBC) (353), low capacity (Vmax = 10 
runol/mg protein in RBCs) system which appears to be responsible for 
· ca2+ when [Ca2+){ is relatively low (35). pumping L 
As [Ca2+li increases in most tissues, Na+/ca2+ exchange moves 
more ca2+ out of the cell (32,35,257) and some investigators believe 
the exchange mechanism is capable of operating in the reverse 
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direction (i.e. increased intracellular [Na+)) (321). Most skeletal 
muscle Na+/Ca 2+ exchange studies have been performed in frog (55,94) 
and barnacle (32,112,257,406) muscle preparations with a few studies 
in mammalian skeletal muscle (157,432). Regulation and 
characteristics of the exchanges appear to be similar in these 
preparations. Exchange operates as an electrogenic mechanism with a 
stoichiometry of 3Na+/lca2+ and overall it is believed to be a low 
affinity (Km for Ca 2+ = 2-10 µM), high capacity (Vmax > 15 nmol/mg 
protein) enzyme that is activated when [Ca2+Ji is elevated (58). 
Investigators are uncertain about the importance of Na+/ca2+ 
exchange in vertebrate skeletal muscle (157,432). A portion of the 
uncertainty stems from the complexity of the exchange mechanism itself 
and from the numerous cellular processes which regulate exchange 
activity (55). Caputo and Bolanos (55) observed that one component of 
Ca2+ efflux depended on [Ca2+]i, another relied on intracellular 
[Na+] ([Na+Ji) and a third component was independent of [ca2+] 0 and 
[Na+]i· In addition, Na+/Na+ exchange also has been observed in 
isolated rabbit skeletal muscle sarcolemmal vesicles (157). 
Alterations in extracellular [Na+) ([Na+] 0 ) or [Na+Ji affected ca2+ 
efflux in these vesicles but increased [Na+] 0 and [Na+)i prevented 
Na+;ca 2+ exchange and favored Na+/Na+ exchange (157). In the same 
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t . investigators were unable to detect Na+ flux in the prepara ion, 
presence of a ca2+ gradient. Yamamoto and Greef (432) observed that 
the basal rate of Na+-dependent 45 ca2+ uptake in guinea pig atria and 
h were similar however, increased [Na+Ji· stimulated 45 ca2+ diap ragm 
uptake in atrial preparations but not diaphragm preparations. These 
and other experiments have shown that the Na+;ca2+ exchange mechanism 
is temperature dependent (157), is modulated by Mg2+ (157), can be 
influenced by membrane potential (321) and the Na+-dependent Ca 2+ 
movements are highly dependent on [ca2+Ji (321). Although Yamamoto 
and Greef (432) suggested that most efflux occurs via ca2+_ATPase 
causing it to be the sarcolemmal efflux component that regulated 
[Ca2+Ji, the complexity of the feedback mechanisms regulating Na+;ca2+ 
exchange indicate that it may be functionally important, especially 
when [Ca2+Ji is elevated (157,321). 
Mitochondria contain approximately 40% of cellular ca2+ (35) and 
appear to buffer large changes in [ca2+li using a ca2+ uniporter for 
ca2+ uptake and an independently regulated Na+/ca2+ exchange for the 
efflux of ca2+ (305). A mitochondrial membrane potential across the 
inner membrane (-150 to -180 mV) (16) is responsible for the uphill 
transport of ca2+ into the mitochondrial matrix via an inner membrane 
Ca 2+ uniport protein (35,305). The ca2+ influx increases as a cubic 
function of cytosolic [ca2+] (305). A Na+/ca2+ exchanger located on 
the inner membrane moves ca2+ out of the mitochondrial matrix and 
functions independently of the ca2+ uniport process (305). Uniporter 
and Na+;ca2+ exchange activities work together to influence [ca2+li 
and free [ca2+] in the matrix ([Ca2+lm) (305). 
sarcoplasmic reticulum (SR) contain -90% of the ca2+ required 
the activation of the contractile mechanism in skeletal muscle for 
(180) . The activator ca2+ can be can rapidly released and 
54 
resequestered by the SR. These characteristics allow SR to act as the 
· le controller of cytosolic free ca2+ in skeletal muscle princip 
(35,322). Calcium is transported into the lumen of the SR via a Ca 2+-
dependent ATPase which is primarily located in the longitudinal 
cisternae and ca2+ is released into the cytosol by a ca2+ release 
channel believed to be located on the terminal cisternae of the SR 
(425,426). The SR and sarcolemmal Ca2+-ATPases share many 
similarities since both are Mg2+ dependent and form a phosphorylated 
intermediate during the ca2+ transport process. However, recent 
studies have shown that inward Ca 2+ pumping by the SR is accompanied 
by the outward movement of K+ (134). When SR K+ channels are blocked, 
H+ and Mg2+ appear to counter balance the ca2+ movements. Kinetic 
studies have shown that the 100 kDa SR ca2+-ATPase has a Km of 0.1-1 
µM for free ca2+ (35,56,274) and a Vmax of 0.4-3.6 µmol/mg protein/min 
(35,56,322). The activity of ca2+_ATPase is modulated by 
phospholamban (Mr 6-11 kDa) (56,155,221) which can modulate ca2+ 
transport and ATPase activity (322). Agents which activate SR ca2+_ 
ATPase activity such as cAMP-dependent protein kinase and calmodulin-
dependent protein kinase are believed to activate the pump via 
phosphorylation of phospholamban, although a recent study suggests 
that they act via separate, additive pathways (153). Once ca2+ enters 
the SR lumen, most of it binds to the acidic 16 kDa protein, 
calsequestrin (56,274). This protein allows the SR to store 
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1 r quantities of ca
2+ while maintaining free [Ca 2+] in the SR 
millimo a 
iumen below 100 µM (322). 
The mechanism responsible for ca2+ release from the SR is not 
completely understood although various agents have been used to probe 
its function. Caffeine or ryanodine stimulate ca2+ release from SR 
(l28) and they are believed to maintain a ca2+ release channel in the 
open configuration (138,283,302,334). Ruthenium red prevents 
ryanodine binding (205,314). Cation counter-transport is postulated 
d . c 2+ 1 11 to occur uring a re ease as we as during ca2+ uptake (134). 
Recently, Imagawa et al. (205) isolated a 450 kDa, ryanodine-sensitive 
protein in the terminal cisternae which is also believe to be the SR 
ca2+ release channel (206,334). A similar function has been ascribed 
to a 60 kDa protein by Kim and Ikemoto (231). In contrast, McWhirter 
et al. (281,282) proposed that since many manipulations affect both 
ca2+ uptake and release, the release mechanism may be accomplished by 
a reversal of SR ca2+_ATPase. However, many of the ca2+_modifying 
agents cited by this group probably modify ca2+ uptake (282) and thus, 
indirectly affect ca2+ release by modifying the activator ca2+ 
available for release. This hypothesis has been largely discounted by 
most investigators (56). Cellular factors or functions which may 
modulate the activity of the ca2+ release channel remain to be 
investigated. 
Ca2+ cycling across the SR has physiological importance since 
skeletal muscle depolarization results in SR ca2+ release followed by 
tension development. Several hypotheses have been proposed to explain 
the mechanism responsible for excitation-contraction coupling. Some 
investigators indicate that ca2+ entry during an action potential 
acted as a trigger to stimulate SR Ca2+ release (144). Veragara et 
al. (388,399) plus Volpe and coworkers (400) propose that 
depolarization stimulates the production of inositol 1,4,5 
triphosphate (IP3) which subsequently diffuses to the terminal 
cisternae of the SR where it binds and causes SR ca2+ release. 
Schneider and Chandler (355) were first to postulate that 
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depolarization stimulates asymmetric charge movement (253) within the 
sarcolemmal membrane and subsequently this movement affected" ... long 
molecules which extended to the adjacent projections of the SR 
terminal cisternal membrane ... " (355), thus stimulating SR ca2+ 
release. In support of this concept Cadwell and Caswell (53) isolated 
a 300-325 kDa protein which they postulate connects the transverse 
tubule to the sarcolemmal SR. Charge movement may be associated with 
ca2+ channels since ca2+ blockers have been shown to modify skeletal 
muscle charge movement (253,406) and charge movements in general act 
as gating currents for ion channel activation (253). The hydantoin 
analog dantrolene has been shown to block depolarization induced ca2+ 
release from barnacle muscle (111) and its mechanism of action may 
provide increased understanding of excitation-contraction coupling 
although dantrolene reportedly acts on both sarcolemmal and 
sarcoplasmic reticular ca2+ release (45,46). 
In skeletal muscle, most research has focused on the effect that 
changing [ca2+]i has on skeletal muscle contraction. In recent years 
investigators have observed other ca2+_dependent activities such as, 
Ca2+-calmodulin sensitive proteins in the SR (358) and cytosol (52) 
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and protein kinases in skeletal muscle (401). Several cytosolic ca2+_ 
calmodulin binding protein in skeletal muscle are associated with 
glucose metabolism (52,92,316). Investigators also have observed that 
[Ca2+li influences skeletal muscle proteolysis (148,443). The 
inositol phosphate - diacylglycerol second messenger system is not 
well understood in skeletal muscle but has been observed in other 
organ systems. Studies in other tissues have revealed that (Ca 2+Ji 
and calmodulin may influence insulin receptor binding and post-binding 
events (166,280), maximal Ica s activation (30), and modulates cAMP-
, 
dependent protein kinase activity by increasing phosphodiesterase 
activity (352,379). Many of these reactions remain to be investigated 
in skeletal muscle. 
4) ca2+ channel antagonists and their effects on skeletal 
muscle. Specific ca2+ agonists and antagonists have been used to 
isolate the ca2+ channel (141,150,151) in order to understand how the 
ca2+ channel is activated and inactivated during cell activities. 
Using organic Ca2+ antagonists, investigators found that the Ica s 
, 
channel was restricted to the transverse-tubule (t-tubule) membrane 
(130,141,150). Binding studies determined that dihydropyridines bind 
with a Ka of 1-2 nM and a Bmax of -so pmol/mg protein (141), 
phenylalkylamines bind with a Ka of 25-30 nM with a Bmax of -S0-70 
pmol/mg protein (150,151,158) and benzothiazepines bind with a Ka of 
35-50 nM and a Bmax of 50 pmol/mg protein (151). More recently, the 
Ca2+ channel protein has been isolated and its subunit composition 
determined with the help of receptor antagonists (64). All three 
types of ca2+ antagonists bind to a 145-170 kDa glycoprotein (64,151). 
maJ·or subunits (a,~,~) of the purified protein have been Three 
isolated using electrophoretic techniques (64,99). Dihydropyridines 
the a-subunit (99), while phenylalkylamines bind to the~­bind to 
subunit and benzothiazepines bind to the ~-subunit (64,99). The 
functional significance of each subunit remains to be investigated 
(64). Agonists and antagonists also have been used to characterize 
lca,s· 
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Studies in the early 1980s showed that the dihydropyridine Bay K 
8644 enhanced Ca 2+ current in heart (188,247,343) and enhanced 4 5ea2+ 
uptake in Nal08-5 cells under resting and depolarized conditions 
(146). Subsequent studies in skeletal muscle have shown that the ca2+ 
agonist Bay K 8644 (0.1 µM) enhanced the amplitude of Iea,s' decreased 
the time to peak lea s and shifted the threshold for Iea s activation 
' ' 
to more negative membrane potentials in voltage-clamped (-90 to -30 
mV) semi-tendinosus muscles from frogs (204). Similar results have 
been observed in isolated myoballs from newborn rats (90) and rabbit 
soleus muscle (253). Members of all three families of organic 
antagonists block voltage-activation of lea s in skeletal muscle (see 
' 
Table 1). In skeletal muscles treated with ea2+ antagonists, 
saturation binding is observed in the nanomolar range but functional 
activity requires 2 to 3 fold higher concentrations (41,357). Whereas 
Schwartz et al. (357) has postulated that many binding sites do not 
represent functional channels, Lamb and Walsh (253) proposed that only 
a fraction of the channels are open at any one time which results in a 
requirement for higher effective antagonist concentrations. The only 
anomalous compound observed so far has been nitrendipine which binds 
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TABLE I. CHARACTERISTICS OF SKELETAL MUSCLE ca2+ CHANNEL BLOCKADE 
Animal model Muscle Calcium Range of [ l source 
antagonist or Ka 
Rana pipiens sartorius Verapamil 5 x 10- 6M (229) 
Rana temporaria semitendinosus Diltiazem Ka= 80µM (3) 
Nifedipine Ka=O. 9µM 
Frog sartorius PN-200/110 Ka=430nH (357) 
Rana esculenta semitendinosus Nifedipine lOµM (204) 
Newborn rat thigh myoblast PN-200/110 I lo-
12
-l0-5M (96) 
Rabbit sternomastoid Diltiazem I lo-4-10-6 (406) 
Ka=63µM 
Verapamil lOµM 
Nitrendipine 1-lOµM-no 
effect 
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keletal muscle, but does not appear to have a functional effect on to s 
skeletal muscle Ica,s (357,420). Although some ca2+ antagonists 
Cellular activities unrelated to the ca2+ channel, 102 to 103 affect 
higher concentrations than those used in electrophysiological or 
mechanical studies must be used before these effects are detectable 
(207,407,408). 
ca2+ agonists and antagonists also have been used to determine 
the role that Ica,s activation and [Ca2+Ji play in excitation-
contraction coupling and tension development in skeletal muscle. The 
calcium agonist Bay K 8644 was first used in 1983 when Schramm et al. 
(356) observed that it increased blood pressure, peripheral 
resistance, vascular smooth muscle contraction, and increased 
contractility of the heart in vivo and in isolated, perfused 
preparations. Their in vitro studies established that a maximal 
response in smooth and cardiac muscle could be obtained with lo-7 to 
lo- 6 M Bay K 8644 and the Ec50 was generally about lo-8 M. 
Concentrations greater than 10-6 to 10-5 M tended to decrease cardiac 
contractility and aortic contraction. Subsequent studies in skeletal 
muscle found that the ca2+ agonist Bay K 8644 enhanced the slow 
component of tension development in frog semitendinosus muscles which 
was also associated with the onset of Ica s activation (204). 
' 
Several investigators also have examined the ability of various 
Ca 2+ antagonists to block tension development in stimulated muscle and 
neuromuscular preparations (10,327,347). They have observed that ca2+ 
antagonists enhanced twitch or low frequency tension development in 
amphibian and mammalian skeletal muscle (10,145,152,161,346,347,405) 
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le activation was thought to be minimal. However, direct 
when a,s 
pressure injection of Ca 2+ blockers (D-600, nifedipine) into muscle 
fibers was without an effect on contraction (279) which suggests that 
these agents may potentiate twitch development through membrane 
effects unrelated to lca,s· Nevertheless, lea s is implicated in the 
' 
development of tetanic contraction and the slow component of tension 
development and ca2+ antagonists do attenuate or block this later 
phase of contractile development (145,152,204,346,347). These results 
indicate that the antagonists may have nonspecific effects on short 
interval twitch development but activation of lca,s• the ensuing 
increase in [Ca 2+Ji, and the subsequent contractile response can be 
blocked by Ca2+ antagonists. Calcium antagonists also influence 
another aspect of excitation-contraction coupling that may or may not 
be related to their effects on ca2+ channels. Lamb and coworker (253) 
as well as Rios and Brum (328) have found that nifedipine (2-lOµM) at 
concentrations which affect lea s• decreases charge movement in 
' 
amphibian and mammalian skeletal muscle and this was associated with a 
reduction in SR calcium release (328). Nifedipine and other 
dihydropyridines appear to either independently affect charge movement 
and lea s (406-408) or affect a single, dihydropyrinde-sensitive 
' 
protein responsible for both the charge movement and leas (328). 
' 
Other ca2+ antagonists such as diltiazem enhance charge movement in 
bullfrog semitendinosus muscle (407). This drug also has been 
associated with twitch and tetanic potentiation (161) as well as 
attenuation of tetanic responses which may indicate a more complex 
association between lea 8 and charge movement. 
' 
overall, the results from antagonist receptor binding, 
electrophysiological and mechanical studies suggest that under 
d]..tions voltage-sensitive Ca 2+ current can influence [Ca 2+Ji con 
influence cellular activities. The role this channel has under 
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some 
and 
physiological conditions is not understood since investigators have 
shown that it is not required for skeletal muscle mechanical activity. 
A report in isolated perfused hearts (110) indicated that Ca2+ 
blockers affect glycolysis although the mechanism may be indirect. An 
earlier report (72) in skeletal muscle reported that verapamil 
attenuated high K+-induced increases in respiration although 
contraction was not affected which suggests that Ica s may cause 
' 
direct or indirect (e.g. via localized changes in [Ca 2+Ji) effects on 
metabolism. 
5) Pathophysiology associated with changes in one or more ca2+ 
controller functions or [Ca2+li· Calcium regulation is altered in 
several pathophysiological conditions which are in some cases 
associated with metabolic abnormalities. Scales et al. (351) observed 
that the maximum ca2+ capacity of the SR was significantly reduced 
along with the SR protein/lipid ratio in a chicken model of muscular 
dystrophy. However, SR ca2+ uptake and ATPase were unaffected in this 
model so the authors concluded that the altered capacity to accumulate 
Ca2+ may be responsible for previously observed defects in excitation-
contraction coupling (338). Joffee et al. (217) observed that 
denervation increased basal levels of mitochondrial ca2+ and reduced 
the capacity of mitochondria to accumulate ca2+ prior to uncoupling of 
oxidative phosphorylation. After denervation, the responsiveness of 
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skeletal muscle glucose metabolism to insulin also is diminished 
( 389 ). They postulated (217) that mitochondrial alterations were due 
to this organelle's attempt to buffer [ca2+li which increased when an 
unregulated ca2+ influx developed across the sarcolemmal membrane. 
Increased sarcolemmal ca2+ permeability was postulated to cause 
alterations in cellular Ca2+ regulation in muscles exposed to ca2+_ 
free media (372) and muscles from malignant hyperthermic pigs (329). 
Studies in rats made diabetic with streptozotocin treatment indicate 
that diabetes is associated with a reduction in sarcolemmal Na+;K+ 
ATPase activity (238), increased cellular (Na)+ and decreased [ATP) 
(294). Moore (292) also observed that insulin stimulated Na+;H+ 
exchange and thus the changes in skeletal muscle [Na+)i found during 
the course of diabetes also were attributed to changes in Na+;H+ 
exchange. Although neither group examined the subsequent effect of 
[Na+Ji on [Ca2+li in the diabetic skeletal muscle, it is possible that 
a reduction or reversal of Na+;ca2+ exchange may have resulted from 
the increased [Na+]i such that there was an increase in [ca2+li· In 
support of this idea is the increased SR Ca2+ uptake and ca2+_ATPase 
activity observed in similarly treated diabetic rats (153). Longer 
intervals of diabetes have been associated with a decrease in SR ca2+ 
uptake (123) and may signal an inability of the SR to maintain a 
compensatory increase in ca2+ uptake over a prolonged interval of 
increased [ca2+li· 
Studies in various animal models of septic shock suggest that 
alterations in ca2+ regulation also may occur in some organ systems 
during this disease state. Nelson and Spitzer (300) observed an 
;n exchangeable ca2+ in adipocytes from endotoxic rats. increase L 
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Although they determined that the increase was due to a change in ca2+ 
bound to the extracellular glycocalyx (300), other investigators have 
reported that cellular exchangeable ca2+ increased in livers and 
skeletal muscle from endotoxic rats (122,348). These changes were 
attributed to alterations in cytosolic, mitochondrial or endoplasmic 
reticulum (ER)/SR pools of Ca 2+ (122,348). In subsequent studies, 
Sayeed and Maitra (350) reported that resting cytosolic free (Ca2+J is 
elevated in hepatocytes isolated from endotoxic rats. 
Earlier investigators have provided evidence that ca2+ movements 
across the plasma membrane, ER/SR and mitochondria were altered in 
numerous organ systems during the septic shock and these alterations 
may contribute to the changes in [Ca2+li· In 1971, Hess and Briggs 
(186) observed that myocardial SR ca2+ uptake was significantly 
depressed when endotoxin was added to the media. When endotoxin was 
added to a heart-lung preparation myocardial SR Ca2+ uptake also 
decreased (187). Similar results were reported by Hulsman et al. 
(201) in myocardial SR and by Sayeed (348) in microsomes isolated from 
rat liver. In addition, Hulsman et al. (201) found that sarcolemrnal 
Ca 2+-ATPase-induced movement of ca2+ was decreased after the addition 
of endotoxin. In contrast, ca2+ uptake increased in liver microsomes 
isolated from acutely- and chronically-treated endotoxic rats (373). 
Initial exposure to endotoxin in the chronic rats appeared to increase 
hepatic endoplasmic reticulum (ER) ca2+ uptake and ca2+ content but a 
similar effect was observed with the vehicle used for chronic 
administration of endotoxin (osmotic pump) which prevented 
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investigators from ascertaining the effects of endotoxin alone. In 
contrast, Sayeed (348) reported that ca2+ uptake was not affected in 
ER isolated from acutely endotoxic rats at a time when exchangeable 
ca2+ and cytosolic free ca2+ (350) were increased in similarly treated 
rats. These results suggest that alterations in ER/SR Ca2+ uptake 
probably did not cause the change in [Ca 2+Ji but may eventually be 
affected by alterations in [ca2+li· In addition, it would appear that 
a direct effect of endotoxin was not responsible for the in vivo 
changes which occurred in ca2+ uptake. Alterations in calcium release 
from the ER/SR during sepsis and septic shock also has been studied. 
In hepatocytes isolated from endotoxic rats (acute), the ability of an 
agonist (ie a-agonist, vasopressin) to transiently raise [Ca2+li was 
markedly attenuated and this was attributed to a decrease in the 
ability of the ER to release ca2+ (109,272). Comparable results were 
observed in hepatocytes from bacteremic rats given b· coli (273). In 
liver slices, norepinephrine-induced ca2+ efflux also was reduced in 
slices from endotoxic rats (348). These results suggest that ER ca2+ 
release may contribute to alterations in the regulation of ca2+ during 
septic shock. 
Studies of mitochondria indicate that this organelle also may 
contribute to changes in cellular ca2+ regulation in endotoxic 
animals. Mela (284) reported that kidney mitochondrial ca2+ uptake 
was reduced 75% in the presence of endotoxin. In addition, ca2+ 
uptake in liver, brain, and kidney mitochondria was significantly 
reduced 16-20 hrs after rats received an LD70 dose of b· coli 
endotoxin (284). Spitzer and Deaciuc (373) observed no change in 
. hondrial ca2+ uptake when livers were removed from acutely- and 
mitOC 
chronically-treated endotoxic rats. These results suggest that 
perturbations in cellular Ca 2+ regulation may occur prior to changes 
in mitochondrial handling of ca2+. 
several studies indirectly suggest that ca2+ movements across 
the plasma membrane may influence [ca2+Ji during septic shock. 
Administration of ca2+ channel antagonists to septic or endotoxic 
animals prevents many of the changes in cellular ca2+ regulation or 
ca2+_dependent processes. Administration of diltiazem along with 
endotoxin attenuated the increase in resting hepatocyte (ca2+]i and 
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restored the ability of an a-agonist to stimulate a transient rise in 
(Ca2+li (350). Diltiazem administration also prevented the 
attenuation of IP3-mediated increase in (ca2+]i (272). These results 
suggest that alterations in plasma membrane ca2+ movements may alter 
(Ca2+li and subsequently affect the ability of the ER to release ca2+. 
Administration of ca2+ blockers also has improved survival in 
endotoxic rats (122) and in bacteremic mice (40). The ca2+ blocker 
verapamil reduced endotoxin-stimulated production of prostaglandins 
and thromboxanes in sheep (1). The authors postulated that these 
agents were responsible for changes in pulmonary mechanical and 
hemodynamic functions during endotoxin shock. Indeed, verapamil not 
only reduced the eicosinoid production but also prevented or 
attenuated the alterations in mechanical and hemodynamic functions 
associated with endotoxin administration. These results suggest that 
plasma membrane ca2+ movements may be altered in several organ 
systems. 
CHAPTER II 
3-0-METHYLGLUCOSE TRANSPORT IN SOLEUS MUSCLE OF BACTEREMIC RATS 
A. INTRODUCTION 
Several clinical studies indicate that sepsis is associated with 
carbohydrate metabolic alterations (88,175). Septic patients are 
frequently found to be glucose intolerant (88,175). Similar results 
were obtained in animals exposed to bacteremia (193,319). The 
carbohydrate metabolic alterations appear to be due to an imbalance 
between glucose production and glucose utilization. 
Overall glucose utilization appears to be elevated (429) or 
unchanged (361) during endotoxemia or bacteremia when metabolic 
clearance rate is measured. Individual organs, such as adipose tissue 
and blood cells appear to utilize glucose at an accelerated rate 
(132,191). Several studies on skeletal muscle have shown alterations 
in basal and insulin-stimulated glucose utilization (132,274,325,326, 
420). Derangements in carbohydrate metabolism in skeletal muscle may 
have serious consequences in septic patients as this organ plays a 
major role in maintaining metabolic homeostasis. 
The locus of the skeletal muscle metabolic defect may be one of 
the control points during glucose metabolism, including glucose 
transport, hexokinase, phosphofructokinase and/or pyruvate 
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dehydrogenase. Recent studies by Vary et al. (397) observed that the 
active form of hindlimb muscle pyruvate dehydrogenase (PDH) is 
decreased during chronic sepsis. Other investigators reported that 
insulin stimulation of PDH also was depressed in septic muscle (337). 
Membrane glucose transport is the first rate-limiting step and defects 
in this step influence substrate availability to glycolysis and the 
tricarboxylic acid (TCA) cycle. A defect in glucose transport may 
also exacerbate muscle PDH activity and energy availability. The 
purpose of this study was to investigate the affect of bacteremia on 
soleus muscle membrane glucose transport in the presence and absence 
of insulin. Glucose transport was measured in soleus muscles under in 
vitro and in vivo conditions using the nonmetabolizable glucose analog 
3-0-methylglucose. 
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B. MATERIALS AND METHODS 
1) Animal model: Male Holtzman rats weighing 80-100 g (4 wks 
old) were fasted (15 hours, 4 p.m. - 7 a.m.) prior to the experiment 
and allowed water ad libitum. Bacteremia was induced in fasted rats 
by an intraperitoneal (ip) injection of Escherichia coli (4 x 1010 
organisms/kg body wt., 0.5 ml) under light ether anesthesia. Control 
rats were fasted along with the bacteremic rats and were killed at the 
same time. Rats were killed by decapitation at 8 and 12 hours after 
injection for the in vitro study. Blood samples were collected in 
heparin-lithium-fluoride coated tubes (Beckman Instruments, Inc.) for 
analysis of plasma glucose and lactate and soleus muscles were rapidly 
excised. 
For the in vivo study, rats (80-100 g) were fasted (15 hrs) and 
then administered~. coli bacteria, intraperitoneally (ip). Pair 
fasted control rats were injected with saline ip. At 12 hrs post-
injection, blood samples and muscles were collected under ether 
anesthesia and then rats were killed. Blood samples were analyzed for 
plasma glucose, lactate and 14 c-3MG. 
2) Preparation of E. coli: &..,,. coli 25922 (American Type Culture 
Collection, Rockville, MD) was maintained on blood agar plates and 
transferred periodically. Brain-heart-infusion (BHI) slants 
containing bacteria obtained from blood agar plates were used to seed 
BHI broth. Prior to injections &..,,. coli was grown sequentially in two 
5 ml tubes of BHI broth and the second tube was used to inoculate 500 
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ml of BHI broth. This culture flask was incubated for 12 hrs and all 
cultures were incubated at 33°C in a Lab-line incubator (model 417). 
To harvest bacteria, aliquots of bacterial suspension were centrifuged 
for 10 minutes in sterile centrifuge tubes at 8600 x g in a Sorvall 
centrifuge. The supernatant was removed and pellets were resuspended 
in sterile, isotonic saline and pooled. The number of bacteria 
present in the suspension was estimated using absorbance at 620 nm as 
an indicator of bacterial number. Serial dilution and pour plate 
methods were utilized to determine absolute bacterial concentration. 
3) Plasma measurements: Blood samples collected from decapitated 
rats were immediately centrifuged in a Beckman Microfuge (model 12) at 
11200 x g for five minutes. Plasma samples were stored at o0 c until 
they were assayed for plasma glucose and lactate. For in vivo 
experiments, blood was collected from the abdominal aorta in 
anesthetized rats and treated in a manner comparable to decapitated 
rat blood. Plasma glucose was determined using a YSI 23A glucose 
analyzer (Yellow Springs Instruments, Inc.) while plasma lactate was 
analyzed with a YSI 23L lactate analyzer. Duplicate readings were 
obtained for each plasma sample. 
4) In vitro soleus muscle 3MG efflux: The glucose transport 
system was evaluated by measuring the efflux of 14 c-3MG from muscles. 
Isolated soleus muscles were incubated in a 'loading' media of 3.0 ml 
Krebs-Ringer-bicarbonate buffer (KRB, pH 7.4) containing 118 rnM NaCl, 
1.2 rnM Mgso4 , 1.2 rnM KH 2Po4 , 4.7 rnM KCl, 2.5 rnM Cacl 2 , 24 rnM NaHco 3 
plus 2.3 rnM pyruvate, 2.0 rnM 3-0-methylglucose (3MG, Sigma) and 4 µCi 
f 14 
° C-3MG (Amersham, 0.65 µCi/mmole). All incubations were carried 
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out at 37°c in a metabolic shaker bath. Each vial was capped with a 
rubber stopper which was attached to a manifold for continuous 
oxygenation with a humidified 95%02:5%C02 mixture. After muscles were 
loaded for a 60 min period, which results in a steady state 
equilibrium of 3MG, they were washed in radioisotope-free KRB media at 
37oc. Washes were carried out by sequentially transferring muscles 
through a series of vials containing 2.5 ml of wash media. When 
insulin was used, it was included at a concentration of 10 mU/ml in 
the wash vials. Soleus muscles incubated in this manner are viable up 
to 240 minutes using viability indicators such as excitability, 
intracellular K+ concentration and oxidation of pyruvate to C02 (246). 
In addition, previous studies in our laboratory have shown that this 
in vitro muscle preparation exhibited active amino acid transport for 
up to 180 minutes at 37°c (223). At the end of the washout, muscles 
were lightly blotted on filter paper (Whatman #42) and weighed after 
removing any tendon attached to the muscle. Muscles were digested 
overnight in 2.0 ml of tissue solubilizer (TS-1, Research Products 
International) at 55°C. The radioactivity in 2.5 ml of washout media 
and digested muscles were counted in a liquid scintillation counter 
(Packard Tri-Garb 460) and corrected for quenching. 
The muscle counts were added to successive media counts in a 
retrograde manner to quantify radioactivity remaining in the muscle at 
various times during the washout. 14c-3MG efflux curves were 
constructed by plotting base 1o logarithm of muscle radioactivity 
(DPM/g) versus washout time. The efflux curves were invariably 
biphasic. The initial, rapid phase represented 14c-3MG efflux from 
the extracellular compartment (78,246). This was followed by a 
prolonged monoexponential efflux phase representing the transport of 
radiolabel from the intra- to extra-cellular compartment. 
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Extrapolation of the monoexponential portion of the curve back to the 
y-axis yields the size of the cellular 3MG compartment at the end of 
the 'loading' period. The cellular 3MG compartment size representing 
steady state cellular uptake of 3MG, was expressed as µmole/g muscle. 
The slope of the monoexponential portion was used to calculate the 
rate coefficient (A) or the fractional efflux value in units of min- 1 
(78) while the half life (t1;2) of the monoexponential phase of efflux 
was equal to 0.693 /A. The values were estimated also by taking 
the proportion of 14c-3MG leaving the muscle cell per unit time for 
each wash interval as given below: 
(Initial DPM/g Final DPM/g)/(Initial DPM/g) 
5 minutes 
5) In vivo soleus muscle glucose uptake: Ten to 40 minutes prior 
to killing the control and bacteremic rats, they were injected iv with 
0.5 ml of a solution containing insulin (50 mU/ml; Sigma, crystalline, 
porcine), bovine albumin, fraction V (0.01%), unlabelled 3MG (50 mM) 
and 14c-3MG (8 µCi/ml). At 12 hours after the bacterial or saline 
injection, rats were anesthetized and then blood samples and soleus 
muscles were quickly removed. Muscles were weighed after removing 
tendon and were then placed in tissue solubilizer and digested 
overnight in a water bath at 55°C. Blood was centrifuged and the 
plasma was assayed for metabolites as described in the plasma 
metabolite section. A 0.1 ml aliquot of plasma was mixed with 1.0 ml 
of tissue solubilizer and incubated overnight at room temperature. 
Muscle and plasma sample radioactivity was counted in the liquid 
scintillation counter. 
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14c-Inulin was used to determine extracellular (ECS) and 
intracellular (ICS) spaces in soleus muscles for calculating intra-
and extra-cellular 14c-3MG concentrations. ICS and ECS were 
determined in both control and bacteremic rats under basal and 
insulin-stimulated conditions. To determine ECS and ICS, rats were 
nephrectomized under ether anesthesia at 11 hours following injection 
of saline or bacteria to prevent clearance of inulin (424). For 
nephrectomy, dorsal lateral incisions were made, kidneys were exposed 
and excised after ligating the renal arteries. Wound clips were 
placed over the incisions and rats were allowed to recover. Thirty 
minutes later, 0.5 ml of saline containing 14c-inulin (Amersham, 11.4 
mCi/mrnol, 2 µCi/ml) with or without insulin (50 mU/ml) was injected 
iv. Thirty minutes after injections (12 hours after bacteria or 
saline injection) rats were again anesthetized with ether to collect 
blood and soleus muscles which were weighed immediately after removal. 
Blood samples were centrifuged (11200 x g, Beckman Microfuge 12) and 
0.1 ml plasma samples were digested in 1.0 ml of tissue solubilizer. 
Meanwhile, muscles were dried in a Thelco vacuum oven (model 10) at 
l00°c to determine the wet weight/dry weight ratio. Muscles were 
subsequently rehydrated with 0.1 ml of distilled water for 3 hours 
before they were digested in tissue solubilizer overnight at 55°c and 
their radioactivity determined. Total, extracellular and 
intracellular water were calculated as shown below: 
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Total tissue water = (wet wt. - dry wt)/wet wt. 
(ml/g) 
Extracellular space (ECS) 
(ml/g) 
musclel4c-inulin (DPM/g) 
plasma 14c-inulin (DPM/ml) 
Intracellular space was determined from the difference between total 
tissue water and extracellular water. The cellular space measurements 
in 12 hr control and bacteremic rat muscles were similar to those 
values reported by Karlstad and Sayeed (224) for control and endotoxic 
rat muscles, respectively. 
Based on cellular space measurements, the intracellular and 
extracellular contents of 14c-3MG were determined. Extracellular 14c-
3MG content ([ 14c-3MGlextracell) was calculated by dividing the plasma 
concentration of 14c-3MG by the specific activity of 14c-3MG. 
Intracellular 14c-3MG was then determined by using the following 
equation: 
[14c-3MGJintracell=(Total muscle 3MG DPM/g)-(Extracell. 3MG DPM/g) 
(nmol/ml) (14c-3MG Specific activity DPM/nmole) 
(Intracell. space ml/g) 
The ratio of [14c-3MG] in the intracellular to extracellular space, 
referred to as the distribution ratio (DR), indicates facilitated 
sugar transport when <1.0 and uphill movement of sugar into the cell 
when >1.0. 
Statistics: Plasma glucose and lactate values in control and 
bacteremic rats were compared using a Student's unpaired t test. In 
Vitro fractional efflux data was analyzed using a two factor analysis 
of variance (ANOVA), Tukey's multiple comparison test and a Trends 
analysis. In vitro washout curves (DPM/g) were fitted using linear 
regression analysis and the y-intercept (3MG compartment size) and 
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rate coefficients derived from the slope were compared using a 
Student's unpaired t test. In vivo data was analyzed using a 3 factor 
ANOVA followed by a Tukey's multiple comparison test and a Trends 
analysis on the SAS statistical computer package (Cary NC). All data 
is expressed as mean±SEM. A p<0.05 was considered significant. 
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C. RESULTS 
1) Lethality study: The lethality associated with various 
bacterial concentrations was established (Table 1). We chose 4 x 1010 
organisms/kg body wt. as the working dose for the metabolic studies. 
At this dose, the mortality was 3% at 8 hours (1/28), 53% by 12 hours 
(15/28) and 71% by 24 hours (21/28). These rats exhibited typical 
signs of sepsis including porphyrin secretion by lacrimal glands, 
piloerection and lethargy. Blood cultures were positive for Gram-
negative rods in similarly treated rats (Table 2). Bacteria were not 
present in blood taken from control rats. 
2) Plasma glucose and lactate in rats used for in vitro muscle 
study: In 8-hr bacteremic rats, plasma glucose was moderately 
elevated above the time-matched control values (Fig. 1). However, 12 
hours after bacterial injection plasma glucose was the same in control 
and bacteremic rats. Although plasma glucose did not change markedly, 
there were marked changes in plasma lactate levels with bacteremia. 
In 8- and 12- hr bacteremic rats, plasma lactate was elevated 2-fold 
above the time-matched control levels. 
3) In vitro soleus muscle 14c-3MG efflux: The biphasic efflux 
of 3MG was apparent in curves shown in Figs. 2 and 3. Efflux curves 
were similar to those described by Clausen and colleagues (78,246). 
The slow efflux phase was linear in each group (Figs. 2,3) indicating 
transport of 3MG out of a single cellular compartment. Correlation 
coefficients (r2) for linear regressions and their significances are 
also given in Figs. 2 and 3. Calculation of t 1; 2 from the regressed 
lines yielded values ranging between 25 to 30 minutes in the four 
Table 1. Twenty four hour lethality of fasted rats given various 
doses of bacteria, i.p. 
% lethality 
Number of rats 
CFU colony forming units. 
2 
20 
5 
E. coli CFUt x 1010/kg 
4 6 
71 
28 
75 
12 
8 
100 
12 
77 
78 
Table 2. Number of colony forming units (CFUs) of Gram-negative rods 
found in the blood of rats injected with 4xlol0 organisms/kg body wt. 
at 6, 12 or 18 hours post-injection. Values are rnean±SEM for rats (n) 
injected with 4 x 1010 organisms/kg body wt. 
Hours post-bacterial CFUs/ml blood n 
injection 
i 
6 3. 8±1. 7 xl06 7 
12 5.0±4.8 xl08 5 
18 1. 0±0. 7 xl06 5 
-180 
170 
160 
150 
140 
~ 130 
Cl 120 E 
- 110 
41 
en 
0 
100 
u 90 
::J 
Cl 80 
0 
E 
en 
0 
a: 
TO 
60 
50 
40 
30 
20 
10 
Plasma Glucose 
• Control 
r::I Bacteremlc 
OJ.-~--'a.:=.a...;.::A..~~~...-...;.;;;a.~.__~ 
8 hour 12 hour 
Plasma Lactate 
3.6 
• Control * 3.4 
3.2 m Bacteremic 
3. 
2.8 
-~ 2.6 
E 2A 
-41 2.2 
-
.2 2. 
u 
0 1.8 
..J 1.6 
0 E 1.4 
en 0 1.2 
a: 1.0 
0.8 
0.6 
0.4 
0.2 
O"-~--~~.:.&-~_..__.,,._;;...._~ 
79 
Figure 1. Plasma glucose and lactate concentrations in fasted 8- and 
12-hr bacteremic and time-matched control rats. Number of blood 
samples shown inside each bar. lllcontrol blood samples;~Bacteremic 
blood samples. *significant difference (p<0.05) compared to time-
matched control. Comparisons were made using a Student's unpaired t-
test. Values are given as mean±SEM. 
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Figure 2. Amount of 14c-3MG radioactivity (DPM/g) appearing in efflux 
media during each 5 minute washout period in 8-hr fasted control (A) 
and bacteremic (B) rat muscles. Values are mean±SEM. Linear 
regression equations were used to derive the rate coefficient (A), y-
intercept and correlation coefficient (r2) from the 30 to 90 minute 
interval for both groups. The significance of each correlation was 
determined using a Student's t test (p value). Control (n=l8), A 
0.025 min-1, y-intercept=357,190 dpm/g, r2=0.70 (p<0.001); Bacteremic 
(n=20), A =0.027 min-1, y-intercept=383,795 dpm/g, r2=0.70 (p<0.001). 
A and y-intercept values were not different in control and bacteremic 
rat muscles (p>0.05). 
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Figure 3. Amount of 14c-3MG radioactivity (DPM/g) appearing in efflux 
media during each 5 minute washout period in 12-hr fasted control (A) 
and bacteremic (B) rat muscles. Data was analyzed by the same method 
described in Fig. 2. Control (n=8), A = 0.020 min- 1 , y-intercept = 
272,897 dpm/g, r2=0.70 (p<0.001) and; Bacteremic (n=8), A = 0.029 
rnin-1*', y-intercept = 457,685 dpm/g *', r2=0.55 (p<0.05). *'using a 
student's unpaired t-test, both A and 3MG content (y-intercept) were 
significantly increased (p<0.05) in bacteremic rat muscles compared to 
time-matched control muscles. 
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· en in Figs. 2 and 3. 
also giv Calculation of t1;2 from the regressed 
· lded values ranging between 25 to 30 minutes in the four lines yie 
ups A t1;2 of 30 minutes for cellular efflux would treatment gro . 
result in a near complete filling of the cellular compartment during 
the 'loading' period of 60 minutes. 
The size of the cellular 3MG compartment at steady state was 
similar in noninsulin-treated muscles from 8-hr bacteremic and time-
matched control rats (Fig. 2). However, 12 hours of bacteremia was 
84 
associated with a larger 3MG compartment compared to its time-matched 
control (Fig. 3). The slope of the entire cellular portion of the 
efflux curve was used to calculate the rate coefficient of efflux. 
There was no difference between rate coefficients from 8-hr control 
and bacteremic rats (Fig. 2). However, the rate coefficient was 
significantly higher in 12-hr bacteremic rat muscles compared to the 
time-matched control values (Fig. 3). 
Fig. 4 illustrates the time course of 14c-3MG fractional efflux 
from sequential washout measurements in soleus muscles from 12-hr 
time-matched control rats. This figure also shows the effect of 
insulin on 3MG fractional efflux. Data obtained in the absence of 
insulin were comparable to those obtained for other control and 
bacteremic rat muscles, in that the fraction of radiolabel leaving the 
cell (i.e. the rate coefficient) became relatively constant by 35 
minutes of washout and remained so for the next 60 minutes. 
Fractional effluxes (i.e. rate coefficients) from 30 to 70 min washes, 
shown in Figs. 5 and 6, allowed comparisons of cellular effluxes from 
various control and bacteremic rat muscles. Basal fractional efflux 
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Figure 4. Fractional efflux of 14c-3MG/g soleus muscle from fasted 12 
hour control rats. Fractional efflux of radiolabel 14C-3MG was 
calculated for each 5 minute interval as described in the Methods 
section. Fractional efflux remained relatively constant between 35 
and 90 minutes in non-insulin treated muscles (n=8). Insulin (10 
mU/ml) transiently stimulated fractional efflux when it was added to 
the washout media between 50 and 90 minutes. Similar curves were 
obtained for 12-hr bacteremic, 8-hr bacteremic and time-matched 
control rat muscles (data not shown). 
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Figure 5. Basal (A) and insulin-stimulated (B) 14c-3MG fractional 
efflux in soleus muscles from fasted 8-hr control (~,A-n=l8, B-n=lO) 
and bacteremic ((), A-n=20, B-n=lO) rats. Values are mean±SEM. 8-hr 
bacteremic group values were not significantly different from 
corresponding controls (p>0.05, 2-factor ANOVA). 
0.06 A ClJ 
-:::::s 
c 
E 0.05 
' )( :::::s 
-ClJ 0.04 
0 
c 
0 
-u 0.03 0 
Lt ~~ i i (.!) ~ 
f'() 0.02 
I 
u 
.. 
0.01 , I I I I I I 35 40 45 50 55 60 65 
Time (minutes) 
0.06 
ClJ 
-:::::s c 
·e 0.05 
' )( :::J 
-Cl> 0.04 
0 
c 
0 
-u 0.03 0 
~ 
LL 
I (!) ~ 
f'() 0.02 
I 
u 
~ 
' 
0.01 
70 
B 
Insulin, 10 mU/ml 
' 
I I 
35 40 45 50 55 60 
Time (minutes) 
I 
65 
I 
70 
00 
00 
Figure 6. Basal (A) and insulin-stimulated (B) 14c-3MG efflux in 
soleus muscles from 12-hr bacteremic ((),A-n=8, B-n=l7) and time-
rnatched control (~, A-n=8, B-n=23) rats. Values are mean±SEM. 
Using a 2-factor ANOVA, basal 14 c-3MG efflux was elevated while 
insulin-stimulated efflux was depressed in muscles from 12-hr 
bacteremic rats compared to time-matched control muscles. *'p<0.05 
control. 
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in muscles from 8-hr bacteremic and time-matched control rats was not 
different (Fig. SA). Similar fractional efflux values were also 
observed after insulin stimulation of muscles from 8-hr bacteremic and 
time-matched control rats (Fig. SB). Basal fractional efflux in 12-hr 
bacteremic rats was significantly elevated compared to time-matched 
control muscles (Fig. 6A). The basal fractional efflux values shown 
in Figs. S and 6 were comparable to slope derived rate coefficients in 
Figs. 2 and 3. Insulin-stimulated fractional efflux was depressed in 
muscles from 12 hour bacteremic rats compared to time-matched controls 
(Fig. 6B). These data indicate that 12 hours of bacteremia inhibits 
the ability of insulin to stimulate glucose transport. The response 
to insulin in 8-hr time-matched control rat muscles was different from 
that observed in muscles from 12-hr control rats. This could be due 
to the difference in the duration of fasting and emphasizes the need 
for time-matched control measurements. 
4) In vivo 3MG transport - To determine if alterations in 
muscle sugar transport were present in vivo, 14c-3MG DRs were measured 
in intact 12-hour bacteremic and time-matched control rats between 10 
and 40 minutes after giving an injection of 14c-3MG with or without 
insulin. The DR increased linearly over time under basal conditions 
in both control and bacteremic rats (Fig. 7A). Basal DRs were not 
different in muscles from bacteremic rats compared to control muscles 
at any time point (p>O.OS) (Fig. 7A). Insulin stimulation of 3MG 
transport was apparent by 10 minutes after 3MG plus insulin 
administration in both groups (Fig. 7B). At 3S and 40 minutes, DR 
exceeded 1.0 in control muscles but not in bacteremic muscles. An 
Figure 7. DR of [3MGlintrace11/[3MGlextracell in soleus muscles 
between 10 to 40 minutes post- 14c-3MG injection in fasted 12 hour 
saline-injected([]) and bacteremic <II) rats in the presence and 
absence of insulin. Number of muscles shown inside each bar. A: 
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Basal DRs in control and bacteremic rats; B: DRs in muscles from 
insulin-treated (250 mU/kg) control and bacteremic rats. Values are 
mean±SEM. Comparisons between groups were carried out using a 3-
factor ANOVA followed by a Trends analysis for time comparisons and 
Tukey's multiple comparison test for treatment and hormone 
interactions with p<O.OS('tf) considered significant. 
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analysis of variance determined that at these two time points, DRs in 
muscles from bacteremic rats were significantly decreased compared to 
control DRs. These data indicate that insulin-stimulation leads to 
uphill transport of sugar in controls but not in bacteremic rat 
muscles. 
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D. DISCUSSION 
In this study, a bacteremic model of Gram-negative sepsis was 
used and verified by identifying Gram-negative rods in cultures of 
blood (Table 2). This model is similar to one described by Short et 
al. with 70% lethality by 24 hours (364). Although hypoglycemia was 
not evident a marked lactic acidosis developed (Fig. 1), indicating 
alterations in carbohydrate metabolism in this model of sepsis. A 
similar hyperlactacidemia has been reported in other bacteremic animal 
models (193,364,420) and has been attributed to an overall increase in 
anaerobic glucose metabolism (193). 
Alterations in carbohydrate metabolism during sepsis have been 
observed both clinically and experimentally (88,175,193). Although 
some investigators have not observed alterations in muscle glucose 
utilization during sepsis (361), others have documented changes in 
overall muscle glucose utilization and in pyruvate dehydrogenase 
activity (274,325,326,397). Alterations in glucose transport may also 
contribute to changes in muscle glucose utilization. 
To study glucose transport, glucose analogs such as 3MG or 2-
deoxyglucose (2DG) are used. 3MG is the preferred analog (366) 
because it is transported but not further metabolized while 2DG is 
transported and phosphorylated by hexokinase. Under pathological 
conditions, phosphorylation may also be a rate-limiting step and thus, 
may complicate interpretation of changes in the transport process. To 
study 3MG transport in vitro, we used the technique of Clausen and 
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colleagues (227,246) which measures 3MG efflux. The efflux technique 
allows the measurement of both the rate coefficient of the transport 
cess and the steady state cellular uptake of 3MG (246). pro 
A change in rate coefficient reflects alteration(s) in the 
transporter independent of any change in fluxes due to altered 
substrate concentrations (78). In the absence of insulin, rate 
coefficients calculated from the slope of the monoexponential efflux 
curve (Figs. 2,3) and from individual wash-out periods (Figs. 5,6) 
were within 5% of each other in all groups of muscles. Due to the 
transient effect of insulin on 14c-3MG efflux, the slope of the 
monoexponential curve was not an adequate indicator of the insulin 
effect. Instead, A derived from individual washouts gave a better 
resolution of the insulin effect. 
Fractional efflux curves obtained in this study (Figs. 5,6) were 
qualitatively similar to those described by Kohn and Clausen (245,246) 
although quantitative differences can be found between the two 
studies. Basal rate coefficients ranged from 0.015 to 0.025 min-1 in 
the present study while Kohn and Clausen measured slightly lower 
values. This difference was most likely due to differences in 
incubation temperatures. In both studies, maximal doses of insulin 
(10-100 mU/ml) produced a 4-fold increase in rate coefficients in 
muscles from control rats (246). 
The technique for measuring 14c-3MG transport in vivo in this 
study was similar to the one described by Hom et al. (197,198). One 
limitation of their method was that changes in plasma glucose could 
alter the uptake of sugar analogs due to competition between 
bstrates (197,249). In the present study, the influence of plasma 5U 
iucose changes was eliminated by calculating the distribution ratio g 
of intracellular to extracellular 3MG concentrations rather than the 
cellular uptake. The time course of insulin stimulation of soleus 
97 
muscle sugar transport in the present study was similar to that found 
by Hom et al. (198). They found maximal stimulation was obtained 
between 30 to 60 minutes following the injection of insulin. 
The in vitro measurements revealed that basal and insulin-
stimulated glucose transport was not affected by 8 hours of 
bacteremia. At this time point, rats developed hyperlactacidemia but 
lethality was still very low (3%). Although the increased plasma 
lactate indicated metabolic changes, muscle membrane sugar transport 
was presumably unaffected (Figs. 2,5). After 12 hours of bacteremia, 
a consistent increase in basal 3MG transport was observed under in 
vitro conditions compared to time-matched control muscles (Figs. 3,6). 
The increased basal transport was evident from measurements of both 
rate coefficients and steady state cellular 3MG uptake. Several 
possible mechanisms may explain this result. Previous studies 
(28,245,369) have shown that an increased influx of Na+ in muscle 
resulted in increased basal sugar transport. In septic animals, 
membrane permeability to Na+ (PNa) has been shown to increase in 
skeletal muscles (137) which may account for the observed increase in 
basal sugar transport found in vitro after 12 hours of bacteremia. 
Other investigators have shown that elevated basal glucose oxidation 
could be due to monokines (362) which are released during sepsis 
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(Z67). The trend for elevated basal glucose transport under in vitro 
conditions was not found in the in vivo experiment. 
The complexity of whole animal experiments probably led to 
different results between the in vivo and in vitro experiments. 
Hormonal or membrane compensations present within the animal but not 
in the in vitro media may account for the discrepancy in results. 
Catecholamines are elevated in septic rats (219,319,361) and both 
epinephrine (E) and norepinephrine (NE) stimulate the Na+/K+ ATPase 
pump (82,136). In vitro muscles were probably not under the influence 
of catecholamines since transport was measured after a 60 min loading 
period. As a result, the increased PNa present in septic muscle (137) 
may result in elevated sugar transport under in vitro conditions. The 
elevated catecholamine levels present under in vivo conditions may 
restore the transmembrane Na+ gradient in bacteremic rat muscles and 
return basal sugar transport to the same level found in control rat 
muscles. 
Despite the elevation in basal 3MG transport under in vitro 
conditions, insulin-stimulated transport was depressed in muscles from 
12 hour bacteremic rats compared to time-matched controls (Fig. 6). 
The diminished insulin-mediated response occurred when both lethality 
(50%) and plasma lactate were markedly increased. Thus, continued 
metabolic deterioration during the course of bacteremia may lead to 
adverse changes in membrane sugar transport and in turn, lead to 
muscle glucose metabolic defects and augmented lethality. 
Generally, skeletal muscle glucose transport is thought to be a 
facilitated diffusion process and not a concentrative process. In 
. tudy the increase in DR above unity, in vivo, in muscles from 
tb1S S ' 
1 . -treated control rats suggests a concentrative process (Fig. insu 1n 
The However, the mechanism of this process remains unknown. 7). 
finding of DR values being equal or less than unity in muscles of 
insulin-treated bacteremic rats may indicate an abrogation of the 
"concentrative" process. 
99 
Insulin receptor or post-receptor defects may be responsible for 
the decrease in insulin-mediated sugar transport observed in vitro and 
in vivo. Insulin receptors may be down-regulated subsequent to a 
bacteremia-induced hyperinsulinemia (319). Post-receptor changes 
including decreased insulin-mediated tyrosine kinase activity or 
altered intracellular signaling may also be responsible for the 
decrease in insulin-mediated sugar transport. The absence of any 
observable change in basal and insulin-stimulated sugar transport in 
muscles from 8 hr bacteremic rats may be due to an absence of any 
alterations in the PNa> insulin receptor or post-receptor defect at 
that stage of bacteremia. 
Altered glucose utilization during sepsis has been the subject 
of numerous investigations. The inappropriately low peripheral 
glucose utilization observed in septic and surgical patients (88,175) 
has been attributed in large part, to decreased skeletal muscle 
glucose utilization (88,326). More recent studies indicate that 
peripheral glucose utilization was actually increased following 
endotoxin administration and therefore, muscle glucose utilization was 
probably elevated (429). Several other investigators have directly 
documented changes in muscle glucose utilization during sepsis. 
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Elevated basal glucose utilization has been reported in rat soleus 
muscles following cecal ligation and puncture (CLP) (420). Filkins 
and Figlewicz (132) also reported elevated glucose uptake in 
diaphragms from endotoxic rats. The results of the present study 
support increased basal muscle glucose utilization previously observed 
during sepsis. Previous studies have shown insulin stimulation of 
glucose utilization to be either unaffected or impaired. Wichterman 
et al. (420) reported no change in soleus muscle glucose uptake in the 
--
presence of insulin (0.5 and 5.0 mU/ml) 16 to 24 hours after CLP. 
However, Raymond and colleagues (274,325) found that glucose uptake by 
gracilis muscles from dogs exposed to endotoxin (0.5 mg/kg) or~. coli 
did not become elevated in response to an insulin infusion (19.4 mU/kg 
x min). Similar results have been reported in soleus muscles from 
acutely uremic rats (276). The rate-limiting steps which may alter 
glucose utilization during sepsis include glucose transport, 
hexokinase, phosphofructokinase and pyruvate dehydrogenase. The 
present study shows that during sepsis, insulin stimulated membrane 
glucose transport is altered. Ryan and Clowes (337) showed that 
insulin-stimulated pyruvate dehydrogenase activity was depressed in 
diaphragms removed from cecal-ligated-rats. These observations are 
supported by the subsequent findings (274,325) of an attenuated effect 
of insulin on glucose utilization during the septic state. 
Alterations in these glucose metabolic rate-limiting steps during 
sepsis are important as they could ultimately affect energy 
availability for the muscle. 
CHAPTER III 
BASAL AND INSULIN-STIMULATED SKELETAL MUSCLE SUGAR TRANSPORT 
IN ENDOTOXIC AND BACTEREMIC RATS 
A. INTRODUCTION 
Alterations in carbohydrate metabolism during the course of 
sepsis have been observed in several studies. Whole body glucose 
disposal is often elevated (429) and muscle is thought to contribute 
to the increase in glucose utilization (13). Paradoxically, sepsis is 
associated with attenuated insulin-mediated glucose utilization (325). 
Studies on muscle glucose metabolism during sepsis confirm the 
increase in basal glucose utilization (420) and the blunting of 
insulin-stimulated glucose utilization (325). 
Recently, our studies have shown that alterations in muscle 
membrane glucose transport also may contribute to changes in glucose 
utilization during sepsis (413). Soleus muscles removed from fasted 
rats given Escherichia coli bacteria exhibited an increase in basal 
sugar transport with attenuated insulin-stimulated transport. Studies 
carried out in vivo revealed that although soleus muscle basal sugar 
transport was comparable to controls, insulin-mediated (250 mU/kg) 
transport remained attenuated in bacteremic rats. The blunting of 
insulin action on muscle membrane glucose transport could contribute 
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the altered muscle carbohydrate metabolism observed during the to 
course of sepsis. 
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The purpose of the present study was to characterize insulin 
stimulation of muscle membrane glucose transport during sepsis. 
Whereas one maximal dose of insulin was used in the previous study 
(413), this study evaluated the dose-response relationship to gain a 
more complete understanding of the coupling between the insulin 
receptor and glucose transport. The sensitivity and responsiveness of 
soleus muscle glucose transport to insulin stimulation was tested in 
the 12 hr fasted bacteremic model described in the previous study. 
Soleus muscle primarily consists of slow-twitch, oxidative fibers (7) 
which are considered highly insulin-sensitive (245). In this study, 
glucose transport was evaluated also in epitrochlearis muscle which 
consists of 65% fast-twitch, glycolytic, 10-15% slow-twitch, 
oxidative, and 20% fast-twitch oxidative fibers (305). Finally, 
muscle sugar transport was measured in endotoxic rats to determine 
whether the changes in basal and insulin-mediated sugar transport 
observed in bacteremia were common to both models. Studies of 
alterations in sugar transport in several skeletal muscle types and 
models of sepsis and septic shock might identify the primary 
regulatory site(s) for changes in glucose metabolism observed in 
septic patients. 
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B. MATERIALS AND METHODS 
1) Animal model: Male Holtzman rats weighing 80-100 g were 
given an intraperitoneal (ip) injection of live ~- coli (American Type 
culture Collection 25922, 4 x 1010 organisms/kg body wt in 0.5 ml), iv 
with Salmonella enteritidis endotoxin (DIFCO, Boivin preparation; 40 
mg/kg in 0.5 ml), or saline (0.5 ml) after a 15 hr fast. All 
injections were done under light ether anesthesia and rats were 
allowed water ad libitum throughout the experiment. Endotoxin-
injected rats (E) and time-matched controls (C-5) were killed by 
decapitation 5 hrs after injection while rats injected with bacteria 
(B) along with time-matched controls (C-12) were killed by 
decapitation 12 hrs after injection. In each group, blood samples 
were collected and centrifuged for analysis of plasma glucose (Yellow 
Springs Instruments, YSI 23A glucose analyzer) and lactate (YSI 23L 
lactate analyzer) and soleus muscles were rapidly excised. In some 
experiments, epitrochlearis muscles were excised from 12-hr bacteremic 
and time-matched control rats. All muscles were mounted on aluminum 
holders and kept at resting length throughout the experiment. 
2) Preparation of E. coli: ~- coli cultures were prepared as 
described previously (413). Briefly,~- coli was grown on blood agar 
plates and maintained on brain-heart-infusion (BHI) slants. Bacteria 
from the slants were grown sequentially in two 5 ml tubes of BHI broth 
and the second culture was used to inoculate 500 ml of BHI media which 
was cultured for 12 hrs. All cultures were incubated at 33°c in a VIP 
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incubator (model 417). Bacteria were harvested by centrifuging the 
suspension and resuspending the pellet in sterile, isotonic saline. 
Bacterial concentration was determined using absorbance (620 nm) and 
dilution pour plate methods described in an earlier paper (413). 
3) 3MG efflux from isolated muscles: Glucose transport was 
evaluated as described previously (420). Briefly, efflux of 14c-3-0-
methylglucose (14c-3MG) from isolated soleus or epitrochlearis muscles 
was measured after incubating muscles in 3.0 ml of Krebs-Ringer-
Bicarbonate (KRB) 'loading' media containing 118 mM NaCl, 1.2 mM 
MgS04 , 1.2 mM KH2P04, 4.7 mM KCl, 2.5 mM CaCl2, 24 mM NaHC03 plus 2.3 
mM pyruvate, 2.0 mM 3-0-methylglucose (3MG) and 4 µCi 14c-3MG for 60 
min. Epitrochlearis muscles were 'loaded' in 2.0 ml of the KRB 
solution containing 5 µCi 14c-3MG. All incubations were carried out 
at 37°c in a metabolic shaker bath and were continuously gassed with a 
humidified 95%02:5%C02 mixture. Muscles were sequentially washed in 
vials containing radioisotope-free KRB (2.5 ml for soleus, 2.0 ml for 
epitrochlearis) for 5 min intervals at 37°C for 70 min following the 
'loading' period. To determine the effect of insulin on sugar 
transport, insulin was added in concentrations ranging from 0.1 to 200 
mU/rnl (0.7-1300 nM), in 50- through 70-min wash vials. At the end of 
the washout, soleus muscles were lightly blotted on filter paper 
(Whatman 42), weighed and digested overnight in 2.0 ml of TS-1 tissue 
solubilizer (Research Products International) at ss0 c. Epitrochlearis 
muscles were treated similarly but were digested in 1.0 ml of tissue 
solubilizer. The radioactivity in the washout media and digested 
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Cles was counted in a liquid scintillation counter (Packard Tri-mus 
carb 460) and corrected for quenching. 
The radioactivity remaining in a muscle (DPM/g) after each wash 
was quantified by adding muscle counts to those in the media in a 
retrograde fashion. 14c-3MG efflux curves exhibited a biphasic 
pattern consisting of an initial rapid efflux of radioactivity from 
the extracellular compartment followed by a more prolonged 
monoexponential phase representing the transport of radiolabel 3MG 
from the intra- to extra-cellular compartment (245,413). The rate 
coefficient or fractional efflux value (A ,min-1) was estimated from 
the prolonged monoexponential phase by measuring the proportion of 
14c-3MG leaving the muscle cell per unit time for each wash interval 
as given below: 
Fractional efflux (~) (Initial DPM/g - Final DPM/g)/(Initial DPM/g) 
5 minutes 
The stimulation of transport by insulin was assessed at the highest 
fractional efflux value obtained for each dose of insulin. 
4) Statistics: A Student's t-test was used to compare plasma 
glucose and lactate values in experimental (i.e. bacteremic or 
endotoxic) and control rats. Fractional efflux in control and 
experimental muscles were compared using a repeated measures 2-way 
analysis of variance (ANOVA) followed by Tukey's multiple comparison 
test on the SAS statistical package (Cary, NC). Maximal response and 
EC5os (1/2 effective concentration) for control and experimental 
muscles were determined from the percent increase in insulin-
stimulated efflux (% increase above basal efflux) for each dose of 
insulin using the ALLFIT (Biomedical Computing Technology Information 
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center, Vanderbilt Medical Center) computer program (108). Control 
and experimental EC50 and maximal responses were compared using a 
Student's unpaired t-test. All data is expressed as mean±SEM with 'n' 
indicating the number of muscles in each group. A p<0.05 was 
considered significant for all statistical analyses. 
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C. RESULTS 
1) Lethality data and plasma metabolites. Lethality in the 
bacteremic model has previously been shown to be 55% at 12 hrs and 70% 
by 48 hrs (413). The rats given~- enteritidis endotoxin exhibited 
33% mortality (26/78 rats) at 5 hrs and 73% mortality at 48 hrs 
(43/59). Plasma glucose (PG) and lactate (PL) were measured as 
indices of metabolic alterations at the time muscles were removed from 
endotoxic or bacteremic rats and their respective time-matched 
controls. Plasma lactate increased in 12-hr bacteremic rats compared 
to time-matched controls (B = 2.7±0.2 mM, n=28; C-12 = 1.1±0.2 mM, 
n=28; p<0.05) while plasma glucose remained unchanged (B = 93.6±2.7 
mg%, n=28; C-12 = 95.3±1.8 mg%, n=28; p>0.05). At 5 hrs post-
endotoxin injection, a more marked increase in plasma lactate (E 
4.9±0.3 mM, n=49; C = 1.1±0.1 mM, n=44; p<0.05) plus a decrease in 
plasma glucose (E = 56.7±4.7 mg%, n=49; C = 95.3±1.7 mM, n=44; p<0.05) 
was found compared to control values. The lethality and plasma levels 
of metabolites in bacteremic and endotoxic rats indicated metabolic 
disturbances in the experimental rats at the time muscles were 
removed. 
2) Basal membrane sugar transport in muscle. As in previous 
studies (245,413) fractional efflux representing the prolonged 
monoexponential phase of 14c-3MG efflux was constant by 35 min of 
washout. Therefore, washouts from 35 min on were analyzed in the 
present study. Basal 14 c-3MG transport was similar among control 
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muscles (Table 1). However, basal 14c-3MG transport in muscles from 
l2-hr bacteremic rats was elevated compared to controls (Table 1) as 
was reported previously (413). Transport was also increased in 
epitrochlearis muscles from bacteremic rats compared to time-matched 
control values (Table 1). Comparable results were found in soleus 
muscles from endotoxic rats, where basal transport increased compared 
to control rat muscles (Table 1). The results of these experiments 
indicate that elevated basal sugar transport in muscle was common to 
different models of septic shock, as well as in muscles of diverse 
fiber types. 
3) Insulin-stimulated membrane sugar transport in rat soleus 
muscle. In 12-hr bacteremic and 5-hr endotoxic rats as well as their 
respective time-matched controls, insulin stimulated soleus muscle 
membrane sugar transport in a dose dependent, saturable manner (Figs. 
1,2). Transport in 12-hr control rat muscles (Fig. 1) was stimulated 
with as little as 0.10 mU/ml of insulin; 1.0 to 10.0 mU/ml insulin was 
required to maximally stimulate 3MG transport. Results with 10.0 
mU/ml of insulin are comparable to those obtained in a previous study 
(413). In 5-hr control muscles (Fig. 2), 0.25 mU/ml of insulin was 
required to stimulate transport with 100 mU/ml insulin required to 
attain maximum stimulation. Maximal insulin-stimulated transport was 
similar among 5-hr and 12-hr control muscles (Table 2). 
In muscles from bacteremic rats, 0.10 mU/ml insulin stimulated 
transport with maximal stimulation occurring at an insulin 
concentration of 10.0 mU/ml (Fig. 1). Transport in bacteremic and 
control muscles was not further stimulated with 100 mU/ml of insulin 
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Table 1. Basal 14c-3MG fractional efflux in soleus and epitrochlearis 
muscles from 12 hr fasted bacteremic (B), and 5 hr fasted endotoxic (E) 
rats and their respective time-matched controls (12-hr-C, 5-hr-C). 
Treatment 
12-hr-C 
12-hr-B 
5-hr-C 
5-hr-E 
Muscle 
Soleus 
Epitrochlearis 
Soleus 
Epitrochlearis 
Soleus 
Soleus 
n 
56 
16 
48 
16 
82 
84 
Basal 14c-3MG Efflux 
/... (min-l)t 
0.0195±0.0007 
0.0193±0.0019 
0.0221±0.0007* 
0.0259±0.0013* 
0.0188±0.0005 
0.0209±0.0006* 
iFractional effluxes in experimental (B,E) and control (C) muscles 
were compared using a Student's unpaired t-test. Values shown are 
mean±SEM with p<0.05 (*) considered significant. 
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Figure 1. The effect of insulin dose on 14c-3MG efflux in 12 hr fasted 
bacteremic (B,()) and time-matched control (C-12,~) rat soleus muscles. 
Insulin concentrations ranged from 0.1 to 10.0 mU/ml as shown by A) 
0.10 mU/ml (C-12 n=8, B n=8); B) 0.50 mU/ml (C-12 n=8, B n=8); C) 1.00 
mU/ml (C-12 n=8, B n=8); and D) 10.00 mU/ml (C-12 n=8; B n=8). Efflux 
responses to representative insulin doses are shown to demonstrate the 
shift from an enhanced to an attenuated response in bacteremic rat 
muscles compared to controls with increasing insulin concentrations in 
the media. Fractional efflux values are mean±SEM with a p<0.05 ("'k) 
considered significant. A 2-factor, repeated measures A.NOVA followed 
by Tukey's multiple comparison test was used to compare fractional 
efflux in bacteremic and control rat muscles using the SAS statistical 
package. 
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Figure 2. The effect of insulin dose on 14c-3MG efflux in soleus 
muscles from 5 hr fasted endotoxic (E,()) and time-matched control (C-5, 
~) rats. Insulin concentrations ranged from 0.10 to 100.00 mU/ml as 
shown by A) 0.10 mU/ml (C-5 n=lO, E n=lO); B) 0.25 mU/ml (C-5 n=lO, E 
n=lO); C) 1.00 mU/ml (C-5 n=9, E n=9); and D) 100.0 mU/ml (C-5 n=9, E 
n=8). Insulin doses shown reflect the shift in response described in 
Fig. 1. Statistical analyses were carried out as described in Fig. 1 
with a p<0.05 (-tc) considered significant. 
113 
0.()6 A 0.06 I 
.. 
I! 
:;J ; lnaulin, 0.1 mUhnl .!: 
.E ~ 0.05 lnaulln,0.2$...Ullnl 
.€ 
0.05 J l .. 
.. i! :;J 
i;: '; 
.. 0.04 0 0.04 
1 c • ~ u ~ 0.03 0 003 ~ 
..... 
• • C> C> ~ ~ 0.02 
"' 
0.02 
"' 
I 
I u 
u ! 
! 
0.01 I I I I I I I I I I I I I I I 0.01 I I I I I I I I I I I I I I I I I 
35 40 45 50 55 60 65 10 75 35 40 45 50 55 60 65 10 15 
Time (minutes) Time (minutes) 
0.07 D 
l1t1Uiin, IOOmU/ml 
0.06 c .. 006 l :; 
c 
.. ~ ~ INulin,1.0mU/ml c 0.05 ~ E l 0.05 
' .. .. 
E 0.04 g 0.04 
.. -~ I u 0 
8 o.o:s it 0.03 C> 
... ~ IL. 
"' C> I l! 0.02 u 0.02 
"' 
! 
I 
u 
! 
0.01 I I I I I I I I I I I I I I 0.01 I I I I I • I I I I I I I I 35 40 45 50 55 60 65 10 15 35 40 45 50 55 60 65 10 75 
Time (minutes) Time (minutes) 
114 
Table 2. Maximum response (min- 1 , and % stimulation) and EC50 (nM) 
values in 12 hr bacteremic (B), 5 hr endotoxic (E) and time-matched 
control (12-hr-C, 5-hr-C) rat soleus muscles. 
Treatment EC50 Maximal Response 
nM %increase above basal 
12-hr-C 1. 34±0. 23 0.0599±0.0018 226.30±17.29 
12-hr-B 1.16±0. 26 0.0515±0.0024* 144. 90±12. 4 7'~ 
5-hr-C 2.39±0.65 0.0586±0.0021 221. 44±18. 74 
-·- 134.64± 9.48* 5-hr-E 0.92±0.20* 0.0512±0.0019A 
tvalues were derived from the insulin dose-response curves shown in 
Figs. 3 and 4 using the ALLFIT computer package. The maximum responses 
and EC50 in experimental (B,E) and control (C) were compared using a 
Student's unpaired t-test. Values are mean±SEM with p<0.05 (*) 
considered significant. 
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= 0.0492±0.0021 min-1, n=8; BA= 0.0437±0.0020 min- 1 , n=8). To (C-12\ 
assess glucose transport sensitivity and responsivity to insulin, 
fractional efflux in the presence of insulin (Fig. 1) as well as the 
ALLFIT dose-response curves (Fig. 3) were analyzed for 12 hr bacterernic 
and control rat muscles. Greater stimulation of sugar transport was 
observed in bacteremic rat soleus muscles at low insulin concentrations 
(0.10 mU/ml) compared to time-matched controls (Fig. 1). At 0.25 and 
0.50 mU/ml of insulin, 3MG transport was similar in muscles from 
control and bacteremic rats (Fig. 1) although the degree of stimulation 
in bacteremic rat muscles was attenuated compared to controls due to 
increased basal transport (Fig. 3). Maximal stimulation of transport 
using 1.0 and 10.0 mU/ml insulin was significantly (p<0.05) lower in 
bacteremic rat muscles compared to controls (Fig. 1). Dose-response 
analysis (ALLFIT, Fig. 3) revealed that the sensitivity (EC50) of 
insulin-mediated transport in bacteremic rat muscles tended to increase 
compared to controls although the difference was not significant due to 
the large variance in the calculated EC50 (Table 2). Maximal percent 
stimulation by insulin (ALLFIT, Fig. 3, Table 2) was clearly lower in 
bacteremic rat muscles compared to controls. 
Membrane 3MG transport in epitrochlearis muscles from 12-hr 
bacteremic rats was measured to determine whether changes in membrane 
sugar transport were present in fast-twitch, glycolytic muscle. An 
elevated basal 3MG transport (Table 1) and attenuated insulin-mediated 
transport (Fig. 4) at high insulin concentrations compared to control 
values indicated that alterations in the sugar carrier were also 
present in fast-twitch, glycolytic muscles. 
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Figure 3. Insulin-mediated 14c-3MG transport (% increase above basal) 
dose-response curve for soleus muscles from 12 hr fasted bacteremic (B, 
()) and time-matched control (C-12,~) rats. The curves were generated 
using the ALLFIT computer package. 
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Figure 4. Basal and insulin-mediated (10 mU/ml) 14c-3MG efflux in 
epitrochlearis muscles from 12 hr fasted bacteremic ((), n-16) and 
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time-matched control (~. n~l6) rats. Values are mean±SEM with p<0.05 
('tr) considered significant. Fractional efflux in bacteremic and 
control rat muscles was compared with a 2-factor, repeated measures 
ANOVA and Tukey's multiple comparison test using the SAS computer 
package. 
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At 0.10 mU/ml, insulin significantly stimulated transport in 
Cles from endotoxic rats and 100 mU/ml of insulin was required for mus 
the maximal transport response (Fig. 2). Sugar transport was not 
stimulated any further with 200 mU/ml insulin (EA= 0.0466±0.0021, n 
9; c-5A = 0.0537±0.0038, n = 10). As with bacteremia, low 
concentrations of insulin (0.10 and 0.25 mU/ml) stimulated transport 
more in endotoxic-treated muscles compared to time-matched controls 
(Fig. 2). At intermediate insulin doses (0.25 to 1.0 mU/ml), muscle 
membrane transport was elevated to similar levels in endotoxin-treated 
and time-matched controls (Fig. 2). As in bacteremic rat soleus 
muscles, 3MG transport with 10.0 and 100.0 mU/ml insulin was 
significantly attenuated in endotoxic rat muscles compared to time-
matched control values (Fig. 2). The greater increase in fractional 
efflux at low insulin concentrations in endotoxic rat muscles was 
supported by the ALLFIT analysis (Fig. 5) showing a decreased EC 5o in 
the endotoxic group compared to controls (Table 2). The maximal 
response determined with ALLFIT was significantly attenuated in muscles 
from endotoxic rats (Fig. 5, Table 2) compared to controls as was shown 
by the fractional efflux measurements at the high insulin 
concentrations of 10.0 and 100.0 mU/ml. Overall, the fractional efflux 
data and the ALLFIT analyses for both endotoxic and bacteremic rat 
muscles indicated a trend for an increased sensitivity of muscle 
glucose transport to insulin with significant attenuation of maximal 
insulin-mediated transport. 
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Figure 5. Insulin dose response curve for 5 hr endotoxic (E,()) and 
time-matched (C-5, ~) control rat soleus muscles. Curve was generated 
as described in Fig. 3. 
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D. DISCUSSION 
This study has provided further information about changes in the 
muscle membrane glucose carrier which occur during a Gram-negative 
septic injury. An endotoxic shock model described previously by our 
laboratory (223) was used in addition to the previously used ~. coli 
bacteremic model (413). Five hrs after endotoxin administration, the 
rats exhibited a pronounced hypoglycemia and hyperlactacidemia 
accompanied by approximately 40% lethality. The bacteremic model was 
associated with 50% lethality at 12 hrs and hyperlactacidemia. The 
pronounced hypoglycemia described in endotoxic models (223,429) was not 
as evident with bacteremia. Both models resulted in 70-90% lethality 
by 48 hrs. The similarity in the lethality at the time of muscle 
removal and at 48 hrs along with the rise in plasma lactate provided 
the rationale for comparing cellular processes in muscles from 
endotoxic and bacteremic rats. 
The measurements of sugar transport in 12-hr bacteremic rat 
soleus and epitrochlearis muscles and in 5-hr endotoxic soleus muscles 
(Table 1) confirmed that basal transport is elevated during the 
development of septic shock as was shown previously by this laboratory 
(413). Since skeletal muscle constitutes approximately 40% of body 
mass and consumes approximately 35% of the available glucose in control 
rats (101), the increase in basal glucose transport activity found in 
muscles from septic rats may contribute to elevated glucose utilization 
observed in various septic animal models (420,429) and in septic 
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patients (89). Increased basal 2-deoxyglucose uptake also has been 
reported in epitrochlearis muscles from endotoxin-treated rats (13). 
The mechanism(s) responsible for changes in basal glucose transport are 
unknown. 
Other physiological and pathophysiological events also alter 
basal glucose transport. Investigators have shown that exercise 
stimulated (436) glucose transport in perfused hindlimb preparations 
while denervation decreased basal glucose transport measured in vitro 
(SO) but not in vivo (389). Unlike denervation, 'unloading' of rat 
soleus muscle for 6 days in vivo (a procedure which leads to muscle 
disuse with altered neural input) leads to an elevation of in vitro 
basal glucose transport (185). These studies indicate that neural 
influences can modulate muscle glucose transport. Studies have also 
been done to examine the effect of diet on sugar transport. Starvation 
resulted in an increase in basal transport (42) while carbohydrate 
feeding reduced the exercise-induced increase in basal 3MG transport 
(436). Streptozotocin-induced diabetes in rats caused a reduction in 
basal glucose transport in epitrochlearis muscles (403). Circulating 
monokines, which are produced in response to endotoxin, also alter 
glucose transport (258). Lee et al. (258) reported that tumor necrosis 
factor (TNF) and an unidentified monokine caused an increase in basal 
glucose transport in the L6 muscle cell line. Thus, alterations in 
neural and humoral influences, and circulating insulin levels, which 
are implicated in the septic injury process, modulate glucose transport 
activity and may be involved in altering glucose transport in sepsis. 
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Mechanisms responsible for the observed increase in basal 
glucose transport following bacterial or endotoxin injection may be 
related to cellular respiratory activity. Decreased mitochondrial ATP 
generation without a change in total tissue ATP is known to increase 
membrane glucose transport (442). In several studies, a change in 
skeletal muscle redox state signaling a shift from aerobic to anaerobic 
metabolism was associated with unaltered total tissue ATP and energy 
charge. The observed increase in basal glucose transport was 
presumably due to decreased aerobic mitochondrial ATP generation 
(420,442). The elevated basal 3MG transport with endotoxemia and 
bacteremia observed in the present study may result from this type of 
metabolic shift. 
The decreased responsiveness of the muscle glucose transporter 
to insulin and the possible shift in insulin sensitivity following 
endotoxic or bacterial injury may result from alterations in insulin 
receptor-glucose transport coupling. Starvation (42), denervation 
(389) and anoxia (442) also have been associated with changes in 
insulin-mediated glucose uptake or transport. These studies implicated 
altered membrane receptor number, insulin-glucose transport coupling or 
the availability of glucose transporters. 
The number of insulin receptors may be reduced during a septic 
injury and this may lead to the reduced 3MG transport response observed 
in muscles incubated with high doses of insulin (10-100 mU/ml). A 
reduction in insulin binding has been described following anoxia (441), 
high fat diets (172), and obesity (203). Investigators also have noted 
the presence of post-receptor defects in these models (172,203,441). 
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However, the decrease in receptor number contributing to a decrease in 
responsiveness was accompanied by a shift in sensitivity to the right 
as discussed by Flier (139). Since in our study, there was a shift in 
sensitivity to the left in the endotoxic rat muscles (Fig. 5, Table 2) 
and a somewhat similar tendency in the bacteremic rat muscles (Fig. 3, 
Table 2), the decreased responsiveness in these two groups could not be 
ascribed to a loss of available insulin receptors. In some conditions, 
such as streptozotocin-induced diabetes, a decrease in insulin 
responsiveness was actually associated with an increase in the number 
of insulin receptors rather than a decrease (51). 
The decreased responsiveness could be alternatively due to an 
alteration in post-insulin-binding events. Altered skeletal muscle 
glucose metabolism with such pathophysiological models as denervation 
(140), diabetes (51), and uremia (276) has been attributed to post-
insulin binding defects. Studies focusing on post-insulin binding 
defects have described alterations in insulin ~-subunit tyrosine kinase 
activity in skeletal muscle following diabetes (51) and obesity (261). 
In these conditions, both autophosphorylation of tyrosine kinase and 
phosphorylation of exogenous substrates by this enzyme were 
significantly reduced (51,261). An alteration in the ATP binding site 
on the insulin ~-subunit also has been described and linked to a 
decrease in responsiveness to hormone (76). The exact nature of the 
insulin signal which activates glucose transport remains unknown. 
Recent investigations have shown a role for ca2+_calmodulin-dependent 
process(es) (166), protein kinase C (33), cGMP and cAMP (15), and 
adenosine (366) in insulin signaling of the transport process. Other 
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studies have shown that ions (e.g. ca2+, Na+) may be involved in 
insulin-mediated transport (85). These ions are normally kept 
regulated but during sepsis their gradients may be altered (349) and 
lead to the changes observed in glucose transport. Additionally, 
insulin is believed to increase glucose transport by mobilizing the 
cytosolic transporters into the plasma membrane (410). Decreased 
intracellular stores of glucose transporters available for 
incorporation into the plasma membrane may also account for a decrease 
in insulin-mediated glucose transport. Alterations in insulin receptor 
tyrosine kinase, ATP available for ~-subunit phosphorylation and/or 
post-receptor mechanisms may account for the findings in the present 
study. 
CHAPTER IV 
SKELETAL MUSCLE CALCIUM UPTAKE IN BACTEREMIC RATS 
A. INTRODUCTION 
Investigators have reported alterations in cellular calcium 
regulation in various organs of animals in endotoxin shock or in 
isolated tissue/cell/organelle preparations exposed to endotoxin in 
vitro (186,201,272,350,373). Direct addition of endotoxin to 
~
incubation media resulted in decreased ca2+ uptake in cardiac 
sarcoplasmic reticulum (186) and decreased ca2+ ATPase activity (201). 
Calcium regulation appeared to be altered in the livers of endotoxic 
rats (272,350,373). Nelson and Spitzer (300) reported altered ca2+ 
regulation in adipocytes from endotoxic rats while Sayeed and Maitra 
(350) observed increased cytosolic free ca2+ in hepatocytes from 
endotoxic rats. Studies have also shown altered hormone-mediated 
intracellular calcium mobilization in livers of endotoxic rats (272). 
Moreover, diltiazem treatment of rats prevented changes in cellular 
calcium regulation in endotoxin-injected rats (272,350). Recently, 
treatment of bacteremic mice with ca2+ channel blockers increased 
survival (40). Alterations in cellular ca2+ regulation may occur in 
several tissues including skeletal muscle. 
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Our previous studies in bacteremic and endotoxic rats have shown 
altered skeletal muscle glucose transport (413,416). Holloszy and 
Narahara (196) first proposed that calcium may modulate membrane 
glucose transport. Experiments in skeletal muscle indicate that agents 
known to increase basal glucose transport also increase ca2+ efflux and 
that changes in cell Ca2+ are thought to mediate the effects of these 
agents on glucose transport (80). In addition, ca2+ has been shown to 
modulate insulin-mediated sugar transport in adipocytes (118,312). 
These modulatory effects of ca2+ led us to hypothesize that altered 
ca2+ regulation contributes to the changes observed in basal and 
insulin-mediated sugar transport during bacteremia. 
The objective of the present study is to determine whether or 
not there are alterations in ca2+ regulation in skeletal muscle of 
bacteremic rats. The cellular ca2+ regulation was assessed through 
measurements of ca2+ uptake in resting and depolarized (60 mM K+) 
soleus muscles from control and bacteremic rats. Bacteremic rats were 
treated with diltiazem to determine whether alterations in ca2+ 
regulation could be attenuated or prevented by this treatment. 
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B. MATERIALS AND METHODS 
1) Animal model. Male, Holtzman rats (80-100 g) were fasted 
overnight and given san intraperitoneal (ip) injection of sterile 
saline (control) or bacteria (4 x 1010 Escherichia coli/kg). Bacteria 
were prepared as described previously (413). In some rats, an 
intravenous (iv) injection of diltiazem (2.4 mg/kg) was administered to 
rats 10 hrs after bacterial or saline injection. Twelve hrs after 
bacterial or saline injection, rats were decapitated and blood was 
collected for measurement of plasma metabolites. Plasma glucose and 
lactate were measured on a YSI 23A and YSI 23L analyzers. After 
decapitation, soleus muscles were quickly removed and placed on 
aluminum holders. 
2) 45ca2+uptake measurements. 45ca2+ uptake was measured using 
a modification of the technique described by van Breeman and McNaughton 
(394). Muscles were preincubated in a metabolic shaker bath (37°C) for 
45 min in 2.5 ml of oxygenated (95%02:5%C02) Krebs-Ringer-Bicarbonate 
(KRB) media containing 1 mM CaCl2 and 5 mM glucose. Muscles were then 
incubated at 37°C in 2.0 ml of the oxygenated KRB containing 1 mM 
CaCl2, 5 mM glucose and 3.0 µCi 45caC12 (Amersham) for intervals 
ranging from 5 min to 4 hrs. To prevent evaporation, incubation vials 
were capped with rubber stoppers and oxygenated for 5 min every hour. 
A 20 µl sample of the uptake media was counted to determine specific 
activity. After the 45ca2+ uptake period, bound and unbound 
extracellular ca2+ were removed by incubating muscles for 60 min in 3.0 
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ml of an oxygenated, radioisotope-free Hepes buffer solution (pH 7.4) 
containing 134 mM NaCl2, 4.0 mM KCl, 1.0 mM MgCl2, 6 mM NaOH, plus 20 
mM Hepes, 2 mM LaCl3 and 5 mM glucose. Muscles were digested overnight 
in tissue solubilizer (Research Products International) and then 
radioactivity was measured in a liquid scintillation counter (Packard 
Tri-Garb 460) and corrected for quenching. Calcium uptake was 
determined from the radioactivity remaining in the muscles using the 
following equations: 
45ca2+ specific activity: ( DPM ) 
(nrnole ca2+) 
DPM/ml medium 
nrnol ca2+;ml medium 
ca2+ uptake: ( nrnol ) 
( g wet wt. ) 45ca2+ Specific Activity 
DPM/g wet wt. 
To measure the efflux of 45ca2+, muscles were incubated at 37°C in 2.5 
ml of KRB containing 45ca2+ for 1 hr and sequentially washed in 2.0 ml 
of radioisotope-free Hepes buffer every 10 min for 100 min. 
Radioactivity in both washes and digested muscles was measured with a 
liquid scintillation counter and corrected for quenching. 
To determine the effect of high K+ on 45ca2+ uptake, the above 
protocol was used except muscles were transferred after 60 min from the 
KRB incubation media to media (pH 7.4) containing 65 mM NaCl, 60 mM 
KCl, 1.1 mM MgS04, 1.1 mM KH2P04, and 1 mM CaCl2 plus 24 mM NaHC03, 5 
rnM glucose and 3 µCi/vial 45ca2+. Incubation times in high K+ media 
ranged from 5 min to 2 hrs. Time-matched muscles were incubated in KRB 
media containing 4.5 mM KCl for similar intervals of time. The 
extracellular radioactivity in muscles incubated in high K+ was removed 
in 3.0 ml of modified Hepes buffer containing 74 mM NaCl, 60 mM KCl, 
1.0 mM MgCl2, 6 rnM NaOH, 20 mM Hepes, 2 mM LaCl3 and 5 mM glucose for 
60 min while time-matched muscles were similarly washed in 4.5 mM K+ 
Hepes buffer. 
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3) Statistics. The results of the sugar transport and 45ca2+ 
studies were compared using multifactorial repeated measures analysis 
of variance (ANOVA) with BMDP (Los Angeles, CA) and post hoc Newman-
Keuls tests with SAS (Cary, NC) statistical packages. Results are 
expressed as mean±SEM. 
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C. RESULTS 
1) Effect of diltiazem on plasma metabolites. Glucose and 
lactate were measured in plasma collected from 12 hr control and 
bacteremic rats treated with iv diltiazem (2.4 mg/kg) at 10 hrs. 
Plasma glucose (PG) was not appreciably changed in bacteremic rats 
(Table 1) as was observed in earlier studies (413). Diltiazem 
treatment did not alter either control or bacteremic PG values (Table 
1). However, plasma lactate (PL) increased significantly in 12 hr 
bacteremic rats compared to controls. Diltiazem treatment had no 
effect on PL in control rats but administration of 2.4 mg/kg diltiazem 
decreased plasma lactate in bacteremic rats. Plasma lactate in 
bacteremic rats treated with diltiazem was still elevated compared to 
control values (Table 1). 
2) Effect of bacteremia on 45ca2+ uptake in soleus muscle. In 
measurements of skeletal muscle 45ca2+ uptake, radiolabeled 45ca2+ was 
removed from extracellular sites by incubating muscles in La3+_ 
containing media. To ascertain whether La3+ caused changes in 45ca2+ 
taken up into the intracellular compartment, we measured release of 
45ca2+ from muscles in the presence and in the absence of La3+. Figure 
1 shows that during the initial 30 min, radiolabeled muscles released 
45
ca2+ at a rapid rate in the presence and absence of La3+. Although 
the rapid release of 4 5ca2+ represents release from extracellular sites 
(125,174), this method does not allow for adequate analysis of 
extracellular 45ca2+ washout. The subsequent release of 45ca2+ during 
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Table 1. Plasma glucose and lactate levels in control and bacteremic 
rats treated with diltiazem. 
Treatment Plasma Glucose Plasma Lactate 
mQ"% rnM 
Control - 12 hr 93.1±6.2 (8)t 1. 2±0. l+ (8) 
Bacteremic 12 hr 97.9±3.6 (8) * (8) - 2.8±0.2 
Control + iv DZ 101.5±5.5 (4) 1. 0±0 .1 + (4) 
(2.4 mg/kg) 
Bacteremic + iv DZ 94.9±3.6 (8) 1.9±0.2*+ (8) 
(2.4 mg/kg) 
t . Diltiazem (2.4 mg/kg) was administered to rats 10 hrs after bacteria 
or saline injection and blood was collected from 12 hr control and 
bacteremic rats following decapitation. Blood was quickly centrifuged, 
plasma samples collected and analyzed for glucose and lactate. Data 
shown is mean±SEM. Results were analyzed with 2-factor ANOVA and 
Newman-Keuls post-hoc tests. *p<0.05 vs control; +p<0.05 vs 
bacteremia; ( ) =number of animals. 
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Figure 1. The effect of La3+ on 45ca2+ release (DPM/g wet wt.) from 
control soleus muscles. All muscles were preincubated at 37°C for 45 
min in radioisotope-free KRB and then incubated in oxygenated KRB 
containing 1.5 µCi 45ca2+/ml for 60 min. Next, muscles were 
sequentially washed every 10 min for 100 min in 2 ml of nominal ca2+ 
(no added ca2+) buffer in the presence ((),n-4) or absence (~,n-4) of 
2 rnM La3+. Muscles were digested overnight and then, muscles plus 
washes were counted in a liquid scintillation counter. The 
radioactivity remaining in muscles after each wash (DPM/g) was 
determined by retrograde addition of muscle and media counts. Results 
shown are mean±SEM. 
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the next 70 min occurred in the absence of La3+ but not in its 
presence. These data confirm previous findings that La3+ blocks the 
efflux of intracellular ca2+ (277,412). The time course of Ca2+ uptake 
by soleus muscles from control and bacteremic rats is shown in Fig. 2. 
Although, during the initial 30 to 90 min the rate of ca2+ uptake 
appeared to be higher in bacteremic rat muscles than in controls, both 
groups of muscles exhibited maximal 45ca2+ uptake by the end of 3-4 
hrs. Clearly, the amount of time required to reach 1/2 maximal uptake 
was significantly reduced in bacteremic rat muscles compared to 
controls. The best fit of uptake curves was determined using Sigmaplot 
(Jandel Scientific; Sausalito, CA) and ca2+ uptake did not conform to 
monoexponential behavior in muscles from control and bacteremic rats. 
Instead, the best fit of the ca2+ uptake was obtained with a third 
order polynomial regression (C r2 = 0.99, p<0.05; B r2 = 0.98, p<0.05 
with ANOVA). An isotopic steady state of ca2+ uptake was achieved by 
90 min in bacterernic rat muscles and by 3 hrs in controls. When 
muscles were depolarized in media containing 60 rnM K+, ca2+ uptake 
transiently increased at 65 min in both control (Fig. 3A) and 
bacteremic rat muscles (Fig. 3B). The increase in 45ca2+ uptake seen 5 
min after presumed depolarization with 60 rnM K+ was larger in 
bacteremic rat muscles (~C=72.5; ~B=203) than in controls in spite of 
the increased level of ca2+ uptake in resting bacterernic rat muscles. 
In both control and bacteremic rat muscles 45ca2+ uptake was not 
different in resting muscles and muscles incubated in high K+ for 
longer than 5 min (data not shown). 
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Figure 2. ca2+ uptake in soleus muscles from 12 hr fasted control <•. 
n-4-8) and bacteremic (4, n=4-8) rats. Some rats received 2.4 mg/kg 
diltiazem iv 10 hrs after bacterial injection cm. n=4). ca2+ uptake in 
control rats which received 2.4 mg/kg diltiazem are not shown. ca2+ 
uptake was measured as described in the Methods. Results shown are 
Mean±SEM. Results were analyzed with 3-factor ANOVA (time, bacteria, 
diltiazem) and post-hoc Newman-Keuls tests with p<0.05 considered 
significant. *p<0.05 vs control. 
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Figure 3. Effect of 60 rnM K+ on Ca2+ uptake in soleus muscles from 
control and bacteremic rats. Values in panel A (control rat muscles) 
are ca2+ uptake at 60 min in the presence of 4.5 rnM K+ ([], n=8), and 
after an additional incubation for 5 min (65 min) in the presence of 
4.5 rnM K+ ([], n=8) or 60 rnM K+ (~, n=8). Values in panel B 
(bacteremic rat muscles) are ca2+ uptake at 60 min in the presence of 
4.5 rnM K+ (~, n=4), and after additional incubation for 5 min (65 min) 
in the presence of 4.5 rnM K+ (~, n=8) or 60 rnM K+ (~, n=8). Results 
shown are mean±SEM. Results after 60 rnM K+ in control and bacteremic 
rats were analyzed using a 3-factor ANOVA (time, bacteria, [K+]) and 
Newman-Keuls post-hoc tests with a p<0.05 considered significant. 
*p<0.05 vs 60 min value; +p<0.05 vs simlarly treated (same [K+] 
media) control muscle. 
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3) 45ca2+ uptake in rats treated with diltiazem. Diltiazem 
(DZ,iV) treatment at 10 hrs reduced 45ca2+ uptake in control rat 
muscles between 2 and 3 hrs of incubation (2hr uptake = 518±24 nmoles/g 
wet wt., n=4; 3hr uptake = 590±49 nmoles/g wet wt., n=4) but did not 
affect the maximal 45ca2+ uptake. This treatment also significantly 
reduced uptake in bacteremic rat muscles between 30 min and 1 hr which 
were the time points where ca2+ uptake increased the most compared to 
control muscles (Fig. 2). When compared to untreated controls, the 
time to 1/2 maximal uptake was no different (C 30 min = 260±3 nmoles/g 
wet wt, n=4; B+DZ 30 min 281±13, n=4; p>0.05; C 1 hr= 448±28, n=8; 
B+DZ 1 hr= 487±54, n=4; p>0.05 using ANOVA). Steady state is reached 
at about 2 hrs in both groups of muscles. 
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D. DISCUSSION 
Overall, the results show increased ca2+ uptake in soleus 
muscles of bacteremic rats (Fig. 2) and enhancement in its response to 
K+-induced depolarization (Fig. 3). The increased ca2+ uptake was 
prevented by treating animals with the ca2+ blocker diltiazem when 
bacteremia (413) and associated metabolic disturbances were present in 
animals (Table 1, Fig. 2). The soleus muscle 45ca2+ uptake 
measurements allowed us to assess both ca2+ ion movements and the 
steady state cellular ca2+ content. The ion movements were presumed to 
be movements into the intracellular compartment, as the washing of 
muscle in La3+_containing, ca2+_free media after the uptake periods 
prevents the uptake and accumulation of ca2+ into extracellular 
compartments (277,394). Several investigators (277,394,412) have used 
La3+ in 45ca2+ uptake experiments as a means to displace extracellular 
bound ca2+ and to prevent the loss of intracellular ca2+. Sometimes 
erroneous results have occurred with the La3+ technique because it has 
not completely inhibited the loss of 45ca2+ from cells (393). In the 
present study, sequential washes of muscle with and without La3+ showed 
complete inhibition of cellular ca2+ loss in the presence of La3+ (Fig. 
1). The steady state cellular exchangeable calcium measured in this 
study (C = 741±34 nmol/g wet wt, n=4; B = 719±58, n=4) was comparable 
not only to other skeletal muscle measurements (174), but also to 
measurements in other organs such as liver (350) and nerve cells (22). 
Borle (35) observed that freshly isolated cells or cultured cells from 
139 
various tissues have an average of 5.0±0.7 nrnol exchangeable ca2+/mg 
protein which also is equivalent to values reported in this study (C 
4 .94±0.23 nrnol/mg protein; B = 4.80±0.39 nrnol/mg protein). Based on 
the observed inhibition of intracellular ca2+ loss with La3+ and the 
similarity of our calculated values of cellular ca2+ with those 
reported in the literature, we believe that the La3+ technique allowed 
a reasonable estimation of the exchangeable cellular ca2+ contents. 
The inward movement of calcium in the control as well as the 
bacteremic rat muscles (Fig. 2) could not be resolved as monoexponen-
tial transport. Thus, the 45ca2+ uptake probably did not represent 
inward movement of ca2+ through a single sarcolemmal calcium entrance 
site. Non-monoexponential behavior is expected when there is movement 
of ca2+ through more than one rate-limiting route. Multiple routes of 
ca2+ entry could be in series or in parallel with each other (390). In 
resting skeletal muscle, cellular ca2+ exchange with sarcoplasmic 
reticulum and mitochondria along with the sarcolemmal ca2+ leak 
channels would account for the multiple routes of inward ca2+ movement 
(125). 
The cellular steady state calcium distribution was unaffected 
with bacteremia (Fig. 2), indicating that the bacteremic injury did not 
produce gross alterations in the exchangeable calcium contents of 
skeletal muscle. In contrast, an increase in skeletal muscle 
exchangeable calcium was found with endotoxemia (122). Although 
endotoxic injury has some features in common with bacteremia, endotoxic 
animals exhibit cardiovascular and metabolic changes over a shorter 
period of time compared to bacteremic animals (416). The lack of 
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in skeletal muscle exchangeable ca2+ in our study could be due 
change 
the slower progression of bacteremic injury. Although cellular 
tO 
exchangeable Ca2+ was unaffected, a substantially shorter time was 
Ul.·red to reach 1/2 maximal calcium uptake in bacteremic rat muscle req 
compared to controls (Fig. 2). This suggests an enhanced rate of 
inward ca2+ movement in bacteremic rat muscles. Increased inward 
movement of ca2+ could result from decreased ca2+ uptake by cellular 
organelles, increased release of Ca2+ from these organelles and 
increased permeability of ca2+ across the plasma membrane. 
Results similar to those observed in bacteremic rat muscle were 
reported by Borle (39) who showed a decrease in the time to 1/2 maximal 
ca2+ uptake without a change in steady state exchangeable ca2+ content 
in monkey kidney cells treated with metabolic inhibitors. Borle (35) 
postulated that an initial decrease in ca2+ uptake by cellular 
organelles resulted in elevated cytoplasmic free ca2+ and the increased 
(Ca2+li was responsible for stimulating ca2+ influx. Increased 
cytosolic free ca2+ appears to stimulate ca2+ influx via a (Na+Ji-
dependent and ATP-dependent mechanism in excitable cells (113). The 
increase in ca2+ influx probably occurs via ca2+_ca2+ exchange, and not 
voltage-gated ca2+ channels. 
An increase in cytosolic free Ca2+ modulating increased Ca2+ 
movement is compatible with previous findings of increased cytosolic 
Ca2+ in the liver cells after endotoxic injury (350). Other investiga-
tors (373) have reported decreased ca2+ uptake in organelles isolated 
from endotoxic rat liver. This information further supports the con-
cept that decreased ca2+ movement into organelles with an intermediary 
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in cytosolic free ca2+ could contribute to an increase in ca2+ increase 
uptake (Fig. 2). A reduction in ca2+ uptake by cellular organelles 
also has been described in skeletal muscles from diabetic rats (123) 
and in denervated rat skeletal muscle (217). These two pathophysio-
logical conditions are associated with attenuated insulin-mediated 
sugar transport as is observed in bacteremic rat muscles (413,416). 
Although cellular exchangeable calcium contents were unchanged 
with bacteremia in the present study, the enhanced rate of ca2+ 
movement may alter intracellular ca2+ availability or ca2+ mobilization 
by organelles in skeletal muscle which could lead to changes in ca2+_ 
dependent cellular functions. Previous studies in our laboratory 
showed alterations of basal and insulin-mediated sugar transport in 
soleus muscles from bacteremic rats (413,416). Several investigators 
propose that ca2+ modulates basal and insulin-mediated glucose 
transport (80,118,312). The observed increase of inward ca2+ movement 
in resting bacteremic rat soleus muscles supports the idea that 
disturbances in ca2+ regulation could modulate skeletal muscle sugar 
transport via unknown mechanism(s). In preliminary experiments, 
diltiazem administered to bacteremic rats 10 hrs after bacterial 
injection prevented the changes in skeletal muscle glucose transport 
while earlier injections were not beneficial (417). 
In the present study, diltiazem prevented the increased inward 
movement of ca2+ observed in bacteremia (Fig. 2). Previous studies of 
hypoxia, anoxia, and ischemia-induced injury suggest that ca2+ blockers 
protected cardiac tissue against injury only when the tissue was 
stimulated, indicating that plasma membrane ca2+ channels were in the 
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activated state (69). The ability of ca2+ antagonists to block tension 
development also was stimulus dependent (152). The skeletal muscle of 
bacteremic rat might also be in an activated state, as there is 
evidence for skeletal muscle depolarization in septic animals (387). 
The beneficial effect of ca2+ blockers is believed to be due to 
prevention of sarcoplasmic reticulum ca2+ release subsequent to 
activation of sarcolernmal ca2+ channels. Sayeed and Maitra (350) also 
proposed that excessive stimulation of agonist-mediated ca2+ channels 
on the plasmalernma of hepatocytes from endotoxic rats caused increased 
cytosolic free ca2+ and eventually resulted in desensitization of 
agonist-stimulated ca2+ mobilization from endoplasmic reticulum. The 
results of the present study are consistent with the concepts derived 
from hypoxic/ischemic studies and work done on endotoxic shock. 
Alternatively, the results may be explained by the vasodilatory 
actions of diltiazem on the vasculature (409). Increased peripheral 
vascular resistance occurs in septic shock, especially in skeletal 
muscle (194), and diltiazem may prevent the resulting 02 deprivation 
from causing the observed increase in bacteremic rat muscle ca2+ uptake 
(Fig. 2). However, vascular resistance presumably was not altered in 
control muscles and diltiazem treatment also caused a decrease in ca2+ 
uptake (Fig. 3) which suggests that diltiazem had a direct effect on 
skeletal muscle. The observed effects of diltiazem on ca2+ regulation 
in hepatocytes (268,350) as well as skeletal muscle (Fig. 2) and on 
survival in bacteremic mice (40) suggest that alterations in ca2+ 
regulation occur in various organs during septic shock. The protective 
effect of diltiazem on skeletal muscle ca2+ regulation (Fig. 2) and on 
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plasma lactate (Table 1) when diltiazem was administered 10 hrs after 
the introduction of bacteria support the use of ca2+ blockers for 
potential benefit in the treatment of septic shock. 
The enhanced ca2+ uptake in the presence of high K+ in 
bacteremic rat muscles (Fig. 3) indicates that the ca2+ mobilization 
across the plasma membrane/sarcoplasmic reticulum upon skeletal muscle 
depolarization is also altered by bacteremia. Several investigators 
have reported increased cellular respiration and metabolism in skeletal 
muscles incubated in high K+ media (307,395). Membrane depolarization 
as well as ca2+ release from the sarcoplasmic reticulum were required 
for the high K+-induced increases in respiration (395). Increased ca2+ 
uptake also has been observed with high K+ (125,307) and it was 
attributed to the entry of Ca2+ across the plasma membrane after 
release of ca2+ from the sarcoplasmic reticulum (395). From these 
observations, we surmise that an indirect stimulation of ca2+ uptake 
may result from increased ca2+ release from the sarcoplasmic reticulum 
in bacteremic rat muscles. Diltiazem also has prevented K+-induced 
contracture (345), which indicates that high K+ depolarization resulted 
in the opening of voltage-gated ca2+ channels on the sarcolemma. Sato 
and Fujino (347) have shown that coupling between high K+-induced 
depolarization and sarcoplasmic reticulum ca2+ release can be blocked 
With the ca2+ channel blocker, nicardipine. They proposed that the 
Ca 2+ channel protein can modulate the conformation of a second protein 
on transverse-tubules which undergoes a conformational change and 
allows sarcoplasmic reticulum ca2+ channels to open. Alterations in 
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these proteins in bacteremic rat muscles may increase ca2+ release from 
the sarcoplasmic reticulum and stimulate overall ca2+ uptake. 
CHAPTER V 
EFFECT OF CELLULAR CALCIUM MODIFIERS ON SKELETAL MUSCLE 
SUGAR TRANSPORT IN BACTEREMIC RATS 
A. INTRODUCTION 
Several investigators have previously described a modulatory 
role for ca2+ in basal sugar transport (25,26,85) and a recent report 
has shown a role for ca2+ in insulin-mediated sugar transport (118). 
Clausen and coworkers reported increased 45ca2+ efflux and elevated 
basal sugar transport in soleus muscles exposed to reagents, trypsin, 
hydrogen peroxide, veratrine, or 2,4-dinitrophenol (368) and to 
electrical stimulation or hyperosmolar media (85). The increases in 
ca2+ efflux and glucose transport were temporally related to each other 
but the magnitude of the 45ca2+ efflux change did not always correlate 
with the magnitude of sugar transport changes. More recent studies in 
adipocytes (312) have shown that increased sugar transport resulting 
from the addition of vanadate, hydrogen peroxide, phorbol ester or, 
concanavalin A can be prevented with [Quin-2-AM] (15-150 µM) which was 
introduced into cells to quench ca2+ signals. In addition, an increase 
in cytosolic ca2+ was detected in adipocytes treated with sulfonylureas 
(117) which are known to stimulate adipocyte and myocyte sugar trans-
port (211,330). These results suggest that agents which increase 
cytosolic free ca2+ stimulate membrane sugar transport. Calcium may be 
145 
146 
involved in the modulation of insulin-mediated transport by protein 
kinase C (236,431). Calcium may also affect calmodulin enhancement of 
insulin receptor kinase activity and thus, modulate the ability of 
insulin to stimulate glucose transport (166). 
Recent studies from our laboratory have shown that calcium 
regulation is altered in skeletal muscles from fasted rats given an 
intraperitoneal (ip) injection of live bacteria (Escherichia coli) 12 
hrs earlier (414). In addition, elevated basal and attenuated insulin-
mediated sugar transport have been observed in these muscles (416). 
The purpose of this study is to determine whether changes in cellular 
ca2+ are involved in the sugar transport alterations observed in 
bacteremic rat muscles. To address this problem, 3MG transport was 
measured in control rat muscles exposed to agents which modify ca2+ 
movements across the sarcolemma and/or cellular organelles. In other 
experiments, we ascertained the effect of the ca2+ modifying agents on 
sugar transport in muscles of bacteremic rats. To modify intracellular 
ca2+ we employed varying extracellular (ca2+], ca2+ ionophores (A23187, 
ionomycin), ryanodine, or a reduced transmembrane Na+ gradient. 
One postulated outcome of these experiments was that these 
agents might change sugar transport in control muscles but may not 
further affect it in bacteremic rat muscles. Alternatively, these 
agents could change transport in control muscles and further alter 
transport in bacteremic rat muscles such that comparable sugar 
transport would be observed in control and bacteremic rat muscles. 
Changes in control muscle transport unrelated to those occurring in 
bacteremic rats would suggest that altered ca2+ regulation did not 
contribute to bacteremic rat muscle alterations in sugar transport. 
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B. MATERIALS AND METHODS 
1) Animal model. Male, Holtzman rats (80-100 g) were fasted 
overnight and given sterile saline (control) or bacteria (4 x 1010 
Escherichia coli/kg) ip. Bacteria were prepared as described 
previously (413). Twelve hrs later, rats were decapitated, soleus 
muscles were quickly removed and mounted on aluminum holders at 
approximately resting length. 
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2) 3-0-Methylglucose transport. Sugar transport was measured 
using an efflux technique (413). Briefly, muscles were 'loaded' with 
14c-3-0-methylglucose (14c-3MG) in 3.0 ml of Krebs-Ringer-bicarbonate 
(KRB) media for 60 min and then sequentially washed in 2.5 ml of 
radioisotope-free KRB every 5 min for 70 min at 37°C. Insulin was 
present in wash media between 50 and 70 min. Muscles were digested in 
tissue solubilizer (TS-1, Research Products International) overnight 
and then muscles and wash media were counted in a liquid scintillation 
counter (Packard Tri-Carb 460). Radioactive counts were added in a 
retrograde fashion to determine the amount of radioactivity remaining 
in the muscle after each wash. Fractional efflux (\ ,min-1) was 
estimated from the DPM/g at the beginning and end of each wash. 
The physiological media (pH 7.4) used to measure 3MG transport 
in experiments with varying extracellular ca2+ ([Ca2+] 0 ) was a modified 
KRB media. The modified media contained 124 mM NaCl, 4.5 mM KCl, 1.1 
mM MgS04, 0-7.5 mM CaCl2, 6 mM NaOH, 30 mM Hepes as well as 2.0 mM 
unlabelled 3MG and 2.3 mM pyruvate and this media was present 
throughout the experiment. No significant difference in basal or 
insulin-mediated transport were observed in control rat muscles 
incubated in these modified media compared to normal KRB media. The 
KRB medium was gassed with 95%02:5%C02 while the modified KRB medium 
was oxygenated with 100% 02. 
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Ionophores, when present were added to both the 'loading' and 
•wash' media and these experiments were performed in the dark. Both 
A23187 (Calbiochem) and ionomycin (Calbiochem) stock solutions (10 mM) 
were prepared with dimethylsulfoxide (DMSO, Sigma) while the ryanodine 
(Calbiochem, 10 mM) stock solution was prepared with saline. The final 
concentration of DMSO in the KRB and modified KRB was ~12mM (0.08%) and 
0.5% DMSO had no effect on basal or insulin-mediated 3MG transport in 
control rat soleus muscles (417). 
In experiments designed to decrease the transmembrane Na+ 
gradient, extracellular (Na+] ([Na+] 0 ) was reduced (40.5, 80.3 mM) in 
another modified KRB buffer for the 'load' and 'wash' periods. The KRB 
used in 80 mM Na+ experiments contained 60 mM choline chloride, 55 mM 
NaCl, 5 mM KCl, 1.2 mM MgS04, 1.2 mM KHzP04, 2.5 mM CaCl2. 23 mM 
NaHC03, 2.3 mM pyruvate (Na+ salt) and 2.0 mM 3-0-methylglucose (3MG). 
The 40 mM Na+ - KRB contained 101 mM choline chloride, 14.2 mM NaCl, 5 
rnM KCl, 1.2 mM MgS04, 1.2 mM KH2P04, 2.5 mM CaCl2, 24 mM NaHC03, 2.3 mM 
pyruvate (Na+ salt) and 2.0 mM 3MG. Media was adjusted to pH 7.4 with 
choline bicarbonate (Sigma). 
3) ca2+ uptake experiments. 45ca2+ uptake was measured using a 
previously described La3+ technique (394). Briefly, the muscles were 
preincubated for 45 min and then incubated for 1 hr in KRB media (1.5 
150 
µCi/ml) before transferring them to KRB media containing 1 µM ryanodine 
3 µCi 45ca2+ to determine the effect of ryanodine on 45ca2+ plus 
uptake. Incubations with ryanodine were carried out for 5 min to 2 
hrs. Ryanodine also was present during the La3+ wash. The same 
protocol was also used to test the effects of 40 mM Na+ on 45 ca2+ 
uptake with modifications to the media. The media used for low [Na+] 0 
(40.2 mM) incubations (2.0 ml) consisted of 101 mM choline chloride, 
16.2 mM NaCl, 5 mM KCl, 1.2 mM MgS04, 1.2 mM KH2P04 and 1 mM CaCl2 plus 
24 mM NaHC03, 5 mM glucose and 3 µCi 45caC12. Muscles were washed in a 
modified Hepes buffer (pH 7.4) containing 92 mM choline chloride, 40 mM 
NaCl, 4.5 mM KCl, 1.0 mM MgCl2 plus 2 mM LaCl3, 5 mM glucose and 20 mM 
Hepes. 
4) Statistics. The results of the sugar transport and 45ca2+ 
studies were compared using multifactorial repeated measures analysis 
of variance (ANOVA) with BMDP (Los Angeles, CA) and post hoc Student's 
Newrnan-Keuls tests with SAS (Cary, NC) statistical packages. In some 
instances, an unpaired Student's t-test was used to compare the percent 
increase above basal 3MG transport caused by insulin with a p<0.05 
considered significant. Results are expressed as mean±SEM. 
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C. RESULTS 
1) Effect of [Ca2+1 0 on 3MG Efflux. The overall effect of 
[Ca2+] 0 on sugar transport in control or bacteremic rat muscles was 
minimal unless ca2+ was excluded from the medium. In the absence of 
ca2+0 , there was an increase in basal transport and an attenuation of 
insulin-mediated response in control muscles (Fig. lA). Lowering 
[Ca2+] 0 to 0.1 mM had no effect on basal or maximum insulin-mediated 
3MG efflux in control muscles compared to control muscles incubated 
with 2.5 mM ca2+ (Fig. lA). As [ca2+] 0 was increased from 2.5 to 5.0 
mM, there was no significant effect on basal or maximum insulin-
mediated transport (Table 1). An increase in [Ca2+] 0 to 7.5 mM 
elevated both basal and insulin-mediated 3MG transport in control 
muscles but the percent increase from basal to hormone-stimulated 
conditions was similar with 2.5, 5.0 and 7.5 mM ca2+0 (2.5mM ca2+ 
181±21%, n=8; 5.0 mM ca2+ = 173±12%, n=l2; 7.5mM ca2+ = 170±26%, n=8; 
p>0.05 using ANOVA). 
Figure lB and Table 1 show the effect of [Ca2+] 0 on sugar 
transport in bacteremic rat muscles. When ca2+ was absent from the 
medium, basal transport was elevated at one time point during sugar 
efflux (42.5 min) but not at the adjacent efflux time points (37.5 or 
47.5 min) compared to results with 2.5 mM ca2+0 . A [ca2+] 0 of 0.1 mM 
had no effect on basal or insulin-mediated sugar transport. Increasing 
Ca2+0 to 5.0 and 7.5 mM had no effect on basal sugar transport (Table 
l) in the muscles from bacteremic rats. Insulin-mediated transport was 
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Figure 1. Effect of decreased extracellular (ca2+] ([Ca2+] 0 ) on basal 
and insulin-mediated (10 mU/ml) 3MG transport in soleus muscles from: 
A) 12 hr control (C) and B) 12 hr bacteremic (B) rats. The (Ca2+J 0 
were: 1) 0 mM added ca2+0 ((), Cn=8,Bn=8); 2) 0.1 mM ca2+0 (~ , 
Cn=8,Bn=8) and; 3) 2.5 mM or 'normal' ca2+0 (~, Cn=8,Bn=8). Muscles 
were 'loaded' and 'washed' in modified KRB media (see METHODS) 
containing the desired (Ca2+] 0 . 3MG transport is expressed as 
fractional efflux of 3MG ( A, min-1) and results shown are mean±SEM. A 
3-factor analysis of variance (ANOVA) with repeated measures 
(Bacteremia, (ca2+] 0 , time) followed by Newman-Keuls post-hoc analysis 
were used to compare 3MG transport in muscles from various groups of 
animals. A p<0.05 was considered significant; *'p<0.05 vs muscles from 
similarly treated rats (C,B) incubated with 2.5 mM ca2+0 . Transport 
differences in muscles from C vs B rats are discussed in the text. 
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Table l. Effect of increases in [Ca2+] 0 on basal and insulin-mediated 
3MG transport in soleus muscles from 12 hr control and bacteremic rats. 
[CaL+] Treatment n Basal Insulin-media tee 
rnM A. x 102(min-l) A. x 102(min- 1 ) 
2.5 Control, 12 hr 8 1. 849±0. 158. 5.580±0.201 
5.0 Control, 12 hr 12 2.140±0.065 5.790±0.149 
2.361±0.208* ·'-7.5 Control, 12 hr 8 6.263±0.115A 
2.5 Bacteremic, 12 hr 12 2.34l±0.10ot 4.106±0.177t 
5.0 Bacteremic, 12 hr 8 2.645±0.139t 4.690±0.185*t 
7.5 Bacteremic, 12 hr 8 2.745+0.249 4.665+0.143*t 
• -l 
. Transport (A. , min ) was measured in soleus muscles from 12-h 
control and bacteremic rats.The desired [Ca2+] 0 was present in the 
'load' and 'wash' media for 3MG transport studies. Results shown are 
rnean±SEM with basal transport recorded from 47.5 min values and 
insulin-mediated transport obtained from the peak (57.5 min) values. 
Results were analyzed using a 3-factor ANOVA (See Table 2) followed by 
a Newrnan-Keuls post-hoc test with p<0.05 considered significant. 
*p<0.05 vs same treatment (C or B) with 2.5 rnM ca2+ in media; tp<0.05 
vs control with same [ca2+] in media. 
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elevated in muscles incubated with 5 or 7.5 mM ca2+ compared to 2.5 rnM 
ca2+ (Table 1) although the percent stimulation by insulin was not 
different (2.5 rnM = 83±12%, n=lO; 5.0 rnM ca2+ = 80±3, n=8; 7.5 mM ca2+ 
83±20%, n=8; p>0.05 using ANOVA). 
As was observed at 2.5 rnM ca2+0 (420,423), basal sugar transport 
was elevated and insulin-mediated transport was attenuated in bactere-
mic rat muscles (Fig. lB, Table 1) incubated with (Ca2+] 0 of 0 to 5 rnM 
compared to control muscles (Fig. lA, Table 1). In the presence of 7.5 
mM ca2+0 , insulin-mediated transport was attenuated in bacteremic rat 
muscles compared to control muscles while basal transport was not 
different (Table 1). 
2) Effect of A23187 on 3MG Efflux. In control soleus muscles, 
A23187 (0.1 or 1 µM) had no effect on basal 3MG transport (Fig. 2) 
compared with transport in the absence of ionophore (Fig. lA). Yet 0.1 
µM A23187 inhibited insulin-stimulated transport slightly and 1 µM 
A23187 caused a large reduction in insulin-mediated 3MG transport (Fig. 
2) compared to measurements without ionophore (Fig. lA). Addition of 1 
µM ionophore to bacteremic rat muscles had no effect on basal (+A23187 
A= 2.440±0.148 min-1, n=lO; -A23187 A = 2.341±0.100, n=l2) or insulin-
mediated 3MG transport (+A23187 \ = 3.906±0.247 min-1, n=lO; -A23187 \ 
= 4.106±0.177, n=l2). Basal and insulin-mediated transport were 
similar in control and bacteremic rats in the presence of 1 µM A23187 
(2.5 rnM ca2+0 ). 
Muscles were incubated with 1 µM A23187 and varying (ca2+] 0 to 
study modulation of sugar transport by (ca2+] 0 in the presence of 
ionophore (Table 2). In control muscles, a reduction of (Ca2+] 0 to 
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Figure 2. Effect of [A23187] on basal and insulin-stimulated (10 
mU/ml) 3MG transport (A, min-1) in muscles from 12 hr control rats. 
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Concentrations included 0.1 µM (I;., n-8) and 1.0 µM (() , n-8) A23187. 
Muscles were 'loaded' and 'washed' in modified KRB media (see METHODS) 
containing 2.5 mM ca2+0 with or without A23187. Mean transport in 
control muscles (no A23187) is shown for comparison(-----, n-8, see 
Fig. 1 for mean±SEM). A repeated measures 2-factor ANOVA followed by 
student's Newman-Keuls post-hoc tests were used to analyze the effect 
of A23187 on sugar transport with p<0.05 <*') considered significant. 
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Table 2. Effect of A23187 on basal and insulin-mediated 3MG transport 
(A, min-1) in soleus muscles from 12 hr control (C) and bacteremic (B) 
rats. 
Treatment n [caz+] 0 Basal Insulin-mediated 
mM >. x 102 (min-l) A x 102 (min- 1 ) 
Control 8 0 2. 380±0. 211 a 3.907±0.238 
Control 6 0.1 2.168±0.122 3.912±0.116. 
Control 8 2.5 2.073±0.149 3.919±0.222• 
Control 8 5.0 2.787±0.369*• 4.742±0.220*• 
Bacteremic 8 0 3 . 011±0 . 198 t • 4.375±0.208* 
Bacteremic 8 0.1 2.783±0.093t 4.380±0.155* 
Bacteremic 10 2.5 2.440±0.148 3.906±0.247 
Bacteremic 10 5.0 2.562±0.153 3.876±0.1nt• 
aA23187 (1 µM) was present in the incubation media throughout the 
experiments. Basal and insulin-mediated 3MG transport values were 
derived as described in Table 1. Results shown are mean±SEM. A 
repeated measures 3-factor ANOVA (bacteremia; [ca2+] 0 ; A23187) followed 
by a Newman-Keuls post-hoc test were used to analyze data. The level 
of significance was set at p<0.05; *p<0.05 vs same treatment (C,B) 
with 2.5 mM ca2+ in media; tp<0.05 vs control incubated with 1 µM 
A23187 plus same [Ca2+] 0 ; •p<0.05 vs same treatment (C,B) incubated 
without A23187 (see Table 1). 
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zero or 0.1 µM in the presence of A23187 had no effect on basal or 
insulin-mediated transport compared to muscles incubated with 2.5 mM 
ca2+ plus A23187 (Table 2). Addition of 5 mM ca2+ along with A23187 
increased basal and insulin-mediated transport in control muscles 
although the percent increase in transport by insulin at 2.5 and 5 mM 
ca2+ was similar (2.5 mM ca2+ 92±11%, n=8; 5.0 mM ca2+ = 91±9, n=8; 
p>0.05 using unpaired Student's t-test). 
The effect of (Ca2+] 0 on 3MG transport in the presence of 
ionophore also was measured in bacteremic rat muscles (Table 2). Basal 
3MG transport in the presence of A23187 was further enhanced when 
[Ca2+] 0 was 0 mM but was unchanged with 0.1 or 5 mM ca2+ compared to 
muscles incubated with 2.5 mM ca2+ (Table 2). Insulin-mediated 
transport in the presence of ionophore tended to be higher when 0 or 
0.1 mM ca2+0 was present than transport measured in the presence of 2.5 
mM ca2+ plus ionophore (Table 2). However, the percent stimulation of 
transport by insulin was not significantly different among the various 
[Ca2+] 0 (60±15% at 2.5 mM ca2+, n=lO; 65±12% at 0.1 mM ca2+, n=8; 55±13 
at 0 mM ca2+, n=8; p>0.05 using ANOVA). Insulin-mediated 3MG transport 
in bacteremic rat muscles incubated with 5 mM ca2+ plus ionophore also 
was not significantly different from the response with 2.5 mM ca2+ plus 
ionophore (Table 2). 
Results also were analyzed to determine whether A23187 affected 
transport in muscles from control or bacteremic rats. As expected, 
ionophore had no effect on basal or insulin-mediated transport in 
control (Fig. lA VS. Table 2) or bacteremic (Fig. lB vs. Table 2) rat 
muscles in the absence of ca2+o· While no effect of ionophore was 
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observed on basal transport with 0.1 - 5 mM ca2+ in bacteremic rat 
muscles (Fig. lB, Tables 1,2), ionophore increased basal transport when 
5 mM ca2+0 was present in control muscles (Table 1 vs 2). A23187 
reduced insulin-mediated 3MG transport in control muscles (Fig. 2) to 
values that were comparable to those observed in bacteremic muscles 
(Table 2). When [Ca2+J 0 was varied in the presence of ionophore 
insulin-mediated 3MG transport in control muscles was only slightly 
different from transport in bacteremic rat muscles (Table 2). 
3) Effect of ionomycin on 3MG transport. Ionomycin (1 µM) 
significantly increased basal 3MG transport in control (Fig. 3) and 
bacteremic (Fig. 4) rat muscles compared to transport in the absence of 
ionomycin (Fig. lA,B respectively). The increase in basal transport 
resulted in similar values in control and bacteremic rat muscles (Figs. 
3,4). Insulin-stimulated 3MG transport was significantly decreased in 
control muscles (Fig. 3) but was unchanged in muscles from bacteremic 
rats (Fig. 4). Ionomycin reduced insulin-mediated transport in control 
and bacteremic rat muscles to comparable values and insulin did not 
significantly stimulate 3MG transport above basal values in either 
group (Figs. 3,4). 
4) Effects of ryanodine or low [Na+0 1 on 3MG transport. In 
control rat soleus muscles, ryanodine (1 µM) produced results similar 
to those of ionomycin (Fig. 3). Basal 3MG transport increased 
significantly (Fig. 3) and insulin did not significantly stimulate 
transport. Basal and insulin-mediated 3MG transport in control rat 
soleus muscles were not altered when [Na+J 0 was reduced from 140 to 80 
rnM (Table 3). Further reduction of [Na+) 0 to 40 mM resulted in 
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Figure 3. Effect of ionomycin (1 µM, ~, n=8), ryanodine (1 µM, .A , 
n=8) or low [Na+) 0 (40 mM, () , n=8) on basal and insulin-mediated 3MG 
transport (A ,min-1) in muscles from 12 hr control rats. Data from 
experiments with ionomycin and 40 mM Na+ were analyzed as described in 
Fig. 4. Results from ryanodine experiments were analyzed using 2-
factor ANOVA followed by Newman-Keuls post-hoc tests with a p<0.05 
considered significant. Mean transport in control muscles (no media 
modifications) is shown for comparison(-----). All results are 
mean±SEM. 1),<0.05 vs control muscles, no media modifications. 
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Figure 4. Effect of ionomycin (1 µM, ~, n=8) or low [Na+) 0 (40 mM,(), 
n-8) on basal and insulin-mediated 3MG transport (min-1) in muscles 
from 12 hr bacteremic rats. Average transport·in bacteremic rat 
muscles incubated without media modifications (-----, Fig. lB) is shown 
for comparison to other treatments. Data from other groups is shown as 
mean±SEM. Results from control (Fig. 1,4) and bacteremic (Fig. 2,5) 
rat muscles incubated with (Fig. 4,5) and without (Fig. lA,B) ionomycin 
were compared using a repeated measures 3-factor (bacteremia, 
ionomycin, time) followed by a Newman-Keuls post-hoc test with p<0.05 
considered significant. Similar analyses were carried out for muscles 
incubated with 40 mM Na+. *'p<0.05 vs C muscles with same media 
modifications; +p<0.05 vs muscles from similarly treated rats (C or B), 
no media modifications. 
Table 3. Effect of 80 rnM Na+ on basal and insulin-mediated 3MG 
transport (A, min- 1 ) in soleus muscles from 12 hr control rats. 
Treatment n Basal Insulin-mediated 
A x 102(min-l) A x 102(min- 1 ) 
Control 8 1.849±0.108. 5.580±0.201 
80 rnM Na+ 7 2.114±0.091 5.357±0.201 
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•Results shown are mean±SEM with basal and insulin-mediated transport 
derived as described in Table 1. The effect of Na+ was analyzed using 
a 1-factor ANOVA and there was no significant effect (p>0.05) of 80 rnM 
Na+ on transport. 
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elevated basal and attenuated insulin-mediated transport in control 
rats (Fig. 3). In muscles from bacteremic rats, media containing 40 mM 
Na+ also was associated with increased basal transport (Fig. 4). Peak 
insulin-mediated transport was similar in bacteremic rat muscles 
incubated with 40 and 140 mM Na+0 although 3MG transport did not return 
toward basal values in muscles incubated with 40 mM Na+ (Fig. 4). 
Basal transport in the presence of 40 mM Na+ was enhanced in bacteremic 
rat muscles (Fig. 4) compared to controls (Fig. 3) at 37.5 and 47.5 
min. Basal and peak insulin-mediated transport were similar in control 
(Fig. 3) and bacteremic (Fig. 4) rat muscles incubated with 40 mM Na+. 
5) 45ca2+ uptake with ryanodine or 40 mM Na+. 45ca2+ uptake 
also was measured to determine whether the ryanodine or low [Na+] (40 
mM) alter cellular ca2+ regulation (Fig. 5). Low [Na+] (40 mM) in the 
media increased both the rate of 45ca2+ uptake and the steady state 
uptake of ca2+ in soleus muscles. Ryanodine had a similar general 
effect although ca2+ uptake at 15 min was comparable to basal uptake 
(Fig. 5). 
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Figure 5. 45ca2+ uptake in muscles from 12 hr control rats which were 
incubated with no additions ([], n=4-8), low [Na+] 0 (40 mM, II, n=4) or 
ryanodine (1 µM, ~, n=4). Muscles were transferred to media 
containing 1.5 µCi/ml 45ca2+ plus 40 mM Na+, ryanodine, or no additions 
after a 1 hr incubation in KRB plus 1.5 µCi/ml 45ca2+. Results shown 
are mean±SEM. Skeletal muscle ca2+ uptake in the presence of ryanodine 
or 40 mM Na+ was compared to uptake in control (no additions) muscles 
using a repeated measures 2-factor ANOVA (ionomycin or [Na+], time) 
followed by a Newman-Keuls post-hoc test with p<0.05 ("'k) considered 
significant. 
D. DISCUSSION 
The modulatory effects of ca2+ on skeletal muscle basal and 
insulin-mediated sugar transport were examined using various agents 
known to increase intracellular ca2+ ((ca2+li). These agents were 
present in the muscle incubation media for a period of 90 min which 
should allow for a steady state of cellular ca2+ and eliminate 
transient ca2+ buffering effects of sarcoplasmic reticulum (SR) and 
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mitochondria. Earlier studies indicated that an increase in extracel-
lular (Ca2+J ([Ca2+J 0 ) stimulated calcium uptake (23). The ionophore 
A23187 increased 4 5ca2+ uptake in soleus muscle (80), raised total ca2+ 
content in perfused rat hindlimbs (28), and elevated resting muscle 
tension without affecting membrane potential (171). Collectively these 
effects should increase [ca2+li· Ionomycin increased the Ca 2+ influx 
(266) and stimulated ca2+ release from organelles (18,226). Both 
A23187 and ionomycin caused a sustained increase in cytosolic ca2+ in 
isolated myoblasts (215). Ryanodine which binds to SR membranes (314) 
increased ca2+ release from the SR into the cytosol (138). Reduction 
of [Na+] 0 also raised [ca2+li via a reduction or reversal of Na+;ca2+ 
exchange (94). Sodium/calcium exchange has been observed in skeletal 
muscle (157) although its physiological importance is unknown. In the 
present study, both ryanodine and 40 mM Na+ significantly stimulated 
Ca2+ uptake compared to resting Ca2+ uptake (Fig. 5). 
The increased basal transport observed in control muscles when 
Ca 2+0 was excluded from the medium (nominal ca2+0 ) is in contrast to 
earlier studies (15,28,80). The elevated basal sugar transport 
observed with nominal ca2+0 may be due to a decrease in [ca2+li under 
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these conditions. Baker and Carruthers (15) reported that media with 
nominal ca2+ decreased [Ca2+Ji in barnacle muscles. It is plausible 
that ca2+i availability may be required for a regulated level of 
glucose transport and with a decrease in [ca2+li there may be release 
of that regulation. Work in isolated cardiac myocytes (71) suggested 
that reducing [ca2+] 0 to very low levels caused alterations in membrane 
permeability to several electrolytes and this affected the cellular 
regulation of these ions. Changes in cellular metabolism (decreased 
protein synthesis) also were observed in these cells. However, some 
investigators have reported that ca2+_free media had no effect on basal 
sugar transport (15,28,80). Reduction of [ca2+] 0 also has been as-
sociated with membrane depolarization (98,215) and increased cytosolic 
ca2+ (215) presumably from SR ca2+ release (215) or altered Na+/ca2+ 
exchange (98). We cannot rule out that exposure to nominal ca2+ media 
for prolonged periods of time may result in the release of intracellu-
lar stores of ca2+ which in turn would lead to an increase in basal 
transport. An increase in [ca2+] 0 to 7.5 mM produced an increase in 
basal transport (Table 1). In support of this data are reports that 
increased [Ca2+] 0 elevated basal sugar transport in skeletal muscle 
(80). 
To obtain greater increases in [Ca2+Ji, calcium ionophores were 
added to the media. Addition of A23187 in the presence of normal 
[Ca2+] 0 (2.5 mM) had no effect on basal 3MG transport (Fig. 2) which 
agrees with work of Hall et al. (178). Other investigators have 
observed that A23187 increased (26,80) or decreased (240) skeletal 
muscle sugar transport and the difference between studies may be due to 
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the different [A23187] (80,178,240), or the length of exposure to 
A23187 (26,80,240). The increased basal transport observed with 5.0 mM 
ca2+ in the presence of A23187 (Table 2) but not in its absence (Table 
1) indicates that A23187 (1 µM) increased basal transport in a Ca2+-
dependent manner. Ca2+ ionophores also increased basal transport in 
previous studies by Clausen (80) and Bihler et al. (26). The elevated 
basal 3MG transport observed with ionomycin was greater than with 
A23187, presumably due to a greater ability of ionomycin to increase 
cellular ca2+ (215) via ca2+ influx (266) and release of ca2+ from 
intracellular stores (18,226). Draznin et al. (118) did not observe 
any effects of ionomycin (1 µM) on 2DG uptake in isolated adipocytes 
but a short incubation period was used in their studies. A23187 
(26,178) and ionomycin (226) sometimes affect the movement of other 
ions in the cell, but the similar actions of both ionophores and 
ryanodine suggests that changes in [Ca2+Ji were involved in the altered 
sugar transport. 
Ryanodine and low [Na+] 0 increased basal 3MG transport (Fig. 3) 
in a manner very similar to the effect of ionomycin in control muscles 
and they also stimulated ca2+ uptake (Fig. 5). The ability of ryano-
dine to increase SR ca2+ release (138) is consistent with the idea that 
major alterations in ca2+i regulation caused the observed increase in 
basal 3MG transport. In earlier studies, cell respiration increased in 
rat diaphragms treated with 6 x 10- 6 M ryanodine (418) without causing 
changes in mitochondrial oxygen consumption or oxidative phosphoryla-
tion (216) and without exhausting the energy supply (359). The 
increased basal transport observed in control muscles incubated with 40 
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mM [Na+J 0 (Table 3, Fig. 3) also appears to be due to changes in 
cellular [Ca2+J. Kipnis and Parrish (234) did not observe any effect 
of decreased [Na+] 0 on basal sugar transport in skeletal muscle. 
However, other investigators reported elevated basal sugar transport 
with decreased [Na+] 0 (246) or with agents which increased [Na+Ji (28). 
These authors (29) postulated that an increase in [Na+Ji indirectly 
elevated basal transport when [Ca2+Ji increased after reduction or 
reversal of sarcolemmal Na+;ca2+ exchange. Bihler et al. (28) also 
suggested that increased [Na+]i caused ca2+ release from intracellular 
organelles. The effects of 40 mM Na+0 are relevant to sepsis since 
membrane depolarization and increased [Na+Ji have been observed in 
skeletal muscles from bacteremic animals (387). 
The results of this study support the concept that an optimal 
range of [ca2+li is required to maintain control of membrane glucose 
transport. The 25% increase of basal sugar transport in control 
muscles incubated with nominal ca2+0 could result from a loss of 
cellular regulation of sugar transport (Fig. 1). At the other extreme, 
muscles incubated with ionomycin, ryanodine or low [Na+] 0 could also 
increase [ca2+Ji (Fig. 3) to such an extent that sugar transport 
regulation is lost. These results suggest an optimal range of [ca2+li 
is required for cellular regulation of sugar transport which is similar 
to the concept of Draznin et al. (118). Ionomycin, ryanodine and 40 rnM 
[Na+] 0 increased basal 3MG transport 65-70% in control muscles and 35-
45% in bacteremic rat muscles such that 3MG transport was not different 
in the two groups. The actions of these agents to increase the uptake 
or release of ca2+ may cause major alterations in basal sugar 
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transport. Since nominal [ca2+J 0 or 5.0 mM ca2+0 plus A23187 (Table 2) 
had no effect on bacteremic muscles (Table 2) but increased basal 
transport in control muscles (+35-40%) to values equal to those 
observed in bacteremic rats, it would appear that the degree of altered 
ca2+ regulation was similar in this set of control and bacteremic rat 
muscles. Altered ca2+ regulation may change basal sugar transport via 
its effects on glucose transporter turnover (81), phosphorylation of 
the glucose transporter by protein kinase C (427), and or indirect 
effects of protein kinase Con the insulin receptor (236,431). 
There has been controversy about the importance of ca2+ in the 
modulation of insulin-mediated sugar transport (80,239). The at-
tenuated insulin-mediated 3MG transport in control muscle observed with 
nominal ca2+0 (Fig. 1) is similar to that observed in dialyzed barnacle 
muscles (15) and isolated adipocytes (118). Although insulin can 
stimulate sugar transport somewhat in the absence of [Ca2+J 0 , it 
appears that a minimal [ca2+) 0 may be required for optimal insulin 
action (15,118). Recent results from Draznin et al. (118) also suggest 
that an optimal range of [ca2+li is required for maximal insulin-
mediated sugar transport and when [ca2+]i is out of this range there is 
an attenuation of insulin-mediated sugar transport. In isolated 
adipocytes insulin-mediated 2DG uptake was enhanced as [Ca2+] 0 was 
raised from 0.1 to 2.0 mM but further elevations or reductions in 
[ca2+] 0 attenuated insulin-mediated sugar transport (118). In the 
present study, [Ca2+] 0 above nominal levels had no effect on insulin-
mediated sugar transport (Fig. 1, Table 1). The discrepancy between 
these findings may be related to increased calcium permeability in 
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isolated cells in comparison to an isolated, intact muscle. In 
agreement with the work of Draznin et al. (118) was the attenuated 
insulin-mediated sugar transport observed in control muscles incubated 
with A23187 (1 µM) or ionomycin (1 µM) (Figs. 2,3). These ionophores 
should have caused larger increases in cellular [Ca2+] than high 
2+] [Ca o· Hall et al. (178) also reported that A23187 decreased 
insulin-mediated skeletal muscle xylose transport and Bihler and 
coworkers (26) observed similar results using 3MG transport 
measurements in rat hemidiaphragms. 
The attenuated insulin-mediated 3MG transport observed in the 
presence of ryanodine or 40 mM Na+ was similar to the effect of 
ionomycin (Fig. 3). The effects of ryanodine on insulin-mediated sugar 
transport have not been studied previously but caffeine which also 
releases SR ca2+ (127), attenuated insulin-mediated sugar transport 
(85). Bihler et al. (25) previously studied the transmembrane [Na+] 0 
gradient effect on sugar transport and they reported that slight 
reductions in the Na+ gradient enhanced insulin-mediated sugar 
transport while large decrements in the gradient led to attenuated 
insulin-mediated transport. Clausen and Flatman (86) reported that 
cardiac glycosides had little or no effect on insulin-mediated 
transport in rat soleus muscles which may be analogous to the effect of 
80 mM Na+0 on insulin-mediated 3MG transport (Table 3). These results 
suggest that large magnitude changes in the [Na+] gradient must occur 
before significant increases in [ca2+li occur and lead to attenuated 
insulin-mediated sugar transport. 
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Overall, these results suggest that when [Ca 2+Ji increases above 
an optimal range, there is a diminshed ability of insulin to stimulate 
sugar transport. Ionophores, ryanodine and 40 mM Na+ all attenuated 
insulin-mediated 3MG transport in control rats (Fig. 3). The lack of 
effect of A23187 and 40 mM Na+ on insulin-mediated 3MG transport in 
bacteremic rat muscles (Table 2, Fig. 4) suggests that a previous 
alteration in ca2+ regulation may occur in vivo in skeletal muscles 
from bacteremic rats which was not further affected by these 
treatments. However, ionomycin attenuated insulin-mediated 3MG 
transport in bacteremic rat muscles (Fig. 4) suggesting that ionomycin 
caused a more profound change in ca2+ regulation which further 
aggravated the sugar transport disturbances that develop during 
bacteremia. The increase in basal transport which may accompany the 
loss of insulin effectiveness may signal a loss of cellular glucose 
transport regulation. Recently, altered ca2+ regulation has been 
described in obese individuals (120) and obesity also is associated 
with an attenuation of insulin-mediated sugar transport (435). 
CHAPTER VI 
THE EFFECT OF CA2+ CHANNEL AGONISTS AND ANTAGONISTS ON 
SKELETAL MUSCLE SUGAR TRANSPORT 
A. INTRODUCTION 
Studies concerned with the relationship between sarcolemmal ca2+ 
movements and skeletal muscle function have focused on ca2+ movements 
during electrical (4,17,116,204,253,406) and mechanical activity (152, 
204,346,347). A channel responsible for most of the ca2+ current (lea) 
is voltage-sensitive (17,73,116,406) and is located primarily in the 
transverse-tubules of the sarcolemma (130,141,150). Electrophysiology 
studies indicate that this channel is analogous to the "slow" inward 
ca2+ channel in cardiac and smooth muscle (159). Although the Ica is 
not necessary for electrical or mechanical activity in skeletal muscle 
(161), it appears to contribute to action potentials (204,229) and 
tension development (152,204) during prolonged depolarizations. ca2+ 
movements through this channel are blocked by dihydropyridine, phenyl-
alkylamine, and benzothiazipine antagonists (3,159,204,229,406) and 
enhanced by dihydropyridine agonists (204). These compounds also 
inhibit receptor operated ca2+ channels in other tissues such as liver 
(200) but receptor-operated channels have not been extensively studied 
in skeletal muscle. 
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Although some studies suggest that inward ca2+ movement may 
influence skeletal muscle metabolism, the effect that ca2+ channel 
activation may have on cellular metabolism in this tissue has not been 
established. Potassium-induced depolarization stimulated oxygen 
consumption (395,396), glycolysis (393,396), and glucose transport 
(391) in skeletal muscle. Verapamil prevented the increase in 
skeletal muscle respiration in K+ depolarized cells (72). These 
results suggest that activation of sarcolemrnal ca2+ channels may 
influence metabolism. In addition, slightly elevated [K+] 0 increased 
cellular respiration without causing contraction which indicates 
metabolic processes may be more sensitive to inward ca2+ movements 
than mechanical activities. 
Intracellular ca2+ appears to modulate skeletal muscle sugar 
transport (298,369) and such a modulation could occur through changes 
in ca2+ channel activation (417). Under pathophysiological conditions 
such as diabetes or bacteremia, attenuated insulin-mediated sugar 
transport is observed (420,423) and is associated with changes in 
cellular ca2+ regulation (415). In a previous study from our 
laboratory (417), treatment of bacteremic rats with a ca2+ antagonist 
prevented alterations in skeletal muscle sugar transport which we 
postulated was the result of the antagonist's ability to maintain 
cellular ca2+ regulation in these rat muscles. 
The purpose of this study was to determine whether the agonists 
and antagonists of the sarcolemrnal ca2+ channel, through their effect 
on cellular ca2+, could modulate basal and insulin-mediated skeletal 
muscle sugar transport. We hypothesized that while a low 
r 
r 
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concentration of agonist may activate inward ca2+ movement and 
stimulate sugar transport, a high agonist concentration may enhance 
inward ca2+ movement to adversely affect cellular ca2+ regulation such 
that (Ca2+Ji fails to modulate sugar transport. 
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B. MATERIALS AND METHODS 
The effect of the dihydropyridine agonist Bay K 8644 on basal 
and insulin-mediated 3-0-methylglucose (3MG) transport and on 45 ca2+ 
uptake were measured in isolated soleus muscles. Other experiments 
assessed the ability of dihydropyridine or benzothiazepine antagonists 
to prevent agonist-mediated effects on transport or ca2+ uptake. 
1) Glucose transport measurements. Fasted male, Holtzman rats 
(80-100 g) were given an intraperitoneal (ip) injection of 0.5 ml 
saline. Twelve hrs later rats were decapitated, and soleus muscles 
were quickly removed and placed on aluminum holders. Sugar transport 
was measured using the efflux technique described in previous studies 
(413,416). Briefly, muscles were 'loaded' with 14c-3-0-methylglucose 
(14c-3MG) for 60 min in Krebs-Ringer-Bicarbonate (KRB) media and then 
washed in radioisotope-free KRB for 5 min intervals over a period of 
70 min at 37°C. Insulin was added to the media during the 50 - 70 min 
washes. Muscles were digested with tissue solubilizer and both 
muscles and washes were counted in a liquid scintillation counter. 
The fractional efflux of 14c-3MG (A,min-1) was calculated from the 
amount of radioactivity present at the beginning and end of each wash. 
When present, calcium agonists (Bay K 8644) and antagonists 
(nifedipine, nitrendipine and diltiazem) were added to both 'load' and 
'wash' media. Bay K 8644 and nitrendipine were gifts of Dr. Scriabine 
from Miles Laboratories, Inc. (New Haven, CT) and diltiazem was the 
gift of Marion Laboratories, Inc. (Kansas City, KS). Nifedipine was 
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obtained from Sigma. Stock solutions (10-20 mM) of Bay K 8644, 
nifedi-pine, and nitrendipine were prepared with dimethylsulfoxide 
(DMSO, Sigma). The highest concentration of DMSO added to the KRB 
media was 12 mM (0.08%) and in a previous study 0.5% DMSO had no 
effect on 3MG transport (417). Diltiazem stock solutions (10-20 mM) 
were prepared in 0.9% saline. 
2) 45ca2+ uptake measurements. To measure 45ca2+ uptake in 
soleus muscles, they were preincubated in KRB (2.5 ml) containing 1.0 
mM ca2+ and 5 mM glucose (KRB-G) for 45 min and then transferred to 
2.0 ml of KRB-G containing 3 µCi of 45ca2+ for 1 hr, at which time 
45ca2+ uptake was approaching a steady state. The muscles were then 
incubated in KRB-G containing 45ca2+ (3 µCi) plus agonist and/or 
antagonists for 5 min up to 2 hrs. A 20 µl aliquot of medium was 
counted in a liquid scintillation counter to determine the specific 
activity. After the 45ca2+ uptake period, muscles were washed for 70 
min in Hepes buffer without added ca2+ but which contained 2 mM La3+ 
to remove extracellu-lar-bound ca2+ and to prevent the loss of 
intracellular ca2+ (415). All incubations were carried out in a 37°c 
water bath. Muscles were digested overnight and the radioactivity was 
measured. Both 3MG transport and ca2+ uptake studies were performed 
in the dark when ca2+ agonist or antagonists were present. 
3) Statistics. The results of the sugar transport and 45ca2+ 
studies were analyzed using a multifactorial repeated measures 
analysis of variance (ANOVA) using the BMPD (los Angeles, CA) statis-
tical package and a post hoc Student's Newman-Keuls test with the SAS 
(Cary, NC) statistical package. Results are expressed as mean±SEM. 
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C. RESULTS 
1) Effect of ca2+ agonist on skeletal muscle 3MG 
transport. Low concentrations of Bay K 8644 (0.25 µM) enhanced 
insulin-mediated sugar transport (Fig. lB) compared to control values 
but had no affect on basal transport. In the presence of 0.5 µM Bay K 
8644, basal 3MG transport increased significantly and insulin-mediated 
transport (Fig. lC) was higher than control values at 52.5 min but not 
when peak stimulation was observed at 57.5 min. Enhanced basal 3MG 
transport was also observed with 2-6 µM Bay K 8644 (Fig. lD-F). The 
two higher concentrations (4, 6 µM) produced a progressive attenuation 
of insulin-mediated 3MG transport (Fig. lE,F) compared to control 
values. 
2) Effect of ca2+ antagonists + Bay K 8644 on 3MG transport. 
The dihydropyridine antagonist nifedipine (Fig. 2) blocked the effects 
of Bay K 8644 on 3MG transport (Fig. 2, Table 1). The enhanced 
insulin-mediated 3MG transport observed with 0.25 µM Bay K 8644 (Table 
1) was prevented with 1 µM nifedipine. Nifedipine alone (1 µM) 
increased basal 3MG transport slightly but had no effect on insulin-
mediated 3MG transport (Table 1). 
Although 2 µM nifedipine had no effect on the Bay K 8644 (6 µM) 
induced elevation of basal 3MG transport, 4 µM nifedipine reduced 
basal transport to values observed in control muscles (Fig. 2). 
Whereas 2 µM nifedipine (Fig. 2) partially countered the agonist-
induced (6µM Bay K 8644) attenuation of insulin-mediated 3MG transport 
Figure 1. Effect of [Bay K 8644] on basal and insulin-mediated 3MG 
transport (A, min- 1 ) in rat soleus muscles. Bay K 8644 was present 
throughout the 'load' and 'wash' and the Bay K 8644 concentrations 
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used were A) 0 µM (n=8), B) 0.25 µM (n=8), C) 0.50 µM (n=ll), D) 2 µM 
(n=4), E) 4 µM (n= 8), F) 6 µM (n=lO). Results shown are mean±SEM for 
efflux measurements made between 35 and 70 min during the 'wash' 
period. Data was analyzed using a 2-factor, repeated measures 
analysis of variance (ANOVA) followed by Newman-Keuls multiple 
comparison test (MCT) with p<0.05 considered significant. ~<0.05 vs 
control, no Bay K 8644. 
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Figure 2. Effect of nifedipine (2 µM - • , n-4; 4 µM - O , n-8) on 
basal and insulin-mediated 3MG transport in the presence of 6 µM Bay K 
864q. Results for experiments done in the presence of nifedipine are 
shown as mean±SEM for efflux measurements made between 35 and 70 min 
during the wash period. Mean values for 3MG efflux in control muscles 
(----, n-8) and muscles incubated with 6 µM Bay K 8644 alone (· ·· ·, 
n-10) also are shown for comparison (see Mean±SEM values in Fig. 1). 
Data was analyzed using a 3-factor, repeated measures ANOVA followed 
by a Newman-Keuls MCT with p<0.05 considered significant. ~p<0.05 vs 
control, no additions; +p<0.05 vs 6-µM ~ay k 8644 alone. 
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Table 1. Basal and insulin-mediated 3MG transport in muscles 
incubated with 0.25 µM Bay K 8644, Bay K 8644 plus 1 µM nifedipine, or 
no additions (control). 
Treatment n Basal Insulin-mediated 
>. x 102 (min-l) >. x 102 (min-l) 
Control 8 1. 849±0 .108• 5.580±0.201 
Nifedipine (lµM) 8 2.454±0.203* 5.298±0.261 
Bay K 8644 (0.25µM) 8 1. 822±0. 087 6.268±0.126* 
Bay K 8644 + 
Nifedipine 8 1.908±0.082 5.681±0.183t 
•When present, the dihydropyridines were added to both the 
'load' and 'wash' media using concentrations shown in the Table. 
Basal 3MG efflux was assessed using the 47.5 min value and insulin-
mediated efflux was determined at 57.5 min. Results shown are 
mean±SEM. Data was analyzed using a 2-factor ANOVA followed by a post 
hoc Newrnan-Keuls test with a p<0.05 considered significant. *p<0.05 
vs control; tp<0.05 vs Bay K 8644 alone. 
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(Fig. lF), 4 µM nifedipine completely released the inhibitory effects 
of 6 µM Bay K 8644 on insulin-mediated 3MG transport (Fig. 2). 
Nifedipine alone (2 and 4 µM) also significantly (p<0.05) increased 
basal (2 µMA = 2.445±0.284, n=4; 4 µMA = 2.179±0.129, n=8) and 
significantly attenuated insulin-stimulated (2 µMA = 4.638±0.343, 
n=4; 4 µM A 3.952±0.148, n=8) 3MG transport compared to control 
values. In contrast to the effect of nifedipine, nitrendipine did not 
reverse the effects of 6 µM Bay K 8644 on basal or insulin-mediated 
3MG transport at any of the concentrations tested (1-10 µM) (Table 2). 
Preincubation of muscles with 10 µM nitrendipine for 10 min however, 
potentiated the Bay K 8644-mediated increase in basal transport (Table 
2) when compared to the effect of Bay K 8644 alone (Fig. lF). 
Nitrendipine alone had no effect on basal or insulin-stimulated 3MG 
transport (Table 2). 
The benzothiazepine calcium antagonist diltiazem has somewhat 
different actions than dihydropyridines (159). Addition of 10 µM 
diltiazem had no effect on the elevated basal 3MG transport observed 
with 6 µM Bay K 8644 but 20 µM DZ (+Bay K 8644) reduced basal 
transport to control values (Fig. 3). Whereas, the addition of 10 µM 
diltiazem partially reversed the attenuation of insulin-mediated 3MG 
transport produced by 6 µM Bay K 8644 (Fig. 3), 20 µM diltiazem re-
stored insulin-mediated transport to control values (Fig. lA). Basal 
and insulin-mediated 3MG transport in muscles incubated with 20 µM 
diltiazem were not different from that in control muscles (Table 3). 
3) Effect of ca2+ calcium channel modifiers on 45ca2+ uptake. 
To determine whether Bay K 8644 and nifedipine affected sugar 
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Table 2. Effect of nitrendipine on basal and insulin-mediated 3MG 
transport in soleus muscles incubated with and without Bay K 8644 (6 
µM). 
+6 µM BAYK8644 -BAYK8644 
[Nitrendipine] 
µM n Basal + Insulin n Basal +Insulin 
0 10 2.336±0.068. 4. 263±0 .115 8 1.849±0.108+ 5. 580±0. 201 +I 
1 6 2.520±0.161 4.200±0.256 4 1.762±0.099+ 5.165±0.471+ 
10 6 2.256±0.240 4.421±0.165 4 2.268±0.251 5.023±0.406 
Preinc-10t 6 2.871±0.164* 4.355±0.194 N.D. N.D. 
•Mean±SEM represent 3MG transport rate coefficients in units of A 
x 102 min-1. 3MG efflux at 47.5 and 57.5 min respectively, represents 
basal and insulin-mediated 3MG transport. Data was analyzed using a 
3-factor (Bay K 8644, nitrendipine, time) ANOVA and NeWIIlan-Keuls MCT 
with p<0.05 considered significant. * p<0.05 vs no nitrendipine; 
+p<0.05 vs +6 µM Bay K 8644. tindicates nitrendipine was added to 
incubation media 10 min prior to Bay K 8644. 
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Figure 3. Effect of diltiazem (10 µM -~. n=8; 20 µM -(), n=8) on 
basal and insulin-mediated 3MG transport in the presence of 6 µM Bay K 
8644. Results for experiments done in the presence of diltiazem are 
shown as mean±SEM for efflux measurements made between 35 and 70 min 
during the wash period. Mean values for 3MG efflux in control muscles 
(----, n=8) and muscles incubated with 6 µM Bay K 8644 alone (· · · ·, 
n=lO) also are shown for comparison (see Mean±SEM values in Fig. 1). 
Results were analyzed using a 3-factor, repeated measures ANOVA 
followed by a post hoc Newrnan-Keuls test with p<0.05 considered 
significant. +p<0.05 vs 6 µM Bay K 8644 alone. 
Table 3. Basal and insulin-mediated 3MG transport in muscles 
incubated with and without diltiazem. 
Treatment n Basal Insulin-mediated 
>. x 102 (min- 1 ) >. x 102 (min- 1 ) 
Control 8 1.849±0.108. 5.580±0.210 
20 µM DZ 8 2.166±0.244 5.158±0.219 
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•niltiazem was added to both the 'load' and 'wash' media. Results 
shown are mean+SEM. Results from control and diltiazem-treated 
skeletal muscles were not significantly different when compared using 
a 2-factor ANOVA followed by post-hoc Newman-Keuls test with p<0.05 
considered significant. 
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transport via changes in cellular ca2+, 45ca2+ uptake was measured 
(Fig. 4). Bay K 8644 (6 µM) significantly increased soleus muscle 
ca2+ uptake at all time points. Although compared to controls the 
uptake remained elevated between 15 min through 2 hrs in the presence 
of Bay K 8644 (6 µM) plus 4 µM nifedipine, the increase was of lesser 
magnitude than that observed with Bay K 8644 (6 µM) alone. 
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Figure 4. Effect of Bay K 8644 (Control=[], n=4-8; 6 µM = ~. n=4) 
or Bay K 8644 (6 µM) plus nifedipine (4 µM, ~ , n=4) on ca2+ uptake in 
rat soleus muscles. Dihydropyridines were added to the ,incubation 
media at 60 min and results shown are mean±SEM for 60 through 180 min 
incubations. ca2+ uptake measurements were analyzed using a 3-factor 
ANOVA and Newman-Keuls MCT with p<0.05 considered significant. 
l\<0.05 vs control, no additions; ..,ftp<0.05 vs 6 µM Bay K 8644, no 
nifedipine. 
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D. DISCUSSION 
Previous studies utilizing the ca2+ agonist Bay K 8644 
primarily focused on the electrophysiologic properties of ca2+ 
channels in nerve (146), cardiac (247,343,356), smooth (142,356), and 
skeletal (90,204,253) muscle. Bay K 8644 effects on ca2+i-dependent 
activities such as contractile force development also have been 
studied (253). In contrast, the present study evaluated the effects 
of the ca2+ channel agonist on a metabolic function in skeletal muscle 
viz. sugar transport. Previous investigators proposed a role for ca2+ 
in the modulation of basal (80) and insulin-stimulated (369) sugar 
transport in skeletal muscle and adipose tissue. The results of the 
present study indicate that alterations in sarcolemmal ca2+ channel 
activity affect both basal and insulin-mediated transport. We 
postulate that the activity of the ca2+ channel can influence (ca2+li 
and in turn lead to modulation of sugar transport. In our study, the 
channel activity was modulated by adding known ca2+ channel agonists 
and antagonists. 
Maximal stimulation of glucose transport, with 10 mU/ml 
insulin, was further enhanced with 0.25 µM Bay K 8644 (Fig. lB); a 
similar Bay K 8644 concentration is known to augment lea (90,204,253), 
to shift the threshold for lea to more negative membrane potentials 
(91), and to enhance depolarization-induced contraction (204) in 
skeletal muscle. These data suggest that 10-7 M Bay K 8644 enhances 
insulin-mediated glucose transport via changes in sarcolemmal ca2+ 
movements. 
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A high [Bay K 8644] (6 µM) attenuated the insulin-mediated 3MG 
transport response (Fig. 1 B-F) and augmented ca2+ uptake (Fig. 4). 
Bay K 8644 also is known to increase 45ca2+ uptake in resting 
neuroblastoma-glioma cells (146). However, in another study, there 
was no effect of the agonist on lea or tension development in skeletal 
muscle (253). Skeletal muscle 45ca2+ uptake has not been previously 
measured in the presence of Bay K 8644. From our results, we 
postulate that 0.25 µM Bay K 8644 increased (Ca2+li to a level within 
an optimal range which resulted in in an enhanced ability of insulin 
to stimulate glucose transport. The high [Bay K 8644] (6 µM) appeared 
to increase (ca2+Ji beyond that optimal range such taht cellular 
regulation of insulin-mediated sugar transport was adversely affected. 
Cardiac contractile responses were also shown to be diminished when 
the [Bay K 8644] was increased to 5 x lo-6 to lo-5 M; these findings 
were interpreted to indicate that the decreased response was due to 
antagonistic effects of Bay K 8644 at higher concentrations (356). 
To confirm that the effects of Bay K 8644 on sugar transport 
resulted from its agonistic actions on ca2+ channels, ca2+ antagonists 
were added along with Bay K 8644 during sugar transport and ca2+ 
uptake measurements. Previous investigators reported that the 
dihydropyridine antagonists nifedipine and nisoldipine blocked Bay K 
8644-induced prolongation of Purkinje fiber action potentials (382) 
and decreased the sensitivity of the cardiac contractile response to 
Bay K 8644 (356). Nifedipine is known to also prevent the effects of 
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high [Bay K 8644] (>5 x lo- 6 M) effects on rabbit aortic strip force 
development (356). A similar antagonism of Bay K 8644 effects was 
observed in the present study. Nifedipine prevented: 1) the 
enhancement by low [Bay K 8644] (0.25 µM) of insulin-mediated sugar 
transport (Fig. lB, Table l); 2) the high [Bay K 8644]-induced (6 µM) 
diminution of the insulin-mediated 3MG transport (Fig.s 2 vs lF) and; 
3) the high [Bay K 8644]-mediated increase in ca2+ uptake (Fig. 4). 
In contrast to the action of nifedipine, nitrendipine had no effect on 
Bay K 8644-induced alterations in sugar transport (Table 2). Previous 
investigators reported that nitrendipine binds to rat and rabbit 
skeletal muscle (141,357) but it apparently is unable to functionally 
block mammalian skeletal muscle ca2+ channels (357,406). 
The benzothiazepine diltiazem also blocks ca2+ channels (406), 
but it apparently does not antagonize the effects of Bay K 8644 in a 
competitive manner (146,235). In the present study, increases in 
[diltiazem] progressively restored the Bay K 8644-induced attenuation 
of insulin-mediated sugar transport toward control values (Fig. 3). 
The [diltiazem] required to prevent the high [Bay K 8644] effects 
(Fig. 3) was approximately 10 fold higher than the nifedipine 
concentration required for similar results (Fig. 2), but it was 
similar in magnitude to the EC50 for its actions on Ica (406). 
Diltiazem administered to bacteremic rats also prevented the 
development of altered skeletal muscle ca2+ regulation (415) and 
prevented changes in sugar transport (417). Although diltiazem blocks 
Ca2+ channel activation, it appears to be less effective than 
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dihydropyriudine antagonists (146) because it enhances dihydropyridine 
binding to the sarcolemma (235,270,327). 
Overall, these results support our hypothesis that Bay K 8644 
increases (ca2+]i which leads to altered insulin-mediated sugar 
transport in skeletal muscle via its actions on a sarcolemmal ca2+ 
channel. Dihydropyridine and benzothiazepine ca2+ antagonists appear 
to inhibit the agonist-mediated inward ca2+ movements (Fig. 4) which 
prevents changes in insulin-mediated transport (Figs. 2,3). In the 
case of high concentrations of Bay K 8644 (6 µM), these antagonists 
appear to prevent cellular (ca2+] from increasing beyond an optimal 
range for cellular function. Draznin et al. (118) recently introduced 
a similar hypothesis from experiments in adipocytes where an optimal 
range of cellular ca2+ was required for maximal stimulation of sugar 
transport by insulin. Although the exact processes affected by 
altered ca2+ regulation are not completely understood, recent studies 
indicate that mobilization of glucose transporters into the plasma 
membrane is ca2+ sensitive (2,427). Other investigators postulate 
that the ca2+ dependent enzyme protein kinase C may phosphorylate the 
insulin receptor and thus, modulate basal and insulin-mediated glucose 
transport (68,129,236,431). 
Basal 3MG transport also was affected by the ca2+ agonist and 
antagonists although the changes were of lesser magnitude than the 
alterations in insulin-mediated transport. Bay K 8644 concentrations 
greater than 0.25 µM increased basal 3MG transport (Fig. 1 B-F) and 
nifedipine (4 µM) and diltiazem (20 µM) concentrations which prevented 
the Bay K 8644-induced alterations in insulin-mediated transport also 
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prevented the increase in basal 3MG transport (Figs. 2,3). Our 
results agree with those of Holloszy and Narahara (196) showing that 
electrical stimulation, which presumably augments lea• increased 
skeletal muscle trnasport. Increased basal glucose transport was 
detectable with 0.5 µM Bay K 8644 (Fig. lC) while higher 
concentrations of agonist were required to observe an effect on 
insulin-mediated transport (Fig. 1 D-F). Detection of basal transport 
changes at lower [Bay K 8644] suggests that alterations in basal 3MG 
transport may be more sensitive to changes in ca2+ regulation than 
insulin-mediated 3MG transport. 
Although 4 µM nifedipine blocked the Bay K 8644-induced 
alterations in insulin-mediated 3MG transport (Fig. 2), nifedipine 
alone (see RESULTS) produced inhibitory effects similar to high [Bay K 
8644) (6 µM) (Fig. lF). Nifedipine alone also enhanced ca2+ uptake 
(see RESULTS) to a similar degree as observed with Bay K 8644 plus 
nifedipine (Fig. 4). Although the enhancement of ca2+ uptake was 
quantitatively similar in the presence of nifedipine alone and Bay K 
8644 plus nifedipine (Fig. 4) these two treatments resulted in 
opposite effects on 3MG transport (Fig. 2 vs. see RESULTS). These 
results suggest that nifedipine alone may have agonistic effects to 
increase ca2+ uptake and that such an agonistic effect of nifedipine 
could have contributed to the alterations in sugar transport in the 
presence of nifedipine alone. In previous studies nifedipine acted 
only as an antagonist as it reduced Ica• decreased charge movement, 
and reduced the slow component of tension development in depolarized 
skeletal muscle (3,5,204,252,253,328). Nifedipine had no effect on 
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resting skeletal muscle (204,252,328). We cannot rule out that the 
effects of nifedipine on skeletal muscle sugar transport may be due to 
nonspecific effects unrelated to its effects on ca2+ channels. 
Nitrendipine (Table 2) had no effect on 3MG transport which agrees 
with previous reports that nitrendipine had no antagonistic actions on 
skeletal muscle (357,406). Diltiazem alone (10,20 µM) also had no 
significant effect on basal or insulin-mediated sugar transport (Table 
3) which supports earlier work indicating that skeletal muscle 
stimulation or depolarization are required for diltiazem action 
(3,308,345,406). 
In summary, our data support the hypothesis (417) that altered 
[Ca2+Ji regulation can contribute to changes in basal and insulin-
mediated sugar transport. ca2+ channel activity appears to influence 
or modulate metabolic functions along with its effects on mechanical 
(253) functions in skeletal muscle. The efficacy of ca2+ blockers may 
be due to their effects on metabolic as well as mechanical functions. 
CHAPTER VII 
EFFECT OF DILTIAZEM ON SKELETAL MUSCLE 3-0-METHYLGLUCOSE 
TRANSPORT IN BACTEREMIC RATS 
A. INTRODUCTION 
Both in vitro (325,420) and in vivo (430) studies have shown 
alterations in skeletal muscle carbohydrate metabolism during septic 
shock. Changes in glucose utilization occur when at least one rate-
limiting step is altered. Membrane sugar transport is the first rate-
limiting step in carbohydrate metabolism (79) and recent studies 
indicate that both basal and insulin-mediated transport are altered in 
skeletal muscles from bacteremic rats (413,416). The intracellular 
signals responsible for modulating both basal and insulin-mediated 
sugar transport under physiological conditions are not completely 
understood. One possibility that may account for these changes is a 
nonspecific increase in sugar permeation into bacteremic rat muscles. 
To evaluate such changes in sugar permeation we measured transport in 
the presence and absence of the specific sugar transport inhibitor 
cytochalasin b and transport activity at low temperature (O.s 0 c) when 
carrier-mediated transport is minimal (245). 
Calcium has been shown to alter sugar transport (245) although 
its site of action and its role under physiological conditions are 
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controversial (79,239). Several investigators have shown that changes 
in intracellular ca2+_binding proteins can alter basal (236,431) or 
insulin-mediated (236) glucose transport activity. Changes in 
intracellular ca2+ regulation are postulated to be involved in the 
pathophysiology of septic shock (350). In a previous study, cytosolic 
free ca2+ was increased (350) while ca2+ release from the endoplasmic 
reticulum was attenuated (272) in hepatocytes from endotoxic rats. 
These effects were prevented when diltiazem was coadministered with 
endotoxin (272,350). A recent study in bacteremic rats also has shown 
that skeletal muscle ca2+ uptake was altered and could be prevented 
with diltiazem treatment (414). 
To evaluate whether an elevation of cell calcium during 
bacteremia contributed to altered sugar transport, a slow-channel 
calcium blocker was administered to rats and its ability to prevent 
changes in sugar transport was evaluated. Also, we ascertained the 
ability of a ca2+ blocker to reverse bacteremia-induced glucose 
transport alterations in vitro. In additional experiments, we 
investigated whether a ca2+ agonist (Bay K 8644) could aggravate the 
bacteremia-induced sugar transport alterations. 
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B. MATERIALS AND METHODS 
1) Animal model. Male, Holtzman rats (80-100 g) were fasted 
overnight and given an intraperitoneal (ip) injection of sterile 
saline (control) or bacteria (4 x 1010 Escherichia coli/kg). Bacteria 
were prepared as described previously (413). In some experiments, 
control and bacteremic rats received an intravenous (iv) injection 
(0.5 ml/injection) of diltiazem (DZ) at one of the times post-saline 
or -bacterial injection and one of the doses listed: A) 1.2 mg/kg DZ 
at 7.5 hrs; B) 1.2 mg/kg DZ at 0 and 7.5 hrs; C) various doses of DZ 
(0.6-2.4 mg/kg) at 10 hrs. Twelve hrs after bacterial injection, rats 
were decapitated, soleus muscles were quickly removed and mounted on 
aluminum holders at approximately resting length. 
2) 3-0-Methyl~lucose transport. Sugar transport was measured 
using an efflux technique (245,413). Briefly, muscles were 'loaded' 
with 14c-3-0-methylglucose (14c-3MG, Arnersham) at 37°c in 3.0 ml of 
Krebs-Ringer-bicarbonate (KRB) media for 60 min and then sequentially 
washed in 2.5 ml of radioisotope-free KRB every 5 min for 70 min at 
37°c. Insulin was present in wash media between 50 and 70 min. 
Muscles were digested in tissue solubilizer (TS-1, Research Products 
International) overnight and then muscles and wash media were counted 
in a liquid scintillation counter (Packard Tri-Garb 460). Radioactive 
counts were added in a retrograde fashion to determine the amount of 
radioactivity remaining in the muscle after each wash. Fractional 
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efflux (A,min- 1 ) was estimated from the DPM/g at the beginning and end 
of each wash. 
In some experiments, muscles were exposed to low temperature 
(0.5°C) or cytochalasin b (cyt b, Sigma) to determine whether changes 
in carrier-mediated sugar transport or nonspecific sugar permeability 
occurred with bacteremia. Muscles in the low temperature study were 
'loaded' with 14c-3MG in KRB buffer at 37°c for 60 min and then 
sequentially washed in radioisotope-free KRB for 70 min at 0.5°C. The 
same protocol was used in cyt b studies except muscles were 'loaded' 
with radioactivity and then sequentially washed in radioisotope-free 
KRB containing 25 µM cyt b at 37°C. In experiments testing the in 
vitro effects of diltiazem or Bay K 8644, the antagonist or agonist 
was added to both the 'load' and 'wash' media. Rats in these 
experiments also were not given iv diltiazem therapy. Stock solutions 
of 30 mM cyt b and Bay K 8644 were prepared with dimethylsulfoxide 
(DMSO, Sigma) and the final DMSO concentration in the KRB media was 
0.08% (~12 mM). DMSO concentrations of 0.5% had no effect on basal (C 
A= 1.849±0.108 min-1, n=8; DMSO A = 1.831±0.112, n=4; p>0.05 with 
unpaired t-test) or insulin-mediated 3MG transport (CA - 5.580±0.201, 
n-8; DMSO A = 5.735±0.423, n-4; p>0.05). Experiments with cyt b, Bay 
K 8644, or DZ added to incubation media (in vitro) were done in the 
absence of room lights. 
3) Statistics. The results of the sugar transport studies 
were compared using multifactorial repeated measures analysis of 
variance (ANOVA) and post hoc Student's Newman-Keuls tests with the 
BMDP (Los Angeles, CA) and SAS (Cary, NC) statistical packages. 
Results are expressed as rnean±SEM. 
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C. RESULTS 
1) 3-0-Methylglucose permeability during bacteremia. Low 
temperature incubations or additions of cytochalasin b to incubation 
media were carried out to determine whether altered membrane 
permeability produced the changes in basal and insulin-mediated 3MG 
transport observed in muscles from bacteremic rats (413,416). In both 
control and bacteremic rats, low temperature substantially reduced 3MG 
transport (C A at 37°C = 1.849±0.108, n=8; BA at 37°c = 2.341±0.100, 
n=l2; vs Fig. 1) and there was no difference in transport between 
control and bacteremic rat muscles at the low temperature (Fig. 1). 
These results suggest that elevated basal 3MG transport in bacteremic 
rats was due to changes in the glucose transport protein rather than 
increased nonspecific sugar permeability. Addition of 25 µM cyt b 
reduced 3MG transport to similar values in 12 hr control and 
bacteremic rats at all time points (Fig. 2). Insulin was unable to 
stimulate 3MG transport in the presence of cyt b in both 12 hr control 
and bacteremic rats indicating that the insulin effect was mediated 
via changes in the glucose transporter. 
2) Effect of diltiazem on sugar transport. Diltiazem added to 
the incubation media did not reverse the changes in 3MG transport 
observed in bacteremic rats (Fig. 3). Diltiazem (20 µM) increased 
basal transport in bacteremic rat soleus muscles and had no effect on 
insulin-mediated transport. Diltiazem administered iv to rats at 0 
and/or 7.5 hrs after bacterial injection did not ameliorate (Fig. 4B) 
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transport in 12 hr control ( • , n=8) and bacteremic ( 0 , n=l6) rat 
soleus muscles. Muscles were 'loaded' with 14c-3MG at 37°C and 
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sequentially washed at 0.5°C. Results are mean±SEM. All points were 
significantly decreased (p<0.05) compared to similar muscles incubated 
at 37°c. 3MG transport was not signficantly different (p>0.05) when 
comparing vlues from control and bacteremic rat muscles with a 2-way 
ANOVA a post-hoc Newman-Keuls test. 
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Figure 2. The effect of cytochalasin b (cyt b, 25 µM) on basal and 
insulin-mediated 3MG transport in 12 hr control ( ~ ,n-8) and 
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bacteremic ( () ,n-8) rat soleus muscles. Muscles were 'loaded' with 
14c-3MG in the absence of cyt b and then washed in media containing 25 
µM cyt b. Results are mean±SEM. All points are significantly 
decreased (p<0.05) compared to similarly treated control (C) and 
bacteremic (B) rats (basal values - see RESULTS; Cw/insulin A = 
5.580±0.201, n=8; B w/insulin A - 4.106±0.177,,n=l2). 3MG transport 
was compared between control and bacteremic rat muscles using 2-way 
ANOVA and post-hoc Newman-Keuls tests and was not significantly 
different (p>0.05). 
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Figure 3. Effect of 20 µM diltiazem (DZ) on basal and insulin-
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75 
mediated 3MG transport in 12 hr bacteremic rat soleus muscles (No DZ = 
~.n-12; w/DZ = () ,n=6). Muscles were 'loaded' and 'washed' in media 
containing 20 µM DZ. Results are mean±SEM. 3MG transport was 
compared in 12 hr bacteremic rat muscles with and without DZ using a 
2-way ANOVA and post-hoc Newman-Keuls tests with a p<0.05 <'*) 
considered significant. 
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the elevated basal and attenuated insulin-mediated 3MG transport 
previously observed in bacteremic rat muscles (413,416). Instead, 
basal 3MG transport increased further in rats given 1.2 mg/kg 
diltiazem at 7.5 hrs (Fig. 4B). Insulin-stimulated 3MG transport was 
significantly increased at 52.5 min in muscles from bacteremic rats 
given 1.2 mg/kg diltiazem at 7.5 (Fig. 4B) or given 1.2 mg/kg at 0 and 
7.5 hrs (Fig. 4B) after bacterial injection compared to untreated 
bacteremic rats. However, peak transport (57.5 min) was not altered 
by diltiazem treatment (Fig. 4B). In control rats, basal transport 
was 1.849+0.108 min-1 (n=8) and insulin-mediated transport was 
5.580±0.201 min-1 (n=8). Basal transport was not altered while 
insulin-mediated transport was decreased slightly in muscles from 
control rats treated with one diltiazem injection at 7.5 hrs compared 
to untreated controls (Fig. 4A). Two diltiazem injections increased 
basal transport and led to a moderate attenuation of insulin-mediated 
3MG transport (Fig. 4A). 
In control rats given diltiazem 10 hrs post-saline injection, 
1.2 mg/kg diltiazem increased basal transport significantly but 2.4 
mg/kg diltiazem had no effect compared to controls (Table 1). 
Insulin-mediated 3MG transport was not altered by 1.2 mg/kg diltiazem 
but 2.4 mg/kg diltiazem decreased peak transport (Table 1). When 
diltiazem treatment was given 10 hrs after bacterial injection, 3MG 
transport was restored toward control values in 12 hr bacteremic rat 
muscles (Fig. 5). Diltiazem (0.6-2.4 mg/kg) given to bacteremic rats 
at 10 hrs did not significantly reduce the elevated basal 3MG 
transport observed in untreated septic rats (Fig. 5A-D). Instead, 
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Figure 4. The effect of 1.2 mg/kg diltiazem on skeletal muscle 3MG 
transport when it was administered iv at 7.5 hrs or at 0 and 7.5 hrs 
(total = 2.4 mg/kg) after saline (Fig. 4A) or bacterial (Fig. 4B) 
injection. Transport is shown before (basal) and after the addtion of 
insulin (10 mU/ml) to soleus muscles from 12 hr control (Fig. 4A,~ , 
7.5 hr n=8;(), 0+7.5 hrs n=6) and bacteremic (Fig. 4B,~ ,7.5 hr n=8; 
() ,0+7.5 hrs n=8) rats. The average fractional efflux values (see 
ref. 416) in non-DZ-treated control (A) and bacteremic (B) rat soleus 
muscles (----) also are shown. Results shown are mean±SEM. Sugar 
transport in diltiazem-treated and nontreated rats (control and 
bacteremic) was compared using a 2-way ANOVA and post-hoc Newman-Keuls 
tests with a p<0.05 considered significant. *°p<0.05 vs. same expt. 
group (control, bacteremic), no DZ. 
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Table 1. Basal and insulin-mediated 3MG transport in skeletal muscles 
from control rats given various doses of diltiazem. 
[ Dil tiazem] n Basal Insulin-mediated 
mg/kg I. x 102 (min- 1 ) I. x 102 (min- 1 ) 
0 8 1.849±0.108. 5.580±0.201 
1. 2 6 2.308±0.176* 5.347±0.184 
2.4 7 2.015±0.088 5.138±0.155* 
•The two doses of diltiazem used are shown in the table. 
Diltiazem was administered 10 hrs after saline-injection and muscles 
were removed for glucose transport measurements 2 hrs later. Basal 
and insulin-mediated transport (mean±SEM) are expressed as fractional 
efflux (). x lo-2 min-1). Results were compared to basal and insulin-
mediated 3MG transport in soleus muscles from non-treated control rats 
using 1-factor ANOVA and Newman-Keuls post-hoc tests. 
was considered significant. 
* A p<0.05 ( ) 
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Figure 5. The effect of various doses of diltiazem (DZ), administered 
iv 10 hrs after bacterial administration, on basal and insulin-
mediated 3MG transport in soleus muscles from 12 hr bacteremic rats. 
The doses of DZ administered were A) 0.6 mg/kg, n=8; B) 1.2 mg/kg, 
n=8; C) 1.8 mg/kg, n=8; D) 2.4 mg/kg, n=8; with average transport 
values in muscles from nontreated 12-hr bacteremic rats also shown 
(----, see Ref. 416). Results of transport in DZ-treated rat muscles 
are shown as mean±SEM. Sugar transport was compared between DZ-tnd 
bacteremic rats were compared using 2-way ANOVA and post-hoc Newman-
Keuls tests with a p<0.05 considered significant. °*p<0.05 vs 
similarly treated control muscle; tp<0.05 vs control or bacteremic 
muscle not incubated in Bay K 8644. 
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basal transport in muscles from 12 hr bacteremic (Fig. SD) rats 
treated with 2.4 mg/kg diltiazem was intermediate between 12 hr 
bacteremic values (untreated) and 12 hr, untreated control vlues. 
Basal transport also was not different when muscles from 12 hr 
bacteremic (Fig. SD) rats treated with 2.4 mg/kg diltiazem were 
compared to controls (Table 1) indicating a tendency for basal 
transport to return toward control values. Diltiazem treatment at 10 
hrs produced more dramatic results in insulin-mediated 3MG transport 
in 12 hr bacteremic rat muscles (Fig. SA-D). The peak insulin-
mediated response was significantly increased in muscles from 12 hr 
bacteremic rats given 1.2, 1.8 and 2.4 mg/kg of DZ at 10 hrs. Peak 
insulin-mediated transport in bacteremic rat muscles after treatment 
with 2.4 mg/kg was not different from control values (Table 1 vs. Fig. 
SD; 2-way ANOVA, p>O.OS at all time points). 
3) Effect of Bay K 8644 of 3MG transport. Two concentrations 
of Bay K 8644 (0.2S, 6 µM) were used in transport studies to determine 
whether further changes in transport occur with a ca2+ agonist in 
bacteremic rat muscles. At both concentrations, basal and peak 
insulin-mediated 3MG transport were not different from transport in 
bacteremic rat muscles incubated without Bay K 8644 (Table 2). In 
addition, basal and insulin-mediated 3MG transport was not different 
in 12 hr control and bacteremic rat muscles incubated with 6 µM Bay K 
8644 (Table 2). 
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Table 2. Effect of [Bay K 8644] (0,0.25,6 µM) on 3MG transport in 
control and bacteremic rat muscles. 
Treatment [Bay K 8644] n Basal Insulin-mediated 
µM AX 102(min-l) ;\ x 102(min- 1 ) 
Control 0 8 1.849±0.108. 5.580±0.201 
Control 6 10 2.336±0.068* 4.263±0.115* 
Bacteremic 0 12 2.341±0.100+ 4. 106±0. 177+ 
Bacteremic 0.25 8 2.557±0.171 4.271±0.146 
Bacteremic 6 8 2.481±0.200 4.184±0.254 
•Muscles were 'loaded' and 'washed' in media containing the same 
[Bay K 8644]. Basal and insulin-mediated 3MG transport were measured 
using fractional efflux values (;\ x 102 min-1) and results shown are 
mean±SEM. Sugar transport in muscles from control and bacteremic rats 
were compared using 2-way ANOVA and post-hoc Newman-Keuls tests with a 
p<0.05 considered significant. *p<0.05 vs similarly treated control 
muscle; tp<0.05 vs control or bacteremic muscle not incubated in Bay K 
8644. 
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D. DISCUSSION 
The results obtained with low temperature and cyt b indicate 
that the altered basal and insulin-mediated 3MG transport observed in 
bacteremic rat muscles (Figs. 1,2) were due to specific changes in 
carrier-mediated sugar transport. Furthermore, the present study 
supported the concept that altered ca2+ regulation could contribute to 
changes in carrier-mediated sugar transport in bacteremic rat muscles. 
The changes in skeletal muscle sugar transport were prevented with the 
ca2+ blocker diltiazem (Fig. 5) and diltiazem has previously been 
shown to prevent the alterations in ca2+ regulation observed in 
muscles from endotoxic or bacteremic rats (122,414). 
In previous studies, ca2+ blockers decreased the lethality (40) 
of a bacteremic insult and partially prevented alterations in 
hepatocyte and skeletal muscle ca2+ regulation (122,254,350). 
Diltiazem added to the bacteremic rat muscles in vitro was unable to 
affect sugar transport (Fig. 3) indicating that diltiazem could not 
reverse cell ca2+ regulation changes which occur in vivo. In 
addition, several regimens of diltiazem administered to bacteremic 
rats were unable to prevent sugar transport alterations (Fig. 4) 
indicating that the dose and time of administration were critical. In 
this study, administration of diltiazem 10 hrs after bacterial 
injection prevented alterations in basal and insulin-mediated sugar 
transport in bacteremic rat muscles in a dose-dependent manner. The 
2.4 mg/kg dose of diltiazem provided maximal protection against 
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changes in muscle ca2+ uptake in a previous study (414) and also 
prevented sugar transport (Fig. 5) alterations in this study. These 
results support the idea that the altered sugar transport observed in 
bacteremia and endotoxic shock models is associated with changes in 
ca2+ regulation (348). As changes occur in cellular ca2+ regulation, 
insulin's ability to regulate sugar transport appears to be 
diminished. This diminution in transport was greater than the 
increase in basal transport observed in bacteremia. Diltiazem 
treatment restores the insulin response to an optimal level. The 
effect of diltiazem on insulin-mediated 3MG transport probably is 
therefore more relevant in the restoration of glucose utilization in 
septic states than diltiazem effects on basal transport. The 
attenuated insulin-mediated sugar transport in muscles from bacteremic 
rats may be a contributing factor to inadequate energy availability 
(89). A diminution in energy availability does not appear to preceed 
the changes in glucose transport in the present experiments. If 
depleted energy stores caused the cahnges in glucose transport, 
insulin would be unable to stimulate transport (442) and the basal 3MG 
fractional efflux would continuously increase as ion gradients 
dissipated and cellular swelling occurred (245). Restoration of the 
insulin response with diltiazem treatment may allow the cell to 
maintain an adequate energy supply and cellular function. 
In skeletal muscle, diltiazem as well as other ca2+ antagonists 
block slow inward ca2+ currents (Ica•s) (3), but appear to have no 
effect on fast inward ca2+ currents (Ica•f) (9). Calcium antagonists 
also block agonist-coupled ca2+ channels in hepatocytes (200,350). 
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Walsh et al. (406) reported the half-maximal inhibition of Ica 
occurred with 63 µM diltiazem in mammalian skeletal muscle. Other 
studies have shown that low concentrations of diltiazem (~ 10- 7 M) 
potentiated mechanical activity (405) but had no effect on Ica· Very 
high concentrations of diltiazem (~ lo-4 M) affect tension development 
as well as sarcoplasmic reticulum ca2+ uptake and release in skinned 
toad muscle (207). Overall, these studies indicate that diltiazem in 
the lo-5 to lo-6s action on sugar transport in bacteremic rat muscles 
was due to restoration of intracellular ca2+ regulation. 
Bay K 8644 primarily acts on transverse-tubule ca2+ channels to 
decrease the threshold required for ca2+ channels to open (204). Bay 
K 8644 effects on ca2+ channel conductance have been demonstrated over 
short periods of time but its effects on tension development suggest 
both short (seconds) and long term (minutes) effects (204). In this 
study, the longer term effects of Bay K 8644 on ca2+ may cause 
alterations in control muscle ca2+ regulation that are similar to 
those observed in bacteremic muscles. 
The steps leading to altered muscle carbohydrate metabolism 
during bacteremia and associated septic shock are not completely 
understood. Previous investigators have postulated that increased 
circulating insulin levels (48) or increased reliance of cells on 
carbohydrates to meet their energy demands leads to the increased 
glucose utilization observed in septic patients (268). The mechanism 
responsible for the glucose intolerance observed in septic patients 
(268) and the decreased ability of insulin to stimulate glucose 
utilization in isolated perfused skeletal muscle (325) has not been 
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elucidated (31). The results of this study suggest that alterations 
in cell ca2+ can modulate muscle sugar transport and altered ca2+ 
regulation may cause the changes in glucose metabolism observed in 
septic shock (Figs. 4,5, Table 2). ca2+ has been known to have a role 
in skeletal muscle glycolysis (227) and cell respiration (395), and 
recent studies have shown that Ca2+ acts as a modulator of sugar 
transport (118). 
CHAPTER VIII 
SUMMARY OF CONCLUSIONS 
Skeletal muscle carbohydrate, lipid, and protein metabolism are 
altered during sepsis and septic shock (232,290). Skeletal muscle 
energy is derived primarily from lipid utilization under physiological 
conditions (304). However, lipid consumption is decreased with sepsis 
(12) and carbohydrate metabolism is increased as a means of meeting 
energy demands (89). Several previous investigators observed 
alterations in skeletal muscle carbohydrate utilization during septic 
shock (13,420). Glucose transport is a primary regulatory step in 
skeletal muscle glucose utilization (233) and alterations in transport 
activity may ultimately affect the ability of the cell to obtain 
energy from carbohydrates. The purpose of this dissertation was to 
determine whether alterations in skeletal muscle glucose transport 
occur during septic shock. To this end, basal and insulin-mediated 
glucose transport were measured and found to be altered in skeletal 
muscles from bacteremic rats. Subsequent studies elucidated possible 
mechanisms involving cellular ca2+ regulation that contribute to the 
changes in transport. In this chapter, a summary of the results and 
conclusions drawn are presented along with possible factors leading to 
changes in transport. 
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A. CHARACTERIZATION OF 3-0-METHYLGLUCOSE TRANSPORT 
IN RAT SOLEUS MUSCLE DURING BACTEREMIA 
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The initial studies characterized the changes in glucose 
transport that occur in rat skeletal muscle during the course of 
bacteremia. Basal and insulin-mediated glucose transport were not 
affected in soleus muscles from 8-hr bacteremic rats despite the 
presence of a slight hyperglycemia and hyperlactacidemia. In 
contrast, soleus muscles from 12-hr bacteremic rats developed elevated 
basal transport but stimulation of 3-0-methylglucose (3MG) transport 
by a supramaximal dose of insulin was attenuated compared to time-
matched, saline-injected control values. Epitrochlearis muscles from 
12-hr bacteremic rats developed changes in glucose transport similar 
to those observed in soleus muscles. Subsequent experiments 
established that the responsiveness of glucose transport to insulin 
was attenuated yet the sensitivity of transport was not changed in the 
muscles from bacteremic rats. Changes similar to those observed in 
bacteremic rats were observed in soleus muscles removed from rats 
receiving endotoxin 5-hrs earlier, except the sensitivity of the 
transport process to insulin was enhanced. The in vitro studies 
presumably indicate inherent changes in skeletal muscle glucose 
transport. When sugar transport was measured in vivo basal transport 
was unaltered in soleus muscles from 12-hr bacteremic rats. Injection 
of a high dose of insulin to animals initially stimulated transport 
equally in soleus muscles of control and bacteremic rats. However, 
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later in the course of the in vivo experiment, insulin supported an 
"uphill" movement of glucose in control muscles but not in muscles 
from the 12-hr bacteremic rats. Thus, compensatory mechanisms appear 
to operate in vivo so that the inherent sugar transport changes (i.e. 
in vitro measurements) are not demonstrable in skeletal muscle glucose 
transport during bacteremia. The changes in transport observed in 
vitro indicate that there is impaired regulation of glucose transport 
in skeletal muscle. 
B. DETERMINATION OF CELLULAR ca2+ ALTERATIONS 
IN SOLEUS MUSCLES FROM BACTEREMIC RATS 
219 
The next study determined whether ca2+ regulation was altered 
in skeletal muscles from bacteremic rats. Cellular ca2+ uptake and 
steady state exchangeable Ca2+ were measured in soleus muscles from 
12-hr bacteremic and time-matched control rats using radiolabeled ca2+ 
(45ca2+). The exchangeable ca2+ content in muscles from bacteremic 
rats was not different from that in controls. However, the time 
required to reach 1/2 maximal ca2+ uptake was substantially reduced in 
soleus muscles from bacteremic rats compared to control values. These 
results suggest that net ca2+ movement was increased across the 
sarcolemmal membrane and/or intracellular organelles such as 
sarcoplasmic reticulum (SR) in muscles from bacteremic rats. 
Administration of the Ca2+-channel antagonist diltiazem to bacteremic 
animals reduced 45ca2+ uptake to control values in soleus muscles. 
This dose of diltiazem had a lesser effect on ca2+ uptake in time-
matched control muscles. In other experiments, high [K+] was added to 
the incubation media to depolarize soleus muscles and stimulate the 
release of SR ca2+ (307,395). This ca2+ release presumably is 
responsible for stimulation of 45ca2+ uptake (125,307,395), which was 
larger in muscles from bacteremic rats than controls. Together these 
results suggest that ca2+ movements are altered in soleus muscles from 
12-hr bacteremic rats. ca2+ movement through the voltage-sensitive 
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channel in the sarcolemma and handling of ca2+ by the SR appear to be 
affected in these muscles. 
C. MECHANISMS OF ALTERED BASAL AND INSULIN-STIMULATED 
3MG TRANSPORT IN BACTEREMIC RAT SOLEUS MUSCLES 
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In two subsequent studies, the hypothesis that altered Ca2+ 
regulation may lead to changes in glucose transport was assessed using 
ca2+_modifying agents. Experiments tested whether incubation of 
control muscles with these agents reproduced the increased basal and 
attenuated insulin-mediated glucose transport observed in skeletal 
muscles from 12-hr bacteremic rats. Skeletal muscles from bacteremic 
rats were also incubated with these agents to determine whether 
additional changes could be induced in these muscles. Agents used to 
modify cellular ca2+ regulation included varying extracellular [ca2+] 
([Ca2+] 0 ), ca2+ ionophores (A23187, ionomycin), 40 mM Na+ media, 
ryanodine, and the ca2+ agonist Bay K 8644. 
1) Effect of Ca2+-modifying agents on skeletal muscle 3MG 
transport. Increased [Ca2+] 0 had little effect on basal and insulin-
mediated glucose transport in skeletal muscles from control and 
bacteremic rats. Reduction of [Ca2+] 0 to 'nominal' levels increased 
basal and attenuated insulin-mediated 3MG transport in muscles from 
control rats; however there was only a slight effect on transport in 
skeletal muscles from bacteremic rats. These results suggested that 
reduction of [ca+] 0 below a certain range prevents the cell from 
regulating basal and insulin-mediated glucose transport. Addition of 
the ca2+ ionophore A23187 attenuated insulin-mediated 3MG transport 
but did not affect basal transport in control muscles. However, there 
222 
was increased basal glucose transport, along with the attenuated 
insulin-mediated transport in control muscles when (Ca2+J 0 was 
increased in the presence of A23187. This ionophore had no effect on 
basal or insulin-mediated 3MG transport in soleus muscles from 12-hr 
bacteremic rats. It would appear that a specific range of (Ca2+Ji is 
required for optimal regulation of basal and insulin-mediated 
transport. "When (Ca2+Ji is outside this range, basal and insulin-
mediated transport are not regulated and as a result, alterations 
occur in both basal and insulin-mediated sugar transport. 
The results obtained with ionomycin, 40 mM Na+0 , and ryanodine 
supported this (Ca2+Ji range hypothesis. Ionomycin produced 
comparable increases in basal and decreases in insulin-mediated 3MG 
transport in control and bacteremic rat muscles. Low [Na+) 0 or 
ryanodine produced effects similar to that of ionomycin and both 
treatments also increased 45ca2+ uptake in similarly treated control 
muscles. In the presence of 40 mM Na+, basal transport was higher in 
muscles from bacteremic rats compared to controls which indicated that 
additional loss of regulation may have occurred in bacteremic rat 
muscles. These experiments show that cellular ca2+ modifications can 
produce effects on skeletal muscle glucose transport that were 
qualitatively similar to those observed in bacteremia. However, in 
muscles from bacteremic rats there was a greater increase in basal 
along with a greater decrease in insulin-mediated transport with 
ionomycin or 40 mM Na+0 than that observed with bacteremia alone. 
Since the Ca2+-modifying agents exaggerated the glucose transport 
alterations in skeletal muscles from bacteremic rats, it appears that 
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they may not quantitatively represent the mechanism(s) responsible for 
the changes observed with bacteremia. 
2) Effect of ca2+ channel agonist on skeletal muscle 3MG 
transport. Muscles from control and bacteremic rats were incubated 
with the ca2+ agonist Bay K 8644 to determine whether increased 
movement of ca2+ through voltage-sensitive channels could produce 
altered glucose transport similar to that observed in bacteremia. The 
lowest [Bay K 8644) enhanced insulin-mediated 3MG transport but had no 
effect on basal transport in control muscles. Higher concentrations 
of Bay K 8644 produced an increase in basal glucose transport in 
control muscles and the higherst Bay K 8644 concentrations led to 
attenuated insulin-mediated transport in these muscles. The highest 
[Bay K 8644] produced changes in basal and insulin-mediated transport 
that were not different from values measured in bacteremic rat 
muscles. Bay K 8644 had no effect on basal or insulin-mediated 
glucose transport in muscles from bacteremic rats. It would appear 
that increased movement of ca2+ through voltage-mediated ca2+ channels 
led to the changes in basal and insulin-mediated glucose transport 
observed in earlier experiments with bacteremic rats. Muscles were 
incubated with ca2+_channel antagonists in the presence of Bay K 8644 
to ensure that the effects of Bay K 8644 were mediated through the 
Ca2+ channel. Indeed, Bay K 8644 effects did appear to be mediated 
via the ca2+ channel since both nifedipine and diltiazem prevented the 
increased basal and attenuated insulin-mediated glucose transport 
observed in the presence of Bay K 8644 alone. An unexpected finding 
of this study was that nifedipine alone appeared to have agonistic 
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properties since it increased skeletal muscle ca2+ uptake and altered 
glucose transport. 
3) Effect of ca2+ antagonist administered during bacterernia on 
skeletal muscle 3-0-rnethylglucose transport. The final set of 
experiments determined whether the ca2+ antagonist diltiazern could 
prevent the changes in basal and insulin-mediated glucose transport 
observed in soleus muscles from 12-hr bacterernic rats. Diltiazern 
added to the incubation media had no effect on basal or insulin-
mediated glucose transport in muscles from 12-hr bacteremic rats. 
When diltiazem was given to the rat at the same time as bacteria 
and/or 7.5 hr after bacteria, it was unable to prevent the increased 
basal and attenuated insulin-mediated 3MG transport in 12-hr 
bacteremic rats. However, diltiazem administered 10 hrs after 
bacterial injection restored basal and insulin-mediated glucose 
transport to control values in soleus muscles from 12-hr bacteremic 
rats. The effect of diltiazern was dose-dependent with the highest 
dose providing the greatest protection. This diltiazem concentration 
also prevented the altered skeletal muscle ca2+ regulation and 
attenuated the hyperlactacidemia present in 12-hr bacterernic rats. 
From this study, I concluded that alterations in ca2+ regulation 
during bacterernia produced the observed changes in glucose transport. 
When the altered ca2+ regulation was prevented in 12-hr bacteremic 
rats, changes did not develop in skeletal muscle glucose transport. 
CHAPTER IX 
EPILOGUE 
Figure 1 depicts the major findings and conclusions of this 
study along with possible events that lead to alterations in skeletal 
muscle ca2+ regulation and glucose transport. A variety of cells 
utilized for host defense are activated in response to sepsis, 
including macrophages, polymorphonuclear leukocytes (PMNs) and 
platelets (6,295,331). Bacteria in the circulation are recognized and 
digested by tissue macrophages (331). Endotoxin released from 
digested bacteria, as well as the bacteria themselves, stimulate the 
production and release of monokines (e.g. IL-1, TNFa, colony 
stimulating factor) from the macrophages (331). Monokines released 
into the circulation may directly or indirectly affect skeletal muscle 
ion permeability. Tracey et al. (385) showed that tumor necrosis 
factor (TNF) added to hindlimb perfusates could cause the 
depolarization of skeletal muscles which was previously observed in 
bacteremic animals (387). Depolarization occurs as a result of 
altered ion permeability and ca2+ movements could be affected also. 
These results suggest that monokines may directly affect cellular ion 
permeability. 
Alterations in the microcirculation also may contribute to the 
altered ca2+ regulation observed in the present study. Platelet 
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aggregation and PMN-derived chemotactic factors initiate blood 
coagulation (6,437) and eventually may reduce skeletal muscle blood 
flow and lead to tissue ischemia (349). Mediators released from PMNs 
as well as other leukocytes also may cause endothelial injury in 
skeletal muscle (6). The combination of ischemia and loss of 
endothelial integrity may impair the delivery of nutrients to skeletal 
muscle. Decreased nutrient delivery may lead to altered ionic 
regulation in skeletal muscle or affect neuro-humoral factors. 
Monokines or alterations in the microvasculature may also 
indirectly affect ion permeability by changing neural or hormonal 
influences on skeletal muscle. Increased levels of hormones which 
regulate metabolism are observed during infection (103,222) and some 
monokines have been shown to increase the release of insulin (434). 
Both insulin and glucose increase [ca2+Ji in adipocytes (117) and its 
possible that elevated insulin and glucose may alter ion permeability 
in muscle (156,344). Monokines also stimulate the release of 
epinephrine and norepinephrine (386), and ~-adrenergic stimulation of 
muscle enhances ca2+ influx via voltage-gated channels (9,100). In 
addition, monokines may alter neural input into skeletal muscle which 
also could alter ca2+ movements although currently there is no direct 
experimental evidence to support this hypothesis. Ischemia increases 
circulating levels of insulin and catecholamines (232,422), which have 
been shown to influence ca2+ movements (84,118). Ischemia also may 
affect neural input into the muscle. 
TNF or IL-1 do not appear to directly cause the alterations in 
glucose transport (258). Raymond et al. (324,327) indicated that 
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ischemia also did not appear to play a direct role in causing 
alterations in insulin-mediated glucose uptake. Instead, the results 
of the present study show that skeletal muscle carbohydrate metabolism 
is affected by alterations in cellular ca2+ regulation. The altered 
ca2+ regulation and attenuated insulin-mediated glucose transport in 
skeletal muscles from bacteremic rats supports the hypothesis recently 
proposed by Draznin et al. (118). They postulated that [Ca2+Ji within 
a specific range was required for optimal insulin-stimulation of 
glucose transport. In addition, it would appear that altered ca2+ 
regulation may produce increased basal glucose transport. Although 
increased glucose utilization is often viewed as a compensatory 
mechanism to meet energy demands (336), it may signal a diminished 
ability of the cell to regulate glucose transport and glucose 
metabolism. The importance of these alterations lies in the blunted 
insulin responsiveness because this indicates that there is a 
decreased capacity for the cell to stimulate glucose metabolism. 
Meanwhile, reduced lipid utilization occurs during bacteremia due to 
decreased lipoprotein lipase activity (12) and some investigators 
suggest that skeletal muscle may increase its reliance on 
carbohydrates to meet its energy demands (89,336). A decreased 
capacity to stimulate glucose transport coupled with increased 
reliance on glucose for energy may eventually lead to a compromise in 
the ability of skeletal muscle to meet energy demands via carbohydrate 
metabolism. The cell may resort to protein catabolism to meet energy 
demands (89,336). Reduced capacity of muscle to use carbohydrates 
along with increased protein catabolism may lead to muscle cell injury 
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and eventually to the muscle wasting characteristic 0 £ chronic sepsis 
in humans (89,336). 
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